AGENDA (REGULAR AND CONSENT)
HOSPITAL AUTHORITY BOARD OF TRUSTEES AND UNIVERSITY BOARD OF TRUSTEES
December 11, 2020 MEDICAL UNIVERSITY HOSPITAL AUTHORITY (MUHA) BOARD OF TRUSTEES REGULAR AGENDA December 11, 2020 101 Colcock Hall/Via Teleconference
Members of the Board of Trustees
Dr. James Lemon, Chairman Dr. Richard M. Christian, Jr. Mr. Charles Schulze, Vice‐Chairman Dr. Paul T. Davis Ms. Terri R. Barnes Dr. Donald R. Johnson II The Honorable James A. Battle, Jr. Ms. Barbara Johnson‐Williams Mr. William H. Bingham, Sr. Dr. G. Murrell Smith, Sr. Dr. W. Melvin Brown III Mr. Michael E. Stavrinakis Dr. Henry F. Butehorn III Thomas L. Stephenson, Esq. Dr. C. Guy Castles III Dr. Bartlett J. Witherspoon
Trustees Emeriti
Ms. Margaret M. Addison Dr. Charles B. Thomas, Jr. Mr. Allan E. Stalvey Dr. James E. Wiseman, Jr.
Item 1. Call to Order ...... Dr. James Lemon Chairman
Item 2. Roll Call ...... Jane Scutt Assistant Board Secretary
Item 3. Date of Next Meeting – February 12, 2021 ...... Jane Scutt Assistant Board Secretary
Item 4. Approval of Meeting Minutes of October 9, 2020 ...... Dr. James Lemon Chairman
Recommendations and Informational Report of the President: Dr. David Cole
Item 5. General Informational Report of the President ...... Dr. David Cole President
Item 6. Other Business ...... Dr. David Cole President
Authority Operations, Quality and Finance Committee: Dr. Murrell Smith, Chair
Item 7. MUHA Status Report ...... Dr. Patrick Cawley Chief Executive Officer, MUSC Health
Item 8. Request for Certificate of Need (CON) ...... Dr. Patrick Cawley Chief Executive Officer, MUSC Health
Approval is requested for the Medical University Hospital Authority to apply for a Certificate of Need Application for an outpatient vascular lab to be located in Charleston County.
Item 9. MUHA Financial Report ...... Lisa Goodlett Chief Financial Officer, MUSC Health
Item 10. Capital Reprioritization Request ...... Lisa Goodlett Chief Financial Officer, MUSC Health
Item 11. Legislative Update ...... Mark Sweatman Chief, Government Relations
Item 12. MUSC Physicians Update ...... Dr. Dirk Elston President, MUSC Physicians
Item 13. Other Committee Business ...... Dr. Murrell Smith Committee Chair
MUHA and MUSC Physical Facilities Committee: Mr. Bill Bingham, Chair
Item 14. Major Projects Status Update ...... Tom Crawford Chief Operating Officer, MUSC Health
Item 15. MUHA Project Charleston Public Works Easement for Approval ...... Brad Taylor Chief Facilities Officer, MUSC
Item 16. MUSC Ehrhardt Street Tunnel Easement for Approval ...... Brad Taylor Chief Facilities Officer, MUSC
Item 17. Water Mitigation Planning (Part 2) ...... Lisa Montgomery, EVP for Finance & Operations Brad Taylor, Chief Facilities Officer, MUSC
Item 18. Other Committee Business ...... Bill Bingham Committee Chair
MUHA and MUSC Audit Committee: Mr. Tom Stephenson, Chair
Item 19. KPMG Exit Conference ...... Jennifer Hall Senior Partner, KPMG
Item 20. Strategic Risk Management Update ...... Reece Smith Director, Strategic Risk Management
Item 21. Report of the Office of Internal Audit ...... Susan Barnhart Director, Internal Audit
Item 22. Other Committee Business ...... Tom Stephenson Committee Chair
Other Business for the Board of Trustees: Dr. James Lemon, Chair
Item 23. Approval of Consent Agenda ...... Dr. James Lemon Chairman
Item 24. Executive Session ...... Dr. James Lemon Chairman
Upon proper motion and vote, the Board may convene a closed session pursuant to SC Code Ann. §30‐4‐70. Although the Board will not vote on any items discussed in closed session, the Board may return to public session to vote on items discussed.
Item 25. New Business for the Board of Trustees ...... Dr. James Lemon Chairman
Item 26. Report from the Chairman ...... Dr. James Lemon Chairman MUSC Health (excluding MUSCP) Interim Financial Statements October 31, 2020
Medical University Hospital Authority (MUHA) Statement of Revenues, Expenses and Changes in Net Assets Consolidated – All Markets 2 Charleston Market 3 - 6 - MUSC Shawn Jenkins Children's Hospital and Pearl Tourville Women's Pavilion Florence Market 7- 9 Lancaster Market 10 – 12
Statements of Net Position Consolidated – All Markets 14 Charleston Market 15 Management Comments - Charleston Market 16 Regional Health Network (RHN) Markets 17 Management Comments - RHN 18
MUHA FASB to GASB Report Consolidated – All Markets 20
MUSC Strategic Ventures (MSV and MHI, INC) Statement of Revenues, Expenses and Changes in Net Assets 22 - 24 Statement of Net Position 25 - 26
Mainsail Health Partners (Mainsail & Spinnaker) Statement of Revenues, Expenses and Changes in Net Assets 28 - 29 Statement of Net Position 30 - 31
Note:
1) During March 2020, MUSC Health went into emergency command structure in response to COVID19. MUHA has recognized CARES stimulus funding in FY2020 and FY2021 as non-operating revenue per GASB guidance.
2) In FY2018, the internal financial statement format was changed to a FASB basis report to appropriately match the income stream of state appropriations and expenses incurred in addition to a presentation format that matches HUD and the credit market expectations.
Unaudited – For Management Use Medical University Hospital Authority - Consolidated Statement of Revenues, Expenses and Change in Net Position For the 4 Month Period Ending - October 31, 2020 Modified FASB Basis
Current Month Fiscal Year To Date Actual Flex Budget Variance Var % Fixed Budget Actual Flex Budget Variance Var % Fixed Budget Operating Revenues: Net Patient Service Revenue $ 160,387,278 $ 165,317,711 $ (4,930,433) -2.98% $ 171,565,509 $ 624,180,949 $ 631,037,076 $ (6,856,127) -1.09% $ 652,736,521 DSH 4,299,450 4,260,734 38,716 0.91% 4,260,734 17,195,090 17,042,935 152,155 0.89% 17,042,935 Retail Pharmacy Revenue 20,718,512 21,073,171 (354,660) -1.68% 17,298,468 78,717,781 81,712,339 (2,994,558) -3.66% 68,179,990 Other Revenue 9,395,955 9,550,939 (154,984) -1.62% 9,550,939 38,062,233 32,892,758 5,169,475 15.72% 32,892,758 State Appropriations (18,051,246) 2,348,754 (20,400,000) -868.55% 2,348,754 9,145,018 9,395,018 (250,000) -2.66% 9,395,018 Total Operating Revenues $ 176,749,949 $ 202,551,309 $ (25,801,361) -12.74% $ 205,024,405 $ 767,301,071 $ 772,080,126 $ (4,779,055) -0.62% $ 780,247,222
Operating Expenses: Salaries Wages $ 53,066,850 54,937,476 (1,870,626) -3.41% 54,374,597 212,458,527 209,092,360 3,366,167 1.61% 212,417,001 Benefits 19,869,995 20,962,580 (1,092,585) -5.21% 20,668,320 80,492,220 79,976,298 515,921 0.65% 81,004,000 Pension Expense 5,297,401 5,300,157 (2,755) -0.05% 5,300,157 21,189,605 21,188,645 961 0.00% 21,188,645 Other Post Employment Benefits 1,629,659 1,629,659 - 0.00% 1,629,659 6,518,629 6,518,629 - 0.00% 6,518,629 Purchased Services 26,503,934 28,795,272 (2,291,338) -7.96% 28,762,051 105,741,914 107,910,045 (2,168,131) -2.01% 107,967,027 Physician Services 11,557,100 13,552,521 (1,995,420) -14.72% 13,552,521 47,264,486 51,259,825 (3,995,339) -7.79% 51,259,825 Pharmaceuticals 15,133,392 13,298,956 1,834,436 13.79% 12,457,571 58,916,673 45,264,933 13,651,740 30.16% 44,987,780 Retail Pharmaceuticals 9,678,163 7,582,141 2,096,021 27.64% 6,383,862 36,165,202 26,250,197 9,915,006 37.77% 22,583,507 Medical Supplies 27,193,284 23,577,524 3,615,761 15.34% 25,141,193 98,990,282 114,084,674 (15,094,392) -13.23% 115,073,272 COVID-19 Supplies 1,201,925 - 1,201,925 0.00% - 14,242,333 - 14,242,333 0.00% - Other Supplies 4,255,624 5,084,649 (829,026) -16.30% 5,064,747 17,378,726 19,462,099 (2,083,373) -10.70% 19,798,561 Utilities 1,777,146 1,951,201 (174,054) -8.92% 1,951,201 8,152,617 8,230,262 (77,645) -0.94% 8,230,262 Insurance 173,356 687,018 (513,661) -74.77% 687,018 2,412,053 2,309,726 102,327 4.43% 2,309,726 Leases 2,952,677 3,246,327 (293,650) -9.05% 3,246,327 11,220,867 13,447,629 (2,226,762) -16.56% 13,447,629 Other 1,962,504 2,582,463 (619,959) -24.01% 2,582,463 8,248,698 9,256,731 (1,008,032) -10.89% 9,256,731 Physician Clinic Expense 2,879,661 1,999,941 879,720 43.99% 1,999,941 9,096,513 7,866,617 1,229,896 15.63% 7,866,617 Total Operating Expenses $ 185,132,673 $ 185,187,884 $ (55,211) -0.03% $ 183,801,627 $ 738,489,346 $ 722,118,669 $ 16,370,677 2.27% $ 723,909,211
EBIDA (8,382,724) 17,363,425 (25,746,150) -148.28% 21,222,777 28,811,725 49,961,457 (21,149,732) -42.33% 56,338,011
Depreciation 9,565,406 9,087,014 478,392 5.26% 9,087,014 35,488,478 33,253,338 2,235,140 6.72% 33,253,338 Interest 3,164,443 3,348,656 (184,212) -5.50% 3,348,656 13,762,087 14,101,303 (339,216) -2.41% 14,101,303
Operating Income (Loss) $ (21,112,573) $ 4,927,756 $ (26,040,329) -528.44% $ 8,787,108 $ (20,438,840) $ 2,606,816 $ (23,045,656) -884.05% $ 8,983,370
Operating Margin -11.94% 2.43% 0.00% 4.29% -2.66% 0.34% 0.00% 1.15%
NonOperating Revenues (Expenses): Gifts and Grants - 1,256,393 (1,256,393) -100.00% 1,256,393 529,880 2,712,695 (2,182,815) -80.47% 2,712,695 Investment Income (502,517) 534,820 (1,037,336) -193.96% 534,820 (49,146) 2,536,020 (2,585,166) -101.94% 2,536,020 Loss on Disposal of Capital Assets (31,127) (268,513) 237,386 -88.41% (268,513) (31,127) (268,513) 237,386 -88.41% (268,513) COVID 22,374,220 - 22,374,220 0.00% - 38,685,767 - 38,685,767 0.00% - Other NonOperating Expenses - 1,722 (1,722) -100.00% 1,722 (346) 6,886 (7,232) -105.02% 6,886 Debt Issuance Costs - - - 0.00% - - - - 0.00% - Total NonOperating Revenues (Expenses) $ 21,840,576 $ 1,524,421 $ 20,316,155 1332.71% $ 1,524,421 $ 39,135,029 $ 4,987,088 $ 34,147,941 684.73% $ 4,987,088
Income (Loss) Before NonOperating Payments to MUSC Affiliates 728,003 6,452,177 (5,724,174) -88.72% 10,311,529 18,696,189 7,593,904 11,102,285 146.20% 13,970,458
Non Operating Payments to MUSC Affiliates 7,770,145 (3,913,565) 11,683,710 -298.54% (3,913,565) (1,963,642) (15,654,261) 13,690,619 -87.46% (15,654,261)
Change in Net Position $ 8,498,148 $ 2,538,612 $ 5,959,536 234.76% $ 6,397,964 $ 16,732,547 $ (8,060,357) $ 24,792,904 -307.59% $ (1,683,803)
Total Margin 4.81% 1.25% 3.12% 2.18% -1.04% -0.22%
Unaudited - For Management Use 2 Medical University Hospital Authority - Charleston Market Statement of Revenues, Expenses and Change in Net Position For the 4 Month Period Ending - October 31, 2020 Modified FASB Basis
Current Month Fiscal Year To Date Actual Flex Budget Variance Var % Fixed Budget Actual Flex Budget Variance Var % Fixed Budget Operating Revenues: Net Patient Service Revenue $ 130,092,650 $ 133,324,279 $ (3,231,628) -2.42% $ 140,165,070 $ 502,927,671 $ 510,411,742 $ (7,484,071) -1.47% $ 528,926,125 DSH 3,327,496 3,327,496 - 0.00% 3,327,496 13,309,983 13,309,983 - 0.00% 13,309,983 Retail Pharmacy Revenue 20,718,512 21,073,171 (354,660) -1.68% 17,298,468 78,717,781 81,712,339 (2,994,558) -3.66% 68,179,990 Other Revenue 8,241,245 7,924,813 316,432 3.99% 7,924,813 33,403,558 26,553,739 6,849,818 25.80% 26,553,739 State Appropriations (16,073,246) 2,348,754 (18,422,000) -784.33% 2,348,754 9,145,018 9,395,018 (250,000) -2.66% 9,395,018 Total Operating Revenues $ 146,306,657 $ 167,998,513 $ (21,691,856) -12.91% $ 171,064,601 $ 637,504,011 $ 641,382,822 $ (3,878,811) -0.60% $ 646,364,855
Operating Expenses: Salaries Wages $ 42,285,068 43,320,462 (1,035,395) -2.39% 43,309,746 170,169,815 167,051,894 3,117,921 1.87% 169,586,669 Benefits 15,821,097 16,535,522 (714,425) -4.32% 16,449,483 64,476,992 63,797,970 679,022 1.06% 64,565,113 Pension Expense 4,426,667 4,426,667 - 0.00% 4,426,667 17,706,667 17,706,667 - 0.00% 17,706,667 Other Post Employment Benefits 1,358,333 1,358,333 - 0.00% 1,358,333 5,433,333 5,433,333 - 0.00% 5,433,333 Purchased Services 22,118,504 25,175,717 (3,057,213) -12.14% 25,139,792 90,567,931 93,791,555 (3,223,623) -3.44% 93,830,174 Physician Services 10,828,765 12,089,800 (1,261,035) -10.43% 12,089,800 41,674,946 43,962,329 (2,287,383) -5.20% 43,962,329 Pharmaceuticals 13,517,668 11,256,484 2,261,184 20.09% 10,673,940 52,228,999 36,921,839 15,307,160 41.46% 38,099,478 Retail Pharmaceuticals 9,678,163 7,582,141 2,096,021 27.64% 6,383,862 36,165,202 26,250,197 9,915,006 37.77% 22,583,507 Medical Supplies 23,388,312 20,072,181 3,316,131 16.52% 21,643,632 83,060,376 100,986,224 (17,925,848) -17.75% 101,207,313 COIVD-19 Supplies 1,201,925 - 1,201,925 0.00% - 14,242,333 - 14,242,333 0.00% - Other Supplies 3,550,904 4,269,676 (718,772) -16.83% 4,218,354 14,582,428 16,276,224 (1,693,796) -10.41% 16,367,473 Utilities 1,327,780 1,401,627 (73,847) -5.27% 1,401,627 5,921,244 5,897,814 23,430 0.40% 5,897,814 Insurance 26,907 498,137 (471,230) -94.60% 498,137 1,822,171 1,559,561 262,610 16.84% 1,559,561 Leases 2,397,966 2,693,188 (295,222) -10.96% 2,693,188 9,363,061 11,291,513 (1,928,453) -17.08% 11,291,513 Other 1,238,148 1,697,812 (459,664) -27.07% 1,697,812 5,313,730 5,817,976 (504,246) -8.67% 5,817,976 Total Operating Expenses $ 153,166,206 $ 152,377,748 $ 788,458 0.52% $ 151,984,372 $ 612,729,230 $ 596,745,096 $ 15,984,134 2.68% $ 597,908,920
EBIDA (6,859,549) 15,620,766 (22,480,315) -143.91% 19,080,229 24,774,781 44,637,726 (19,862,945) -44.50% 48,455,936
Depreciation 8,192,209 8,348,687 (156,478) -1.87% 8,348,687 30,820,998 30,300,033 520,965 1.72% 30,300,033 Interest 2,529,462 2,660,450 (130,988) -4.92% 2,660,450 10,738,765 10,621,763 117,002 1.10% 10,621,763
Operating Income (Loss) $ (17,581,220) $ 4,611,628 $ (22,192,848) -481.24% $ 8,071,092 $ (16,784,982) $ 3,715,930 $ (20,500,912) -551.70% $ 7,534,140
Operating Margin -12.02% 2.75% 0.00% 4.72% -2.63% 0.58% 0.00% 1.17%
NonOperating Revenues (Expenses): Gifts and Grants - 1,256,393 (1,256,393) -100.00% 1,256,393 529,880 2,712,695 (2,182,815) -80.47% 2,712,695 Investment Income (503,895) 501,567 (1,005,462) -200.46% 501,567 (54,748) 2,403,010 (2,457,758) -102.28% 2,403,010 Loss on Disposal of Capital Assets (31,127) (268,513) 237,386 -88.41% (268,513) (31,127) (268,513) 237,386 -88.41% (268,513) COVID 20,268,261 - 20,268,261 0.00% - 20,268,261 - 20,268,261 0.00% - Other NonOperating Expenses - - - 0.00% - - - - 0.00% - Debt Issuance Costs - - - 0.00% - - - - 0.00% - Total NonOperating Revenues (Expenses) $ 19,733,240 $ 1,489,447 $ 18,243,792 1224.87% $ 1,489,447 $ 20,712,267 $ 4,847,192 $ 15,865,075 327.30% $ 4,847,192
Income (Loss) Before NonOperating Payments to MUSC Affiliates 2,152,020 6,101,076 (3,949,056) -64.73% 9,560,539 3,927,284 8,563,122 (4,635,838) -54.14% 12,381,332
Non Operating Payments to MUSC Affiliates 7,770,145 (3,913,565) 11,683,710 -298.54% (3,913,565) (1,963,642) (15,654,261) 13,690,619 -87.46% (15,654,261)
Change in Net Position $ 9,922,165 $ 2,187,510 $ 7,734,654 353.58% $ 5,646,974 $ 1,963,642 $ (7,091,140) $ 9,054,782 -127.69% $ (3,272,929)
Total Margin 6.78% 1.30% 3.30% 0.31% -1.11%
Unaudited - For Management Use 3 Medical University Hospital Authority - MUSC Shawn Jenkins Hospital and Pearl Tourville Women's Pavilion Statement of Revenues, Expenses and Change in Net Position For the 4 Month Period Ending - October 31, 2020 Modified FASB Basis
Current Month Fiscal Year To Date Actual Flex Budget Variance Var % Fixed Budget Actual Flex Budget Variance Var % Fixed Budget Operating Revenues: Net Patient Service Revenue $ 15,487,292 $ 15,011,789 $ 475,504 3.17% $ 15,208,975 $ 56,178,040 $ 48,540,308 $ 7,637,732 15.73% $ 54,719,253 Retail Pharmacy Revenue 752,862 719,295 33,567 4.67% 398,068 2,750,101 1,939,780 810,321 41.77% 1,618,553 Other Revenue 195,505 131,370 64,135 48.82% 131,370 508,691 584,461 (75,770) -12.96% 584,461 Total Operating Revenues $ 16,435,659 $ 15,862,454 $ 573,205 3.61% $ 15,738,414 $ 59,436,832 $ 51,064,549 $ 8,372,283 16.40% $ 56,922,267
Operating Expenses: Salaries Wages $ 6,479,174 6,124,593 354,581 5.79% 6,461,680 26,714,439 24,242,009 2,472,430 10.20% 25,584,097 Benefits 2,416,442 2,159,948 256,494 11.87% 2,205,741 9,922,149 8,479,066 1,443,083 17.02% 8,726,312 Purchased Services 9,881,107 9,457,465 423,642 4.48% 9,532,980 38,538,770 44,585,008 (6,046,238) -13.56% 37,455,964 Physician Services 1,087,411 599,463 487,947 81.40% 599,463 4,321,754 2,397,835 1,923,920 80.24% 2,397,835 Pharmaceuticals 548,438 1,001,282 (452,844) -45.23% 1,014,328 2,589,076 3,653,988 (1,064,912) -29.14% 3,983,688 Retail Pharmaceuticals 586,528 255,236 331,293 129.80% 142,622 1,849,242 955,411 893,831 93.55% 570,490 Medical Supplies 1,825,331 1,383,580 441,751 31.93% 1,350,944 8,424,322 5,410,465 3,013,857 55.70% 5,299,864 Other Supplies 568,449 328,366 240,083 73.11% 322,577 1,997,965 1,329,930 668,035 50.23% 1,346,378 Utilities 27,434 195,856 (168,422) -85.99% 195,856 87,892 783,443 (695,550) -88.78% 783,443 Insurance 32 - 32 0.00% - 32 - 32 0.00% - Leases 22,604 42,346 (19,742) -46.62% 42,346 109,090 169,537 (60,447) -35.65% 169,537 Other 1,208 62,155 (60,947) -98.06% 62,155 167,931 167,737 194 0.12% 167,737 Total Operating Expenses $ 23,444,160 $ 21,610,290 $ 1,833,869 8.49% $ 21,930,692 $ 94,722,663 $ 92,174,428 $ 2,548,235 2.76% $ 86,485,344
EBIDA (7,008,500) (5,747,836) (1,260,664) 21.93% (6,192,279) (35,285,831) (41,109,879) 5,824,048 -14.17% (29,563,077)
Depreciation 2,369,197 2,369,197 - 0.00% 2,369,197 8,818,447 8,818,447 - 0.00% 8,818,447 Interest 750,974 750,974 - 0.00% 750,974 4,325,223 4,325,223 - 0.00% 4,325,223
Operating Income (Loss) $ (10,128,671) $ (8,868,007) $ (1,260,664) 14.22% $ (9,312,449) $ (48,429,501) $ (54,253,549) $ 5,824,048 -10.73% $ (42,706,747)
Operating Margin -61.63% -55.91% 0.00% -59.17% -81.48% -106.25% 0.00% -75.03%
NonOperating Revenues (Expenses): Gifts and Grants - - - 0.00% - - - - 0.00% - Investment Income - - - 0.00% - - - - 0.00% - Loss on Disposal of Capital Assets - - - 0.00% - - - - 0.00% - COVID - - - 0.00% - - - - 0.00% - Other NonOperating Expenses - - - 0.00% - - - - 0.00% - Debt Issuance Costs - - - 0.00% - - - - 0.00% - Total NonOperating Revenues (Expenses) $ - $ - $ - 0.00% $ - $ - $ - $ - 0.00% $ -
Income (Loss) Before NonOperating Payments to MUSC Affiliates (10,128,671) (8,868,007) (1,260,664) 14.22% (9,312,449) (48,429,501) (54,253,549) 5,824,048 -10.73% (42,706,747)
Non Operating Payments to MUSC Affiliates - - - 0.00% - - - - 0.00% -
Change in Net Position $ (10,128,671) $ (8,868,007) $ (1,260,664) 14.22% $ (9,312,449) $ (48,429,501) $ (54,253,549) $ 5,824,048 -10.73% $ (42,706,747)
Total Margin -61.63% -55.91% -59.17% -81.48% -106.25%
Unaudited - For Management Use 4 MEDICAL UNIVERSITY HOSPITAL AUTHORITY – Charleston Market Notes to the Interim Financial Statements
Statement of Revenues, Expenses and Changes in Net Assets: YTD October 31, 2020 (Unaudited) and June 30, 2020 (Audited) Actuals Compared to Fixed Budget
The Authority’s October 2020 operating income was under budget by $24,319,119 on a modified FASB basis. The rollforward comparison below displays the major drivers of this favorable variance.
Fixed Budget Actual YTD October 2020 YTD October 2020
Operating Income (Loss) $ 7,534,139 $ (16,784,980)
Revenue $8.9 million total unfavorable variance Favorable (Unfavorable) Adjusted Discharges $ (35,431,273) Inpatient Surgeries (16,318,070) Outpatient Surgeries (5,046,813) Transplant Procedures 9,995,019 Case Mix Index 2.03 20,489,882 2.20 Retail Pharmacy 10,537,791 Other Revenue 6,599,819
Expenses $15.5 million total unfavorable variance (Favorable) Unfavorable FTE/AOB CMI FTE/AOB CMI FTE per AOB CMI Adjusted 3.19 $ (26,586,591) 2.55 Salaries and Benefits rate variance 27,081,616 Medical Supplies and Other Supplies (explained by volume) (5,779,186) Medical Supplies and Other Supplies (not explained by volume) (14,152,795) COVID Supplies 14,242,333 Pharmaceuticals (explained by volume) (1,526,523) Pharmaceuticals (not explained by volume) 15,656,044 Retail Pharmaceuticals 13,581,695 Physician Services (2,287,383) Purchased Services (3,262,243) Depreciation 520,965 Interest 117,002 Utilities, Insurance, Leases (2,146,658)
Revenue Explanation: October year-to-date adjusted discharges were below budget by 4.1%. Inpatient surgeries, outpatient surgeries, transplant procedures, and Case Mix Index were over (under) budget by (4.2%), (10.0%), 38.0%, and 8.3%, respectively. Retail pharmacy revenues are favorable by $10.5M. Other Revenues are above budget mainly due to accrual of additional COVID funding of $5.4M, $1.8M in State Appropriations for Ebola research and $1.3M in 340B revenue. Charity care and bad debt expenses were $10.6M favorable to budget.
Unaudited – For Management Use 5 MEDICAL UNIVERSITY HOSPITAL AUTHORITY – Charleston Market Notes to the Interim Financial Statements
Expense Explanation: FTE per Adjusted Occupied Bed – Case Mix Adjusted was favorable to budget by 19.9%, which equates to 815 FTEs less or $26.6M. Accordingly, the salary rate variance is negatively impacted by $27.1M.
Medical Supplies and Other Supplies, not explained by volume, were $14.2M under budget year-to-date, mainly due to a a larger portion of COVID supplies being purchased in the 4Q of 2020.
Pharmaceuticals, not explained by volume, are over budget by $15.7M for the year, mainly due to continuing growth in retail pharmacy. Retail pharmacy revenues, net of expenses, were unfavorable by $3.0M on a year-to-date basis.
Physician Services were under budget $1.3M for the month mainly due to the timing of expenses related to the College of Medicine and under budget $2.3M on a year-to-date basis.
Insurance is over-budget year-to-date by $0.3M, while Leases and Other were favorable by $2.4M mainly due to leased properties at Rutledge Tower and Parkshore and employee travel expenses being lower than budgeted.
Unaudited – For Management Use 6 Medical University Hospital Authority - Florence Market Statement of Revenues, Expenses and Change in Net Position For the 4 Month Period Ending - October 31, 2020 Modified FASB Basis
Current Month Fiscal Year To Date Actual Flex Budget Variance Var % Fixed Budget Actual Flex Budget Variance Var % Fixed Budget Operating Revenues: Net Patient Service Revenue $ 21,596,999 $ 21,488,141 $ 108,857 0.51% $ 21,297,435 $ 85,249,638 $ 81,384,157 $ 3,865,481 4.75% $ 81,346,132 DSH 567,598 536,009 31,589 5.89% 536,009 2,311,971 2,144,036 167,935 7.83% 2,144,036 Other Revenue 459,785 913,290 (453,504) -49.66% 913,290 2,250,459 3,653,158 (1,402,699) -38.40% 3,653,158 State Appropriations (1,234,000) - (1,234,000) 0.00% - - - - 0.00% - Total Operating Revenues $ 21,390,382 $ 22,937,440 $ (1,547,058) -6.74% $ 22,746,734 $ 89,812,069 $ 87,181,351 $ 2,630,718 3.02% $ 87,143,326
Operating Expenses: Salaries Wages $ 6,988,866 7,102,930 (114,065) -1.61% 7,219,330 27,921,605 26,518,322 1,403,283 5.29% 27,506,539 Benefits 2,651,945 2,686,604 (34,659) -1.29% 2,728,376 10,508,999 10,126,353 382,645 3.78% 10,501,468 Pension Expense 520,000 520,000 - 0.00% 520,000 2,080,000 2,080,000 - 0.00% 2,080,000 Other Post Employment Benefits 162,826 162,826 - 0.00% 162,826 651,296 651,296 - 0.00% 651,296 Purchased Services 2,622,812 2,530,778 92,034 3.64% 2,533,261 9,605,942 9,764,986 (159,044) -1.63% 9,783,040 Physician Services 780,428 923,177 (142,749) -15.46% 923,177 3,111,831 3,546,695 (434,864) -12.26% 3,546,695 Pharmaceuticals 1,316,611 1,799,400 (482,790) -26.83% 1,535,066 5,515,250 7,351,309 (1,836,059) -24.98% 5,898,729 Medical Supplies 2,654,395 2,345,418 308,977 13.17% 2,426,354 11,659,268 8,714,848 2,944,419 33.79% 9,274,793 Other Supplies 597,079 676,558 (79,480) -11.75% 695,619 2,315,808 2,550,179 (234,371) -9.19% 2,675,872 Utilities 265,593 363,816 (98,223) -27.00% 363,816 1,340,384 1,589,415 (249,032) -15.67% 1,589,415 Insurance 95,650 98,190 (2,541) -2.59% 98,190 407,477 387,403 20,074 5.18% 387,403 Leases 346,433 330,712 15,721 4.75% 330,712 1,208,543 1,267,663 (59,120) -4.66% 1,267,663 Other 483,611 605,136 (121,525) -20.08% 605,136 1,937,334 2,320,695 (383,361) -16.52% 2,320,695 Physician Clinic Expense 1,925,710 1,464,594 461,116 31.48% 1,464,594 5,775,617 5,725,230 50,387 0.88% 5,725,230 Total Operating Expenses $ 21,411,957 $ 21,610,140 $ (198,183) -0.92% $ 21,606,458 $ 84,039,354 $ 82,594,395 $ 1,444,959 1.75% $ 83,208,838
EBIDA (21,575) 1,327,300 (1,348,875) -101.63% 1,140,276 5,772,715 4,586,956 1,185,758 25.85% 3,934,487
Depreciation 928,004 438,215 489,789 111.77% 438,215 2,886,744 1,752,861 1,133,883 64.69% 1,752,861 Interest 473,952 505,909 (31,957) -6.32% 505,909 2,245,044 2,478,842 (233,798) -9.43% 2,478,842
Operating Income (Loss) $ (1,423,531) $ 383,176 $ (1,806,707) -471.51% $ 196,152 $ 640,927 $ 355,253 $ 285,674 80.41% $ (297,216)
Operating Margin -6.66% 1.67% 0.00% 0.86% 0.71% 0.41% 0.00% -0.34%
NonOperating Revenues (Expenses): Gifts and Grants - - - 0.00% - - - - 0.00% - Investment Income 993 - 993 0.00% - 4,035 - 4,035 0.00% - Loss on Disposal of Capital Assets - - - 0.00% - - - - 0.00% - COVID 1,287,037 - 1,287,037 0.00% - 4,835,105 - 4,835,105 0.00% - Other NonOperating Expenses - - - 0.00% - - - - 0.00% - Debt Issuance Costs - - - 0.00% - - - - 0.00% - Total NonOperating Revenues (Expenses) $ 1,288,029 $ - $ 1,288,029 0.00% $ - $ 4,839,140 $ - $ 4,839,140 0.00% $ -
Income (Loss) Before NonOperating Payments to MUSC Affiliates (135,502) 383,176 (518,678) -135.36% 196,152 5,480,067 355,253 5,124,814 1442.58% (297,216)
Non Operating Payments to MUSC Affiliates - - - 0.00% - - - - 0.00% -
Change in Net Position $ (135,502) $ 383,176 $ (518,678) -135.36% $ 196,152 $ 5,480,067 $ 355,253 $ 5,124,814 1442.58% $ (297,216)
Total Margin -0.63% 1.67% 0.86% 6.10% 0.41%
Unaudited - For Management Use 7 Medical University Hospital Authority - Florence Market Notes to the Interim Financial Statements Statement of Revenues, Expenses and Changes in Net Assets: YTD October 31, 2020 (Unaudited) Actuals Compared to Fixed Budget The Florence Division YTD October 2020 operating income was above budget by $938,141 on a FASB basis. The rollforward comparison below displays the major drivers of this variance.
Fixed Budget Actual YTD October 2020 YTD October 2020
Operating Income (Loss) $ (297,215) $ 640,927
Revenue $2.7 million total favorable variance Favorable (Unfavorable) Adjusted Discharges $ 3,177,694 Inpatient Surgeries (1,061,724) Outpatient Surgeries (1,629,012) Case Mix Index 1.51 3,584,483 1.62 Other Revenue (1,402,699)
Expenses $1.7 million total unfavorable variance (Favorable) Unfavorable FTE/AOB CMI FTE/AOB CMI FTE per AOB CMI Adjusted 1.69 $ 1,449,297 1.81 Salaries and Benefits rate variance (1,026,701) Medical Supplies and Other Supplies (explained by volume) 573,469 Medical Supplies and Other Supplies (not explained by volume) 1,450,942 Pharmaceuticals (explained by volume) (852,230) Pharmaceuticals (not explained by volume) 468,751 Physician Services (including MUSCP) (384,477) Purchased Services (177,098) Depreciation 1,133,883 Interest (233,798) Utilities, Insurance, Leases (671,438)
Revenue Explanation: October year-to-date net patient service revenue was favorable to budget by 4.80% driven by a higher acute patient population. Discharges were unfavorable by 72, Inpatient Surgeries were unfavorable by 103, and Outpatient Surgeries were unfavorable by 473. Other revenues were unfavorable to budget by $1.4M, primarily driven by 340B revenues.
Unaudited – For Management Use 8 Medical University Hospital Authority - Florence Market Notes to the Interim Financial Statements continued
Expense Explanation: FTE per AOB CMI adjusted was unfavorable. FTE’s for the Florence and Marion hospitals were above budget on a year-to-date basis. There was a wage rate variance due to overtime and incentive pay increasing the amount paid to be higher than expected.
Benefits are higher than expected however appropriate for the Salary Expense.
Pharmaceuticals were $383K favorable for the division, primarily due to the Contracted 340B reduced volume. Year- to-date 340B program savings were $1.1M.
Medical and Other supplies were $2.0M unfavorable year to date as contract pricing efforts continue on a monthly basis.
Physician clinic expenses from MUSCP were unfavorable to budget by $50K.
Purchased Services expenses were favorable to budget by $178K, multiple departments with favorable variances with Information Systems being the most favorable to budget.
Hospital based services were favorable to budget by $434K, primarily due to the thrombectomy project timing.
Leases were favorable by $59K primarily at Florence due to reduced rentals of patient beds, various biomed equipment, and the Omnicell conversion. Other expenses were favorable by $383K mainly due to hospital tax and placement fees.
Unaudited – For Management Use 9 Medical University Hospital Authority - Lancaster Market (including Edgewater Surgery Center) Statement of Revenues, Expenses and Change in Net Position For the 4 Month Period Ending - October 31, 2020 Modified FASB Basis
Current Month Fiscal Year To Date Actual Flex Budget Variance Var % Fixed Budget Actual Flex Budget Variance Var % Fixed Budget Operating Revenues: Net Patient Service Revenue $ 8,697,629 $ 10,505,291 $ (1,807,662) -17.21% $ 10,103,004 $ 36,003,640 $ 39,241,177 $ (3,237,537) -8.25% $ 42,464,265 DSH 404,356 397,229 7,127 1.79% 397,229 1,573,136 1,588,916 (15,780) -0.99% 1,588,916 Other Revenue 694,925 712,836 (17,912) -2.51% 712,836 2,408,216 2,685,861 (277,645) -10.34% 2,685,861 State Appropriations (744,000) - (744,000) 0.00% - - - - 0.00% - Total Operating Revenues $ 9,052,909 $ 11,615,356 $ (2,562,447) -22.06% $ 11,213,070 $ 39,984,992 $ 43,515,953 $ (3,530,962) -8.11% $ 46,739,041
Operating Expenses: Salaries Wages $ 3,792,917 4,514,083 (721,167) -15.98% 3,845,521 14,367,107 15,522,144 (1,155,037) -7.44% 15,323,793 Benefits 1,396,953 1,740,454 (343,501) -19.74% 1,490,461 5,506,229 6,051,975 (545,746) -9.02% 5,937,419 Pension Expense 350,735 353,490 (2,755) -0.78% 353,490 1,402,939 1,401,978 961 0.07% 1,401,978 Other Post Employment Benefits 108,500 108,500 - 0.00% 108,500 434,000 434,000 - 0.00% 434,000 Purchased Services 1,762,618 1,088,776 673,842 61.89% 1,088,998 5,568,040 4,353,504 1,214,535 27.90% 4,353,813 Physician Services (52,093) 539,543 (591,637) -109.66% 539,543 2,477,709 3,750,801 (1,273,092) -33.94% 3,750,801 Pharmaceuticals 299,113 243,071 56,042 23.06% 248,565 1,172,423 991,784 180,639 18.21% 989,574 Medical Supplies 1,150,577 1,159,925 (9,347) -0.81% 1,071,207 4,270,638 4,383,601 (112,963) -2.58% 4,591,166 Other Supplies 107,641 138,415 (30,774) -22.23% 150,773 480,490 635,697 (155,207) -24.42% 755,216 Utilities 183,774 185,758 (1,984) -1.07% 185,758 890,989 743,033 147,957 19.91% 743,033 Insurance 50,800 90,691 (39,891) -43.99% 90,691 182,405 362,762 (180,357) -49.72% 362,762 Leases 208,278 222,428 (14,150) -6.36% 222,428 649,262 888,452 (239,190) -26.92% 888,452 Other 240,745 279,515 (38,769) -13.87% 279,515 997,634 1,118,059 (120,425) -10.77% 1,118,059 Physician Clinic Expense 953,951 535,347 418,604 78.19% 535,347 3,320,896 2,141,387 1,179,509 55.08% 2,141,387 Total Operating Expenses $ 10,554,510 $ 11,199,996 $ (645,487) -5.76% $ 10,210,797 $ 41,720,762 $ 42,779,178 $ (1,058,416) -2.47% $ 42,791,453
EBIDA (1,501,601) 415,360 (1,916,960) -461.52% 1,002,273 (1,735,771) 736,775 (2,472,546) -335.59% 3,947,588
Depreciation 445,192 300,111 145,081 48.34% 300,111 1,780,736 1,200,445 580,292 48.34% 1,200,445 Interest 161,030 182,297 (21,267) -11.67% 182,297 778,278 1,000,697 (222,420) -22.23% 1,000,697
Operating Income (Loss) $ (2,107,822) $ (67,048) $ (2,040,774) 3043.73% $ 519,865 $ (4,294,785) $ (1,464,367) $ (2,830,418) 193.29% $ 1,746,446
Operating Margin -23.28% -0.58% 0.00% 4.64% -10.74% -3.37% 0.00% 3.74%
NonOperating Revenues (Expenses): Gifts and Grants - - - 0.00% - - - - 0.00% - Investment Income 385 33,252 (32,867) -98.84% 33,252 1,567 133,010 (131,443) -98.82% 133,010 Loss on Disposal of Capital Assets - - - 0.00% - - - - 0.00% - COVID 818,922 - 818,922 0.00% - 13,582,401 - 13,582,401 0.00% - Other NonOperating Expenses - 1,722 (1,722) -100.00% 1,722 (346) 6,886 (7,232) -105.02% 6,886 Debt Issuance Costs - - - 0.00% - - - - 0.00% - Total NonOperating Revenues (Expenses) $ 819,308 $ 34,974 $ 784,334 2242.62% $ 34,974 $ 13,583,622 $ 139,896 $ 13,443,726 9609.81% $ 139,896
Income (Loss) Before NonOperating Payments to MUSC Affiliates (1,288,515) (32,074) (1,256,440) 3917.27% 554,839 9,288,838 (1,324,471) 10,613,309 -801.32% 1,886,342
Non Operating Payments to MUSC Affiliates - - - 0.00% - - - - 0.00% -
Change in Net Position $ (1,288,515) $ (32,074) $ (1,256,440) 3917.27% $ 554,839 $ 9,288,838 $ (1,324,471) $ 10,613,309 -801.32% $ 1,886,342
Total Margin -14.23% -0.28% 4.95% 23.23% -3.04%
Unaudited - For Management Use 10 Medical University Hospital Authority – Lancaster Market (including Edgewater Surgery Center) Notes to the Interim Financial Statements
Statement of Revenues, Expenses and Changes in Net Assets: YTD October 31, 2020 (Unaudited) Actuals Compared to Fixed Budget The Lancaster Division YTD October 2020 operating income was below budget by $6,041,231 on a modified FASB basis. The rollforward comparison below displays the major drivers of this variance.
Fixed Budget Actual YTD October 2020 YTD October 2020
Operating Income (Loss) $ 1,746,446 $ (4,294,785)
Revenue $6.8M total unfavorable variance Favorable (Unfavorable) Adjusted Discharges $ (6,434,401) Outpatient Surgeries (1,498,600) Case Mix Index 1.31 1,472,377 1.44 Other Revenue (293,425)
Expenses $0.7M total favorable variance (Favorable) Unfavorable FTE/AOB CMI FTE/AOB CMI FTE per AOB CMI Adjusted 2.61 $ 904,153 2.77 Salaries rate variance (1,860,838) Benefits rate variance (430,229) Pharmaceuticals (explained by volume) (209,892) Pharmaceuticals (not explained by volume) 392,741 Medical Supplies and Other Supplies (explained by volume) (1,133,986) Medical Supplies and Other Supplies (not explained by volume) 538,732 Physician Services (93,582) Purchased Services 1,214,227 Depreciation 580,292 Utilities, Insurance, Leases, Other Expenses (614,435)
Revenue Explanation: October year-to-date net patient revenues were unfavorable by 15.2%. Adjusted discharges were unfavorable to budget by (21.2%). Inpatient surgeries were in line to budget, and outpatient surgeries were unfavorable to budget by (21.3%). Other Revenues were unfavorable $0.3M, primarily driven by 340B pharmacy revenues.
Unaudited – For Management Use 11 Medical University Hospital Authority ‐ Lancaster Market (including Edgewater Surgery Center) Notes to the Interim Financial Statements continued
Expense Explanation: FTE per AOB was favorable by $2.5M. This was due to the staffing management and services lines continuing to recover. Benefits were lower than expected. Pension expense and Other Postemployment Benefits expense were in line with budget.
Pharmaceuticals supplies were unfavorable by $0.2M, and medical and other supplies were favorable by $0.6M mainly due to lower volume and better supply management and oversight.
Physician Services were favorable by $0.1M mainly due to the favorable physician collections in the emergency room. Purchased services were unfavorable by $1.2M mainly due to repairs and maintenance contract costs. Utilities, Insurance, Leases and Other expenses were favorable by $0.6M.
Unaudited – For Management Use 12 Statements of Net Position Medical University Hospital Authority - Consolidated Statements of Net Position October 31, 2020 and June 30, 2020
Assets and Deferred Outflows At 10/31/2020 At 6/30/2020 (unaudited) (audited) Current Assets: Cash and Cash Equivalents $ 293,491,426 $ 344,995,313 Cash Restricted for Capital Projects and Major Programs 13,040,756 13,040,756 Cash Restricted for COVID-19 Stimulus Funding 2,284,617 10,470,416 Investments Unrestricted 228,117,808 59,624,988 Investments Restricted for Capital Projects and Major Programs 45,515,247 42,347,752 Patient Accounts Receivable, Net of Allowance for Uncollectible 321,487,567 298,277,631 Accounts of approximately $139,900,000 and $119,700,000 Due from Related Parties - 8,000,106 Due from Third-Party Payors 15,720,352 19,959,892 Due from Joint Ventures and Partnerships 22,820,309 4,354,770 Other Current Assets 249,145,835 162,509,050
Total Current Assets $ 1,191,623,917 $ 963,580,674
Investments Held by Trustees Under Indenture Agreements $ 57,881,031 $ 58,342,530 Investments in Joint Ventures and Partnerships 1,356,791 1,356,791 Other Non-Current Assets 14,153,482 6,121,667 Capital Assets, Net 973,413,606 994,261,635
Total Assets $ 2,238,428,827 $ 2,023,663,297
Deferred Outflows $ 252,181,960 $ 252,963,949
Total Assets and Deferred Outflows $ 2,490,610,787 $ 2,276,627,246
Liabilities, Deferred Inflows and Net Position
Current Liabilities: Current Installments of Long-Term Debt $ 31,595,930 $ 31,261,596 Current Installments of Capital Lease Obligations 7,707,091 6,610,403 Current Installments of Notes Payable 1,522,455 1,509,249 Short-Term Debt - 120,000,000 Due to Related Parties 18,975,826 - Accounts Payable 111,091,893 107,412,453 Accrued Payroll, Withholdings and Benefits 109,367,818 90,658,686 Other Accrued Expenses 106,602,882 52,801,078 Unearned Revenue 203,399,364 2,947,134
Total Current Liabilities $ 590,263,259 $ 413,200,599
Long-Term Debt $ 722,058,319 $ 732,641,115 Capital Lease Obligations 73,594,294 68,756,709 Notes Payable 2,346,468 2,732,070 Net Pension Liability 845,535,984 824,346,380 Net OPEB Liability 750,820,953 744,302,324
Total Liabilities $ 2,984,619,277 $ 2,785,979,197
Deferred Inflows $ 76,874,234 $ 76,874,234
Total Liabilities and Deferred Inflows $ 3,061,493,511 $ 2,862,853,431
Net Position: Net Investment in Capital Assets $ 143,164,219 $ 155,273,592 Restricted: Under Indenture Agreements 57,881,031 58,342,530 Expendable for: Capital Projects 23,280,451 9,239,695 Major Programs 33,485,131 29,974,897 COVID-19 Stimulus Funding 2,284,617 10,470,416 Unrestricted (deficit) (830,978,173) (849,527,315)
Total Net Position $ (570,882,724) $ (586,226,185)
Total Liabilities, Deferred Inflows and Net Position $ 2,490,610,787 $ 2,276,627,246
Unaudited - For Management Use 14 Medical University Hospital Authority - Charleston Market Statements of Net Position October 31, 2020 and June 30, 2020
Assets and Deferred Outflows At 10/31/2020 At 6/30/2020 (unaudited) (audited) Current Assets: Cash and Cash Equivalents $ 276,791,901 $ 342,628,759 Cash Restricted for Capital Projects and Major Programs 13,040,756 13,040,756 Cash Restricted for COVID-19 Stimulus Funding 2,284,617 10,470,416 Investments Unrestricted 228,117,808 59,624,988 Investments Restricted for Capital Projects and Major Programs 45,515,247 42,347,752 Patient Accounts Receivable, Net of Allowance for Uncollectible 253,755,923 231,401,885 Accounts of approximately $82,900,000 and $73,600,000 Due from Related Parties - 7,787,997 Due from Third-Party Payors 9,946,044 12,846,560 Due from Joint Ventures and Partnerships 22,532,062 4,012,915 Start-up Investment in RHN 23,749,258 37,099,517 Other Current Assets 225,792,106 133,924,472
Total Current Assets $ 1,101,525,722 $ 895,186,017
Investments Held by Trustees Under Indenture Agreements $ 57,881,031 $ 58,342,530 Investments in Joint Ventures and Partnerships 1,356,791 1,356,791 Other Non-Current Assets 14,153,482 6,121,667 Capital Assets, Net 843,815,583 860,926,057
Total Assets $ 2,018,732,609 $ 1,821,933,062
Deferred Outflows $ 226,864,475 $ 227,646,464
Total Assets and Deferred Outflows $ 2,245,597,084 $ 2,049,579,526
Liabilities, Deferred Inflows and Net Position
Current Liabilities: Current Installments of Long-Term Debt $ 28,057,690 $ 27,754,282 Current Installments of Capital Lease Obligations 7,099,813 6,017,359 Current Installments of Notes Payable 1,522,455 1,509,249 Short-Term Debt - 65,000,000 Due to Related Parties 18,817,336 - Accounts Payable 103,436,759 100,941,259 Accrued Payroll, Withholdings and Benefits 93,523,107 76,471,870 Other Accrued Expenses 52,337,893 50,625,706 Unearned Revenue 202,264,172 2,947,134
Total Current Liabilities $ 507,059,225 $ 331,266,859
Long-Term Debt $ 601,355,363 $ 610,751,183 Capital Lease Obligations 64,022,568 59,119,594 Notes Payable 2,346,468 2,732,070 Net Pension Liability 842,053,045 824,346,380 Net OPEB Liability 749,735,657 744,302,324
Total Liabilities $ 2,766,572,326 $ 2,572,518,410
Deferred Inflows $ 76,874,234 $ 76,874,234
Total Liabilities and Deferred Inflows $ 2,843,446,560 $ 2,649,392,644
Net Position: Net Investment in Capital Assets $ 143,164,219 $ 157,565,419 Restricted Under Indenture Agreements 57,881,031 58,342,530 Expendable for: Capital Projects 23,280,451 9,239,695 Major Programs 33,485,131 29,974,897 COVID-19 Stimulus Funding 2,284,617 10,470,416 Unrestricted (deficit) (857,944,925) (865,406,075)
Total Net Position $ (597,849,476) $ (599,813,118)
Total Liabilities, Deferred Inflows and Net Position $ 2,245,597,084 $ 2,049,579,526
Unaudited - For Management Use 15 MEDICAL UNIVERSITY HOSPITAL AUTHORITY – Charleston Market Balance Sheet: As of 10/31/20 (Unaudited) and 06/30/2020 (Audited)
Cash and Cash Equivalents Unrestricted cash and cash equivalents decreased by $65,836,858 from June 30, 2020. Significant FY21 events increasing cash include $24.3M received Federal CARES funding, Hospital cash collections were $45M more than forecasted, $10M received in TeleHealth and Adult Burn state appropriations, $4.8M received in Health Innovation funds from the State of SC, $120M payment in revenue anticipation notes, $14.3M payment in prepaid rent for Summey Pavilion, checkwrites were $13M more than forecasted, and an additional $2M for a sublease with MUSC.
Net Accounts Receivable Net patient accounts receivable increased $22.4M from June 30, 2020. Net accounts receivable days in October 2020 totaled 53 number days.
Other Current Assets Other current assets increased $91.9M from June 30, 2020, mainly due to $55M revenue anticipation note (“RAN”) being paid on behalf of RHN, $14.9M increase in inventory, and an accrual for State Appropriations for additional At-Risk testing of $18.6M.
Accounts Payable Accounts Payable increased by $2.5M from June 30, 2020, mainly due to an increase in the volume of payments, such as increased volume in Transplant procedures.
Other Accrued Expenses Other Accrued Expenses increased $1.7M from June 30, 2020, mainly due to increase in volume of payments in the Commerce E-Pay program.
Unearned Revenue Unearned revenue increased $199.3M from June 30, 2020, due to Advanced Medicare funding and increase in deferred revenues related to Telehealth and DSH funds.
Long Term Debt As of October 2020, Current Installments of Long-Term Debt relates to HUD debt for ART, SJCH and the Central Energy Plant. Current Installments of Notes Payable relate to the note payable for the Sabin St. energy plant. A table of outstanding balances by major issuance is listed below: 10/31/2020 Balance CEP $ 32,984,351 ART 248,222,128 SJCH 306,398,729 Edgewater 6,425,348 Nexton and CSC 35,382,497 Sabin Street 3,868,923 Capital Leases 71,122,381 $ 704,404,357
Pension and Other Post Employment Benefit (OPEB) Liabilities As of October 31, 2020, the net pension liability increased by $17.7M from June 30, 2020. As of October 31, 2020, the net other post-employment benefit liability increased $5.4M from June 30, 2020.
Unaudited – For Management Use 16 Medical University Hospital Authority - RHN Consolidated Statements of Net Position October 31, 2020 and June 30, 2020
Assets and Deferred Outflows At 10/31/2020 At 6/30/2020 (unaudited) (audited) Current Assets: Cash and Cash Equivalents $ 16,699,525 $ 2,366,554 Patient Accounts Receivable, Net of Allowance for Uncollectible 67,731,644 66,875,746 Accounts of approximately $57,000,000 and 46,000,000 Due from Related Parties - 212,109 Due from Third-Party Payors 5,774,308 7,113,332 Due from Joint Ventures and Partnerships 288,247 341,855 Other Current Assets 23,353,729 28,584,578
Total Current Assets $ 113,847,453 $ 105,494,174
Capital Assets, Net $ 129,598,023 $ 133,335,578
Total Assets $ 243,445,476 $ 238,829,752
Deferred Outflows $ 25,317,485 $ 25,317,485
Total Assets and Deferred Outflows $ 268,762,961 $ 264,147,237
Liabilities, Deferred Inflows and Net Position
Current Liabilities: Current Installments of Long-Term Debt $ 3,538,240 $ 3,507,314 Current Installments of Capital Lease Obligations 607,278 $ 593,044 Short-Term Debt - 55,000,000 Due to Related Parties 158,490 - Accounts Payable 7,655,134 6,471,194 Accrued Payroll, Withholdings and Benefits 15,844,711 14,186,816 Start-up Investment in RHN 23,749,258 37,099,517 Other Accrued Expenses 54,264,989 2,175,372
Total Current Liabilities $ 106,953,292 $ 119,033,257
Long-Term Debt $ 120,702,956 $ 121,889,932 Capital Lease Obligations 9,571,726 9,637,115
Total Liabilities $ 241,796,209 $ 250,560,304
Total Liabilities and Deferred Inflows $ 241,796,209 $ 250,560,304
Net Position: Net Investment in Capital Assets - - Restricted Under Indenture Agreements - - Expendable for: Capital Projects - - Major Programs - - Unrestricted (deficit) $ 26,966,752 $ 13,586,933
Total Net Position $ 26,966,752 $ 13,586,933
Total Liabilities, Deferred Inflows and Net Position $ 268,762,961 $ 264,147,237
Unaudited - For Management Use 17 Medical University Hospital Authority ‐ Regional Health Network Consolidated Balance Sheet: As of 10/31/2020 and 6/30/2020 (Audited)
Cash and Cash Equivalents Cash and Cash Equivalents increased by approximately $14.3M mainly driven by increased cash collections and $4.0M state appropriation funding received for the Williamsburg Medical Center rebuild.
Net Accounts Receivable Net patient account receivable increased by $0.8M.
Due from Third-Party Payors Due from third-party payors decreased $1.3M, mainly due to the accrual and payments related to the Medicare cost report settlement.
Other Current Assets Other current assets decreased by $5.3M, mainly due to decrease in receivable related to the CARES Act Relief Fund accrual, state appropriation funding for the Williamsburg Medical Center and an increase in prepaid payroll insurance.
Current Liabilities Current liabilities decreased by $12.1M, mainly due payments made on the start-up investment in RHN.
Long-Term Debt Long-term debt decreased by $1.2M due to normal monthly amortization. On December 12, 2019, the bridge loan used for the acquisition of the four regional hospitals was refinanced through HUD. The total loan amount was $133,385,200 bearing an interest rate of 3.0%, which is lower than the bridge loan’s interest rate of 3.21%. The loan is fully amortized over a 25 year term.
Unaudited – For Management Use 18 Crosswalk of Financial Accounting Standards Board (FASB) Income Statement Presentation to Government Accounting Standards Board (GASB) Medical University Hospital Authority - Consolidated Statement of Revenues, Expenses and Change in Net Position For the 4 Month Period Ending - October 31, 2020 Modified FASB Basis
Crosswalk from FASB to GASB FASB GASB Fiscal Year To Date Fiscal Year To Date Actual Budget Variance Actual Budget Variance
Operating Revenues: Operating Revenues: Net Patient Service Revenues $ 624,180,949 $ 652,736,521 -4.37% Net Patient Service Revenues $ 624,180,949 $ 652,736,521 -4.37% Other Revenues - DHS Revenue 17,195,090 17,042,935 0.89% Other Revenues - DSH Revenue 17,195,090 17,042,935 0.89% Retail Pharmacy Revenue 78,717,781 68,179,990 15.46% Retail Pharmacy Revenue 78,717,781 68,179,990 15.46% Other Revenues 38,062,233 32,892,758 15.72% Other Revenues 38,062,233 32,892,758 15.72% State Appropriations 9,145,018 9,395,018 -2.66%
Total Operating Revenues 767,301,071 780,247,222 -1.66% Total Operating Revenues 758,156,053 770,852,204 -1.65%
Operating Expenses: Operating Expenses: Salaries Wages 212,458,527 212,417,001 0.02% Salaries Wages 212,458,527 212,417,001 0.02% Benefits 80,492,220 81,004,000 -0.63% Benefits 80,492,220 81,004,000 -0.63% Pension Expense 21,189,605 21,188,645 0.00% Pension Expense 21,189,605 21,188,645 0.00% Other Postemployment Benefits 6,518,629 6,518,629 0.00% Other Postemployment Benefits 6,518,629 6,518,629 0.00% Purchased Services 105,741,914 107,967,027 -2.06% Purchased Services 105,741,914 107,967,027 -2.06% Physician Services 47,264,486 51,259,825 -7.79% Physician Services 47,264,486 51,259,825 -7.79% Pharmaceuticals 58,916,673 44,987,780 30.96% Pharmaceuticals 58,916,673 44,987,780 30.96% Retail Pharmaceuticals 36,165,202 22,583,507 60.14% Retail Pharmaceuticals 36,165,202 22,583,507 60.14% Medical Supplies 98,990,282 115,073,272 -13.98% Medical Supplies 98,990,282 115,073,272 -13.98% COVID-19 Supplies 14,242,333 - 100.00% COVID-19 Supplies 14,242,333 - -100.00% Other Supplies 17,378,726 19,798,561 -12.22% Other Supplies 17,378,726 19,798,561 -12.22% Utilities 8,152,617 8,230,262 -0.94% Utilities 8,152,617 8,230,262 -0.94% Insurance 2,412,053 2,309,726 4.43% Insurance 2,412,053 2,309,726 4.43% Leases 11,220,867 13,447,629 -16.56% Leases 11,220,867 13,447,629 -16.56% Other 8,248,698 9,256,731 -10.89% Other 8,248,698 9,256,731 -10.89% Physician Clinic Expense 9,096,513 7,866,617 15.63% Physician Clinic Expense 9,096,513 7,866,617 15.63%
Total Operating Expenses 738,489,346 723,909,211 2.01% Total Operating Expenses 738,489,346 723,909,211 2.01%
EBIDA 28,811,725 56,338,011 -48.86% EBIDA 19,666,707 46,942,993 -58.11%
Depreciation 35,488,478 33,253,338 6.72% Depreciation 35,488,478 33,253,338 6.72% Interest Expense 13,762,087 14,101,303 -2.41%
Operating Income (Loss) (20,438,840) 8,983,370 -327.52% Operating Income (Loss) (15,821,771) 13,689,655 -215.57%
Operating Margin -2.66% 1.15% Operating Margin -2.09% 1.78%
NonOperating Revenues (Expenses): NonOperating Revenues (Expenses): State Appropriations 9,145,018 9,395,018 -2.66% Gifts and Grants 529,880 2,712,695 -80.47% Gifts and Grants 529,880 2,712,695 -80.47% Investment Income (49,146) 2,536,020 -101.94% Investment Income (49,146) 2,536,020 -101.94% Interest Expense (13,762,087) (14,101,303) -2.41% Loss on Disposal of Capital Assets (31,127) (268,513) 88.41% Loss on Disposal of Capital Assets (31,127) (268,513) 88.41% COVID-19 Stimulus Funding 38,685,767 - 100.00% COVID-19 Stimulus Funding 38,685,767 - 100.00% Other NonOperating Expenses (346) 6,886 105.02% Other NonOperating Expenses (346) 6,886 105.02%
Total NonOperating Revenues (Expenses) 39,135,029 4,987,088 684.73% Total NonOperating Revenues (Expenses) 34,517,959 280,803 12192.59%
Income (Loss) Before NonOperating Payments 18,696,189 13,970,458 33.83% Income (Loss) Before NonOperating Payments 18,696,189 13,970,458 33.83% to MUSC Entities to MUSC Entities
NonOperating Payments to MUSC Entities (1,963,642) (15,654,261) 87.46% NonOperating Payments to MUSC Entities $ (1,963,642) $ (15,654,261) 87.46%
Change in Net Position 16,732,547 (1,683,803) -1093.74% Change in Net Position 16,732,547 (1,683,803) -1093.74%
Total Margin 2.18% -0.22% Total Margin 2.20% -0.22%
Unaudited - For Management Use 20 MUSC Strategic Ventures and MSV Health, Inc. MUSC Strategic Ventures and MSV Health, Inc. ‐ Consolidated Statement of Revenues, Expenses and Changes in Net Position For the 4 Month Period Ending - October 31, 2020 Modified FASB Basis
Current Month Fiscal Year to Date Actual Budget $ Variance % Variance Actual Budget $ Variance % Variance Revenues Net Clinical Service Revenue $ 2,173,305 $ 1,438,800 $ 734,505 51.0%$ 7,168,729 $ 5,149,456 $ 2,019,272 39.2% Interest income 166,790 167,196 (406) ‐0.2% 671,363 671,305 58 0.0% Investment income 70,686 63,626 7,059 11.1% 463,824 197,434 266,391 134.9% Management income 62,020 ‐ 62,020 90,780 ‐ 90,780 Other revenue 721,549 18,348 703,201 3832.6% 1,654,779 73,392 1,581,387 2154.7%
Total revenues $ 3,194,349 $ 1,687,970 $ 1,506,379 89.2%$ 10,049,475 $ 6,091,587 $ 3,957,888 65.0%
Expenses Salaries & Benefits $ 83,164 $ 120,596 $ (37,432) ‐31.0% $ 341,315 $ 482,384 $ (141,069) ‐29.2% Contractual Services 585,946 425,472 160,474 37.7% 1,690,382 1,652,302 38,080 2.3% Pharmaceutical 25,628 17,211 8,417 48.9% 71,923 61,410 10,513 17.1% Medical Supplies 597,629 435,344 162,285 37.3% 1,879,611 1,547,460 332,151 21.5% Other supplies 209,068 159,370 49,698 31.2% 611,763 567,778 43,985 7.7% Accounting & legal 75,000 18,100 56,900 314.4% 75,462 72,399 3,063 4.2% Insurance 27,157 18,247 8,910 48.8% 94,426 72,989 21,437 29.4% Property & Equipment Leases 17,344 31,350 (14,006) ‐44.7% 41,131 125,399 (84,268) ‐67.2% Utilities 11,253 11,642 (389) ‐3.3% 52,615 46,568 6,047 13.0% Depreciation 35,101 26,707 8,393 31.4% 113,860 106,829 7,030 6.6% Other operating expenses 33,124 41,416 (8,293) ‐20.0% 169,144 165,666 3,478 2.1%
Total expenses $ 1,700,413 $ 1,305,455 $ 394,957 30.3%$ 5,141,633 $ 4,901,185 $ 240,448 4.9%
Operating Income (Loss) $ 1,493,936 $ 382,515 $ 1,111,422 290.6%$ 4,907,842 $ 1,190,402 $ 3,717,440 312.3% Non‐Operating Revenue (Expenses) Interest expense $ (54,858) $ (122,758) $ 67,900 ‐55.3% $ (219,443) $ (491,034) $ 271,591 ‐55.3% Minority Interest (303,776) (134,285) (169,491) 126% (1,060,946) (401,881) (659,065) 164%
Income (loss) $ 1,135,302 $ 125,471 $ 1,009,831 804.8%$ 3,627,453 $ 297,488 $ 3,329,965 1119.4% (Gain to MUHA)/ Loss from MUHA$ 62,019.50 $ (22,927.97) $ 84,947.47 ‐370% $ 90,780 $ (91,712) $ 182,492 ‐199% Edgewater Interest transfer to MUHA (318,205) (126,794) (191,412) 151% (1,132,256) (393,292) (738,965) 188% Change in Net Position $ 879,116 $ (24,250) $ 903,367 ‐3725.2%$ 2,585,977 $ (187,516) $ 2,773,493 ‐1479.1%
* Edgewater ASC is included in this view of the Statement of Revenues, Expenses, and Changes in Net Position. MSV's majority interest is reflected as a transfer to MUHA
Unaudited ‐ for Management Use 22 MUSC Strategic Ventures and MSV Health, Inc. Consolidated Notes to the Interim Financial Statements
Statement of Revenues, Expenses and Changes in Net Assets: YTD October 31, 2020 (Unaudited) Actuals Compared to Fixed Budget
MSV’s October 2020 operating income was above budget by $3,717,440 on a modified FASB basis. The rollforward comparison below displays the major drivers of this favorable variance.
Fixed Budget Actual YTD October 2020 YTD October 2020
Operating Income (Loss) $ 1,190,402 $ 4,907,842
Favorable Revenue $3,957,888 total favorable variance (Unfavorable) Clinical Services $ 2,019,272 Interest Income 58 Investment Income 266,391 Management Income 90,780 Other Revenue 1,581,387
(Favorable) Expenses $240,448 total unfavorable variance Unfavorable Salaries and Benefits $ (141,069) Pharmaceuticals 10,513 Medical and other supplies 376,136 Insurance 21,437 Leases (84,268) Depreciation 7,030 Other expenses 50,668
Revenue Explanation: October year-to-date clinical revenue was $2.0M above budget. Edgewater Ambulatory Surgery Center (ASC)’s year-to-date surgical cases were 192 cases above budget. Investment Income was above budget by $266K due to favorable budget variances for Cancer Care Network, Bayada, South of Broad and East Cooper Radiology. Management income was $91K above budget related to the East Cooper Radiology contract. Other revenue was $1.6M above budget as a result of additional rent payments for the Summey Pavilion that were recognized in September and October.
Unaudited – For Management Use 23 MUSC Strategic Ventures and MSV Health, Inc. Consolidated Notes to the Interim Financial Statements
Expense Explanation: Salaries and benefits were under budget $141K due to lower than budgeted expense for Carolina Orthotics and East Cooper Radiology. Medical supplies, other supplies, and pharmaceuticals were over budget $387K due to the increased surgical volume at the ASC. Insurance was over budget $21K for East Cooper Radiology professional liability insurance. Leases were under budget $84K due to the renegotiated Applebee’s lease now being with MUHA. Other expenses were over budget $51K due to increased contractual services expense for the ASC.
Unusual and non-recurring items impacting current earnings: Non-recurring additional rent payments from MUHA for Summey Pavilion in eth a mount of $1.6M as required under Article V, Section 5.01(q) of the Bond Purchase and Loan Agreement.
Unaudited – For Management Use 24 MUSC Strategic Ventures and MSV Health, Inc. ‐ Consolidated Statement of Net Position October 31, 2020 and June 30, 2020
October 31, 2020 June 30, 2020 ASSETS (unaudited) (audited) Current assets: Operating cash $ 6,770,383 $ 8,072,947 Cash ‐ Strategic Reserves 3,247,367 3,133,876 Cash ‐ Restricted 1,699,424 1,699,367 Patient Receivables, Net 2,665,689 1,378,692 Prepaids and other current assets 72,956 86,342 Inventory 528,953 539,934 Due from Related Parties 774,954 1,717,106 Investment in capital lease receivable 1,382,349 1,382,349 Accounts Receivable 17,000,000 ‐
Total current assets $ 34,142,076 $ 18,010,613
Noncurrent assets: Land $ 871,642 $ 871,642 Buildings, Net of Accum Depreciation 3,712,738 3,678,307 Equipment, Net of Accum Depreciation 291,240 410,485 Capitalized Leased Equipment 143,845 157,159 Investment in Capital Lease 43,643,660 44,097,645 Investment in Joint Ventures 4,246,734 3,782,909 Deferred outflow 653,094 663,628 Other non current assets 250 250
Total assets $ 87,705,278 $ 71,672,637
LIABILITIES Current liabilities: Accounts Payable $ 719,082 $ 726,920 Income Tax Payable 660,724 660,724 Prepaid Rent 15,187,964 4,430,828 Due to Related Parties 2,252,886 2,128,095 Other current liabilities 2,423,494 1,227 Current portion Capital Lease Payable 33,890 33,890 Current portion of Long‐term debt 194,529 194,529 Current Portion of Bonds Payable 1,830,000 1,830,000
Total current liabilities $ 23,302,569 $ 10,006,213
Noncurrent liabilities Long‐term note payable to related party $ 782,046 $ 782,046 Note payable 5,865,042 5,903,491 Capital lease payable 136,505 136,505 Bond payable 41,915,000 42,825,000 Total liabilities $ 72,001,162 $ 59,653,254
NET POSITION Strategic Reserves $ 3,247,367 $ 3,247,367 Non‐controlling interest 1,741,144 1,250,423 Unrestricted 10,715,605 7,521,593
Total net position $ 15,704,116 $ 12,019,383
Total Liabilities and Net Position $ 87,705,278 $ 71,672,637
* Edgewater ASC is included in this view of the Statement of Net Position.
Unaudited ‐ For Management Use 25 MUSC Strategic Ventures and MSV Health, Inc. Consolidated Notes to the Interim Financial Statements
Statement of Net Position: As of 10/31/2020 and 6/30/2020 (Audited)
Current Assets Cash and Cash Equivalents had a net decrease of $1.2M from June 30, 2020 related to transfers made to Mainsail in the months of August and September, which were offset by prepaid lease payments received from MUHA for the Summey Medical Pavilion.
Net patient receivables increased by $1.3M as a result of increased volume at the ASC.
Accounts Receivable increased by $17.0M related to a receivable due from Mainsail.
Noncurrent Assets
Buildings and Equipment decreased $85K as a result of monthly depreciation.
Investments in Capital Lease Receivable decreased by $467K for the payment due from MUHA on the Summey Medical Pavilion.
Investments in Joint Ventures increased by $464K due to favorable results for Cancer Care Network, Bayada and South of Broad.
Current Liabilities
Accounts Payable increased by $8K related to routine monthly payables activity and accruals.
Prepaid rent increased by $10.8M related to pre-payments received from MUHA for the Summey Medical Pavilion capital lease.
Other current liabilities increased by $2.4M related to the ASC Medicare advance payment at the Edgewater ASC.
Long Term Debt
Long-term note payable includes debt due to MUHA by MSV for the purchase of the Edgewater ASC ($782K).
Notes Payable of $5.9M is Edgewater ASC’s new loan with South State Bank. The proceeds were used to pay off a mortgage note and long-term debt due to MUHA ($4.9M reported as Long-term note payable as of June 30, 2019).
MSV has $41.9M in JEDA revenue bonds for the construction of the Summey Medical Pavilion. Principal payments are secured by the lease payments due from MUHA.
Unaudited – For Management Use 26 Mainsail Health Partners and Spinnaker Health, LLC Mainsail Health Partners and Spinnaker Health, LLC - Consolidated Statement of Revenues, Expenses and Changes in Net Position For the 4 Month Period Ending - October31, 2020 Modified FASB Basis
Current Month Fiscal Year to Date Actual Budget $ Variance % Variance Actual Budget $ Variance % Variance Revenues Interest income $ 114 $ ‐ $ 114 $ 359 $ ‐ $ 359 Other revenue 91,370 ‐ 91,370 91,370 ‐ 91,370
Total revenues $ 91,484 $ ‐ $ 91,484 $ 91,729 $ ‐ $ 91,729
Expenses Insurance $ 171 $ ‐ $ 171 $ 682 $ ‐ $ 682 Other operating expenses ‐ ‐ ‐ 45 ‐ 45
Total expenses $ 171 $ ‐ $ 171 $ 727 $ ‐ $ 727
Operating Income (Loss) $ 91,313 $ ‐ $ 91,313 $ 91,001 $ ‐ $ 91,001 Non‐Operating Revenue (Expenses) ‐ ‐
Income (loss) $ 91,313 $ ‐ $ 91,313 $ 91,001 $ ‐ $ 91,001 Change in Net Position $ 91,313 $ ‐ $ 91,313 $ 91,001 $ ‐ $ 91,001
Unaudited ‐ for Management Use 28 Mainsail Health Partners and Spinnaker Health, LLC - Consolidated Notes to the Interim Financial Statements
Statement of Revenues, Expenses and Changes in Net Assets: YTD October 31, 2020 (Unaudited) Actuals Compared to Fixed Budget
Mainsail’s October 2020 operating income was above budget by $91,001 on a modified FASB basis. The roll-forward comparison below displays the major drivers of this favorable variance.
Fixed Budget Actual YTD October 2020 YTD October 2020
Operating Income (Loss) $ - $ 91,001
Favorable Revenue $91,729 total favorable variance (Unfavorable) Interest Income 359 Other Revenue $ 91,370
(Favorable) Expenses $727 total unfavorable variance Unfavorable Insurance 682 Other expenses $ 45
October 2020 represents the second month of activity for Mainsail Health Partners and included the following:
The formation of a SC limited liability company: Spinnaker Health, LLC that as of October 1, 2020 holds a 50% membership of Encompass Health Rehabilitation Hospital and a 50% membership of TribeONE SC, LLC.
Revenue Explanation: October other revenue of $91,370 was related to Encompass JV and $359 related to interest earned on deposits.
Expense Explanation: Expenses for October include $682 for business insurance and $45 for banking fees.
Unusual and non-recurring items impacting current month earnings: Nothing noted for the month of October.
Unaudited – For Management Use 29 Mainsail Health Partners and Spinnaker Health, LLC ‐ Consolidated Statement of Net Position October 31, 2020 and June 30, 2020
October 31, 2020 ASSETS (unaudited) Current assets: Operating cash $ 1,383,814 Prepaids and other current assets 1,365 Total current assets $ 1,385,178
Noncurrent assets: Investment in Joint Ventures $ 15,707,870 *
Total assets $ 17,093,048
LIABILITIES Due to Related Parties $ 2,047
Total current liabilities $ 2,047
Noncurrent liabilities Long‐term note payable to related party $ 17,000,000 Total liabilities $ 17,002,047
NET POSITION Unrestricted $ 91,001
Total net position $ 91,001
Total Liabilities and Net Position $ 17,093,048
* Pending further review with legal counsel
Unaudited ‐ For Management Use 30 Mainsail Health Partners and Spinnaker Health, LLC - Consolidated Notes to the Interim Financial Statements
Statement of Net Position: As of 10/31/2020 (Unaudited)
Current Assets
Operating Cash balance of $1.4M related to transfers from MSV for set up of Mainsail. This transfer consisted largely from the prepaid rent of the Summey Medical Pavilion by MUHA as well as distributions from Edgewater ASC.
Prepaid Insurance $1.4K related to payment of annual business premium.
Noncurrent Assets
Investment in Joint Ventures of $15.8M includes investments in Tidelands for $4M, Encompass Health for $10M, and TribeOne SC for $1.6M. This classification is currently being reviewed with legal counsel.
Current Liabilities
Due to Related Parties of $2.0K relates to amount owed to MUHA for the payment of insurance premiums.
Long Term Debt
Long-term note payable due to MSV for transfers received related to set up of Mainsail.
Unaudited – For Management Use 31
FACILITIES HOSPITAL AUTHORITY EASEMENT FOR APPROVAL
DECEMBER 11, 2020
DESCRIPTION OF EASEMENT: CPW Easement for Utilities / Cherry, Bee and Cannon Streets
REQUESTOR: Commissioners of Public Works of the City of Charleston
REQUESTOR CONTACT: John Gaffney, Charleston Water & Sewer
LOCATION: TMS 460-10-04-040 Vacant Lot / City of Charleston Recorded Address BEE ST
DESCRIPTION: Commissioners of Public Works intends to construct sewer lines in the Cherry Street and Cannon Street areas of Charleston County. The Commission requests a permanent easement underground across the vacant Bee St property for connection of surrounding sewer lines necessary to serve the Charleston Peninsula. This easement will run with the land and continue so long as it is used for utility purposes.
JUSTIFICATION: Support the Commissions of Public Works of City of Charleston to provide service for the Charleston Peninsula including the Charleston Medical District.
STATE OF SOUTH CAROLINA ) ) GRANT OF PERMANENT EASEMENT COUNTY OF CHARLESTON )
WHEREAS, the Commissioners of Public Works of the City of Charleston, South Carolina
(referred to herein as the “Commission”) intends to construct sewer lines in the Cherry Street and
Cannon Street areas of Charleston County, South Carolina; and
WHEREAS, the undersigned grantor, Medical University Hospital Authority (referred to
herein as the “Grantor”), owns that certain parcel of land bearing Charleston County TMS #460-
10-04-040; and
WHEREAS, the Commission has requested a permanent easement across such property of
the Grantor, which the Grantor has agreed to grant.
NOW, THEREFORE, KNOW ALL MEN BY THESE PRESENTS, that MEDICAL
UNIVERSITY HOSPITAL AUTHORITY, in consideration of the sum of One Dollar and 00/100
($1.00) to the Grantor in hand paid for the easement granted hereunder, at and before the sealing
of these presents, by the COMMISSIONERS OF PUBLIC WORKS OF THE CITY OF
CHARLESTON, SOUTH CAROLINA, the receipt of which is hereby acknowledged, has granted,
bargained, sold and released, and by these presents does grant, bargain, sell and release unto the
COMMISSIONERS OF PUBLIC WORKS OF THE CITY OF CHARLESTON, SOUTH
CAROLINA, its successors and assigns, the following:
1. A permanent transferable right-of-way and utility easement for a commercial purpose over, under and across a strip of land designated “NEW 25’ SEWER EASEMENT (1,649 sq ft/0.038 acres)” and shown as being contained between the lines running between the points designated A, B, C, D and A on a plat entitled “PLAT OF A NEW 25’ SEWER EASEMENT
THROUGH THE PROPERTY OF MEDICAL UNIVERSITY HOSPITAL AUTHORITY” by
43297563 v2 F. Elliotte Quinn, III, SCPLS No. 10292, Thomas & Hutton Engineering Company, No. C00285, dated
November 19, 2018, and recorded in Plat Book at Page in the Register
of Deeds Office of Charleston County, South Carolina. Such strip of land has such size, shape,
dimensions, butting and boundings, courses and distances as will by reference to the plat more fully appear (hereinafter referred to as the “Permanent Easement”).
Together with the right to lay, construct, locate, install, operate, maintain, inspect, repair
and replace underground sewer lines with necessary valves, fittings, manholes, service lines,
controls, devices, hydrants, equipment and other usual appurtenances within the Permanent
Easement; and
Together with the right by the Commission and its contractors to use the Permanent
Easement for ingress and egress, and ingress and egress to other easements owned by the
Commission on properties adjacent to the property of the Grantor.
TOGETHER with all the rights and privileges necessary or convenient for the full
enjoyment or use thereof.
It is further agreed that:
1) The Commission will have the right of ingress, egress, and access to and from
the Permanent Easement across and upon such lands of the Grantor as may be
necessary or convenient solely for purposes connected with the Permanent
Easement. In addition, the Commission shall have the right from time to time
to trim, cut or remove trees, underbrush and other obstructions that are over,
under or upon the Permanent Easement and shall provide notice of such to
Office of General Counsel, MUSC c/o MUSC Health, 22 WestEdge Suite 300,
Charleston, South Carolina 29403.
43297563 v2 2 2) The Grantor and Grantor’s heirs, successors and assigns will have full use of
the surface area of the Permanent Easement, provided, however, that neither
Grantor nor Grantor’s heirs, successors or assigns shall construct, build or place
any permanent structure over the surface of the Permanent Easement without
providing Grantee notice, it being the purpose of the Commission (1) to protect
the integrity of the utility lines which will be located below the surface, and (2)
to allow quick and ready access to the utility lines to facilitate repairs.
3) The Permanent Easement will run with the land and continue to exist so long
as it is used for utility purposes. In the event the Commission should determine
to abandon the Permanent Easement, written notice may be given to the then
owners of the property subject to the Permanent Easement stating that the
Commission has given up all rights in the Permanent Easement.
4) The Commission shall be responsible for any and all damage to the Permanent
Easement related to or caused by the activities of Commission (or anyone acting
on behalf of or under Commission). All such repair and/or restoration shall be
done promptly, at no cost or expense to the Grantor or the State and shall be
subject to the satisfaction of Grantor. Commission further agrees that upon
completion of construction, to restore the surface of any unpaved or paved
portions of the Permanent Easement which are disturbed by the construction to
include but not be limited to replanted with grass, repair any pavement damaged
by the construction or other damage. The surface of any unpaved portions of
the Permanent Easement which are wetlands or marsh that are disturbed by the
43297563 v2 3 construction, if any, will be restored in accordance with the permits issued by
the authority or authorities having jurisdiction over the wetlands or marsh.
5) The Permanent Easement granted herein is for commercial purposes and may
be transferred and assigned by the Commission and its successors and assigns
with the consent of the Grantor.
6) The agreements contained herein shall be binding upon the Commission and
Grantor and their respective heirs, successors and Grantor authorized assigns.
It is further understood and agreed that this easement is not to be construed as an
easement granted to the exclusion of Grantor or to others later granted a similar
right. This easement is subject to all easements, permits, restrictions and
covenants of record, or of plats of record, or which may be revealed upon
inspection of the property.
TO HAVE TO HOLD, all and singular, the easement rights and privileges above described unto the COMMISSIONERS OF PUBLIC WORKS OF THE CITY OF CHARLESTON, SOUTH
CAROLINA, its successors and assigns, forever.
[Signature pages to follow]
43297563 v2 4 IN WITNESS WHEREOF, the undersigned has set its hand and seal this ____ day of
______2020.
GRANTOR:
WITNESSES: MEDICAL UNIVERSITY HOSPITAL AUTHORITY
______By: (SEAL)
Print Name:
______Its:
STATE OF SOUTH CAROLINA ) ) ACKNOWLEDGMENT COUNTY OF )
I, ______, Notary Public for the State of South Carolina, do hereby certify that MEDICAL UNIVERSITY HOSPITAL AUTHORITY by its , appeared before me this day and acknowledged the due execution of the foregoing instrument, on behalf of the limited liability company.
Subscribed to and sworn before me this day of , 2020.
Print Name: Notary Public, State of South Carolina My commission expires:
In accordance with provision § 10-1-130 of the Code of Laws of South Carolina, as amended, at its meeting held on ______, approval was given by the State Fiscal Accountability Authority to the Easement herein.
By: Delbert H. Singleton, Jr., Secretary for the Authority
43297563 v2 5 IN WITNESS WHEREOF, the undersigned has set its hand and seal this ____ day of
______2020.
THE COMMISSION:
WITNESSES: COMMISSIONERS OF PUBLIC WORKS OF THE CITY OF CHARLESTON, SOUTH CAROLINA
______By: ______(SEAL)
Print Name:
Its: ______
STATE OF SOUTH CAROLINA ) ) ACKNOWLEDGMENT COUNTY OF CHARLESTON )
I, ______, Notary Public for the State of South Carolina, do hereby certify that the COMMISSIONERS OF PUBLIC WORKS OF THE CITY OF CHARLESTON, SOUTH CAROLINA, by , its , personally appeared before me this day and acknowledged the due execution of the foregoing instrument, on behalf of the Commissioners.
Subscribed to and sworn before me this ______day of ______, 2020.
Print Name: Notary Public, State of South Carolina My commission expires:
43297563 v2 6 Insurance Addendum to Permanent & Temporary Utility Easements:
Article A.1 General
City shall cause each general Contractor to purchase and maintain insurance as set forth herein.
Article A.2 General
Prior to commencement of the work, the Contractor shall secure the insurance and provide the Grantor with evidence of the coverage required under this Contract with the City for the stormwater project, and upon the Grantor’s request, provide a copy of the policies required herein. The copy of the policy or polices provided shall contain all applicable conditions, definition, exclusions, and endorsements.
Liability Insurance
The Contractor shall be responsible for purchasing and maintaining the usual general liability insurance.
A.3.1 Certificates of Insurance.
The Contractor shall provide certificates of insurance to the Grantor evidencing compliance with the requirements of this Contract at the following times: 1) prior to commencement of the work; 2) upon renewal or replacement of each required policy of insurance; and 3) upon Grantor’s written request. An additional certificate evidencing the continuation of commercial liability coverage, including coverage for completed operations, shall be submitted to the Grantor with the final Application for Payment submitted to the City and thereafter upon renewal or replacement of such coverage until the expiration of the required herein in section A.3.2.1. The Certificates will show the Grantor as an additional insured on the Contractor’s Commercial General Lability and excess or umbrella liability policy or policies. Information concerning the reduction of coverage on account of revised limits or claims paid under the general aggregate, or both shall be furnished by the Contractor to Grantor with reasonable promptness.
A.3.1.2 Deductibles and Self-Insured Retentions.
The Contractor shall disclose to the Grantor any deductible or self-insured retentions applicable to any insurance required to be provided by the Contractor.
A.3.1.3 Additional Insured Obligations.
To the fullest extent permitted by law, the Contractor shall cause the commercial general liability coverage to include (1) the Grantor, the Architect/Engineer or their consultant as additional insured for the claims caused in whole or in part by the Contractor’s negligent acts or omissions during the Contractor’s operations; and 2) the Grantor as an additional insured for claims caused in whole or in part by the Contractor’s negligent acts or omissions for which loss occurs during completed operations. The additional insured coverage shall be primary and non-contributory to any of the Grantor’s general liability insurance policies and shall apply to both ongoing and completed operations, whether such operations be by the Contractor or by the Subcontractor or by anyone directly or indirectly employed by any of them, or by anyone for whose acts any of them may be liable. To the extent commercially available, the additional insured coverage shall be no less than that provided to the City for the Work referenced in this Contract, with respect to the Architect and the Architect’s and or design consultants.
1
A.3.1.4 A failure by the City to either i) demand a certificate of insurance or written endorsement required by section A.3, or ii) reject a certificate or endorsement on the grounds it fails to comply with Section A.3, shall not be considered a waiver of Contractor’s obligation to obtain the required insurance.
A.3.2 Contractor’s Required Insurance Coverage
The Contractor shall purchase and maintain the following types and limits of insurance from an insurance company or companies lawfully authorized to issue insurance in the jurisdiction where the Project is located. The Contractor shall maintain the required insurance until the expiration of the period for correction of work as set forth in this Contract, for such other period for maintenance of completed operations coverage as specified in the Contract documents, or unless different duration as below:
COMMERCIAL GENERAL LIABILITY: (Including premises or operations and contractual liability)
• Bodily Injury and Property Damage: o $1,000,000 Each Occurrence o $2,000,000 Aggregate (per project) • Products and Completed Operations coverage shall be maintained for (three) 3 years after final payment: $2,000,000 Aggregate
CONTRACTOR'S EXCESS (UMBRELLA) LIABILITY INSURANCE policy covering excess over the limits specified for all employer's liability, commercial general liability, and business auto liability with minimum limits of $5,000,000 aggregate per policy year.
A.3.2.1 Commercial General Liability
Commercial General Liability insurance for the Project written on an occurrence form with policy limits of as described in A.3.2 and not less than $1,000,000 each occurrence, $2,000,000 general aggregate, $1,000,000 aggregate for products completed operations hazard, $1,000,000 personal advertising injury, $50,000 fire damage (any one fire, and $5,000 medical expense (any one person) providing coverage for claims including:
1. Damages because of bodily injury, sickness, disease, including occupational sickness or disease, and death of any person; 2. Personal injury and advertising injury; 3. Damages because of physical damage to destruction of tangible property including loss of use of such property; 4. Bodily injury or property damage arising out of completed operations; and 5. The Contractor’s indemnity obligations to the City for the Contract re: installing a Stormwater System that connects the surface collection systems to a deep tunnel conveyance system servicing the Spring/Fisburne Basin within the Charleston Peninsula.
A.3.2.2 The Contractor’s Commercial General Liability policy under this Section A.3.2.2 shall not contain an exclusion or restriction of coverage for the following:
2
1. Claims by one insured against another insured, if the exclusion or restriction is based solely on the fact that the claimant is an insured, and there would otherwise be coverage for the claim. 2. Claims for property damage to the Contractor’s Work arising out of the products-completed operations hazard where the damaged work or the work out of which the damage arises was performed by a subcontractor. 3. Claim for bodily injury other than to employees of the insured. 4. Claims for indemnity under Contractor’s indemnity obligations to the City under its Contract re: installing a Stormwater System that connects the surface collection systems to a deep tunnel conveyance system servicing the Spring/Fisburne Basin within the Charleston Peninsula. 5. Claims or loss excluded under a prior work endorsement or other similar exclusionary language. 6. Claims or loss due to physical damage under a prior injury endorsement or similar exclusionary language 7. Claims related to residential, multifamily, or other habitational projects, if the work is to be performed on such a project, 8. Claims related to roofing, if the work involves roofing, 9. Claims related to exterior insulation finishing systems (EIFS), synthetic stucco or similar exterior coatings or surfaces if the work involves such coatings or surfaces. 10. Claims related to earth subsidence or movement, where the work involves such hazards. 11. Claims related to explosion, collapse and underground hazards, where the work involves such hazards.
A.3.2.3
Automobile Liability covering vehicles owned, and non-owned vehicle(s) used, by the Contractor, with policy limits of not less than $1,000,000 per accident, for bodily injury, death of a person, and property damage arising out of the ownership, maintenance, and use of those motor vehicles with any other statutorily required automobile coverage.
A.3.2.4 The Contractor may achieve required limits and coverage for Commercial Lability, Employers Liability, and Automobile Liability through a combination of primary and excess or umbrella liability insurance, provided such primary and excess umbrella insurance policies result in the same or greater coverages required under section A.3.2.2 and A .3.2.3, and in no event shall any excess or umbrella liability insurance provide narrower coverage that then primary policy. The excess policy shall not require the exhaustion of the underlying limits only through the actual payment by the underlying insurers. The umbrella policy limits shall not be less than $5,000,000.
A3.2.5 Worker’s Compensation Insurance as required by the State of South Carolina with statutorily limits.
A.3.2.6 Employer’s liability with policy limits of not less than $100,000 each accident; $100,000 each employee, and $500,000 policy limits for claims, disability benefit and other similar employee benefit acts that are applicable to the work to be performed.
A.3.2.7 Jones Act and Longshore &Harbor Worker’s Compensation Act, as required, if the work involves hazards arising from work on or near navigable waterways, including vessels and docks.
3
A.3.2.8 Insurance maritime liability risks associated with the operation of a vessel, if the work requires such activities, with policy limits of not less than $100,000 each accident, 100,000 each employee, and $500,000 policy limits for claims.
A.3.2.9 Insurance for the use or operation of a manned or unmanned aircraft, if the work requires such activities, with policy limits of not less than less than $100,000 each accident, 100,000 each employee, and $500,000 policy limits for claims.
A.3.3 Required Property Insurance
A.3.3.1 The Contractor shall purchase and maintain, from an insurance company or insurance companies lawfully authorized to issue insurance in the jurisdiction where the Project is located, property insurance written on a builder’s risk “all-risks” completed value or equivalent policy form and sufficient to cover the total value of the entire project on a replacement cost basis. The Contractor’s property insurance coverage shall not be less than the amount of the initial Contract Sum of the Contract with the City for the Stormwater Project, plus the value of subsequent modifications and labor performed and material for equipment supplied by others. The property insurance shall be maintained until substantial completion and thereafter as provided in Section A.3.3.1.3, unless otherwise provided in the Contract Documents or otherwise agreed to by all the parties to this agreement. The insurance shall include the interests of the Grantor, Contractor, and Subcontractors in the Project as insured.
A.3.3.2. Causes of Loss. The insurance required by this Section A.3.3.1 shall provide coverage for direct physical loss or damage and shall include the risks of fire (with extended coverage), explosion, theft , vandalism, malicious mischief, collapse, earthquake, flood, or windstorm. The insurance shall also provide coverage for ensuring loss or resulting damage from error, omission, or deficiency in construction methods, workmanships or materials.
A.3.3.3. Specific required Coverages. The insurance required by this Section A.3.3.1 shall provide coverage for loss of damage to falsework and other temporary structures, and to building systems from testing and startup. The insurance shall also cover debris removal, including demolition occasioned by enforcement of any applicable legal requirements, and reasonable compensation for the Architect’s and Contractor’s services and expenses required as a result of such insured loss, including claim preparations expenses.
A.3.3.4 Unless the parties agree otherwise, upon substantial completion, the City shall replace the insurance policy required under Section A.3.3.1 with property insurance written for the total value of the project.
A.3.3.5 If insurance required by this Section is subject to deductibles or self-insured retentions, the Contractor shall be responsible for all loss not covered because of such deductible or retentions.
A.3.3.6. If the Grantor requests in writing that insurance or risks other than those described herein or other special causes of loss be included in the property insurance policy, the Contractor, if possible, will include such insurance, and the cost thereof shall be charged to the City by appropriate Change Order.
A.3.3.7 Before an exposure to loss may occur, the Contractor shall file with Grantor a copy of each policy that includes insurances as required by this section A.3.3. Each policy shall contain all generally applicable conditions, definitions, exclusions and endorsements related to this Project.
A.3.4. Contractor’s Other Insurance Coverage
4
A.3.4.1 Insurance selected and described in this section A.3.4, if applicable to the project, shall be purchased from an insurance shall company or insurance companies lawfully authorized to issue insurance in the jurisdiction where the Project is located. The Contractor shall maintain the required insurance until the expiration of the period for correction of work as set forth in the Contract with the City for the Stormwater Project and beyond the state of limitations.
A.3.4.2 The Contractor shall purchase and maintain the following types and limits of insurance.
A.3.4.2.1 Reserved
A.3.4.2.2 Insurance for physical damage to property while it is in storage and in transit to the construction site on an “all-risks” completed value form.
A.3.4.2.3 Property insurance on an “all-risks” completed value form, covering property owned by the Contractor and used on the Project, including scaffolding and other equipment.
A.3.4.2.4 Boiler and Machinery Insurance
The Contractor shall purchase and maintain boiler and machinery insurance as required, which shall specifically cover such injured objects during installation and until final acceptance by the City; this insurance shall include the interests of the Grantor, Contractor, Sub-Contractors and Sub-sub Contractors in the Work, and the Grantor and City shall be named insureds.
A.3.5 Third Party Indemnification
Without limitation and notwithstanding any provision in this agreement, the Contractor shall indemnify and hold harmless the Indemnitees for and against claims, damages, losses, expenses (including attorney’s fees) asserted by a third party against an Indemnitee arising or resulting from negligent acts or omissions of the Contractor, a consultant, or anyone directly or indirectly employed by them or anyone for whose acts they may be liable, regardless of whether or not such claim, damage, loss or expense is attributable to bodily injury, sickness, disease or death, or to injury to or destruction of tangible properly (other than the Work itself). The Contractor shall not be required to indemnify an Indemnitee to the extent of the Indemnitee’s damages result from Indemnitee’s own negligence. Such obligation shall not be construed to negate, abridge, reduce any other rights, including any other obligations of indemnity, which would otherwise exist as to a party or person described in this Section A.3.5. As used in this paragraph, “Indemnitees” means the State (including its instrumentalities, agencies, departments, boards, political subdivisions), the Contractor, the subcontractors at all tiers, and the officers, agents and employees of all the forgoing.
B. Architect/Engineer/Design Expert (hereinafter “Architect”) Insurance Coverages
B 2.5 The Architect and all other professional consultants for the Stormwater System that connects a surface collection system to a deep tunnel conveyance system serving the Spring/Fishburne Basin within the Charleston Peninsula shall procure and maintain in effect during the term of the Work the professional insurance coverages described below, which insurance shall be placed with insurance companies authorized to do business in the State of South Carolina and rated A minus VII or better by the current edition of Best’s Key rating Guide or otherwise approved by City and Grantor. If any of the
5
B.2.5.7.1. Prior to performing services, and thereafter upon replacement of each required policy of insurance, the Architect shall provide to the Grantor a written endorsement to the Architect’s general Liability Insurance Policy that (i) names the Grantor, its officials, employers, and volunteers, as additional insureds, and states ii) that coverage shall not be cancelled, except with notice to Grantor.
B2.5.7.2 Information concerning the reduction of coverage on account of revised limits or claims paid under the General Aggregate, or both, shall be furnished by the Architect with reasonable promptness.
B.2.5.8 Insurance Requirements for Consultants
The Architect agrees to require its consultants and sub-consultants to comply with the insurance provisions required of the Architect pursuant to this agreement unless the Architect, the City and the Grantor mutually agree to modify these requirements for the consultants whose work is relatively small scope. The Architect agrees that it will contractually obligate its consultants to advise the Architect promptly of any changes or lapses if the requisite insurance coverages and the Architect agrees to promptly advise the City and the Grantor of any such notices the Architect receives form its consultants. The Architect agrees that it will contractually obligate its consultants to indemnify and hold harmless the Grantor for consultant’s negligent acts or omissions.
B.2.5.9 Additional Requirements
The Architect shall not make changes in or allow the required insurance coverages to lapse without the Grantor’s prior written approval thereto. Should notice of cancellation be issued for non-payment of premiums or any part thereof, or should the Architect fail to provide and maintain certificates as set forth herein, the City and or Grantor shall have the right, but not the obligation to pay such premium to the insurance company or to obtain such coverage and seek reimbursement for said payments from the Architect. Any sums paid by the Grantor shall be due and payable immediately by the Architect upon notice from the Grantor. Receipt and Review by the City of any copies of insurance policies or insurance certificates shall not relieve the Architect of his obligation to comply with the insurance provisions of this Agreement. The insurance provisions of this Agreement shall not be construed as a limitation on the Architect’s responsibilities and liabilities pursuant to the terms and conditions of its Agreement with the City.
B2.5.10 Certificates of Insurance
B2.5.10.1 The Architect shall provide certificates of insurance to the Grantor that evidence compliance with the requirements in this Section B 2.5.
B2.5.10.2 Prior to performing services, and thereafter upon renewal or replacement of each required policy of insurance, the Architect shall provide to the Grantor a signed, original certificate of liability (if applicable ACORD 25). The certificate shall identify the types of insurance, state the limits of liability for each type of coverage, include a provision for written notice prior to cancellation as set forth in Section B2.5.7(ii), name the Grantor as a Certificate Holder, provide the general aggregate limit applies per project, and provide that coverage is written on a occurrence basis. Both the certificates and the endorsements must be received directly from with the Architect’s insurance agent or the insurance company.
B.3.5 Third Party Indemnification
7
Without limitation and notwithstanding any provision in this agreement, the Architect shall indemnify and hold harmless the Indemnitees for and against claims, damages, losses, expenses (including attorney’s fees) asserted by a third party against an Indemnitee arising or resulting from negligent acts or omissions of the Architect, a consultant, or anyone directly or indirectly employed by them or anyone for whose acts they may be liable, regardless of whether or not such claim, damage, loss or expense is attributable to bodily injury, sickness, disease or death, or to injury to or destruction of tangible properly (other than the Work itself). The Architect shall not be required to indemnify an Indemnitee to the extent of the Indemnitee’s damages result from Indemnitee’s own negligence. Such obligation shall not be construed to negate, abridge, reduce any other rights, including any other obligations of indemnity, which would otherwise exist as to a party or person described in this Section B.3.5. As used in this paragraph, “Indemnitees” means the State (including its instrumentalities, agencies, departments, boards, political subdivisions), the Contractor, the subcontractors at all tiers, and the officers, agents and employees of all the forgoing.
8
FACILITIES ACADEMIC EASEMENT FOR APPROVAL
DECEMBER 11, 2020
DESCRIPTION OF EASEMENT: City of Charleston Stormwater Drainage Project
REQUESTOR: City of Charleston
REQUESTOR CONTACT: Frank Newham, City of Charleston
LOCATION: TMS 460-11-04-027 91 President Street TMS 460-15-01-017 100 Doughty Street TMS 460-15-01-027 43 Bee Street
DESCRIPTION: The City of Charleston plans to install and maintain a Stormwater Collection and Conveyance System that connects a surface collection system to a deep tunnel conveyance system serving the Spring/Fishburne Basin within the Charleston Peninsula. The Stormwater System will serve as the main source for the conveyance of stormwater for a portion of the Charleston Peninsula requiring a rights-of-way and utility easement under and across property owned by the Medical University of South Carolina.
JUSTIFICATION: Support the City of Charleston’s comprehensive master drainage plan to improve quality of life in the City of Charleston including the Charleston Medical District.
STATE OF SOUTH CAROLINA ) ) PERMANENT & TEMPORARY COUNTY OF CHARLESTON ) UTILITY EASEMENTS
WHEREAS, the Medical University' of South Carolina is the owner in control and
possession of certain parcels of land in the City of Charleston which are designated by Charleston
County tax map numbers 460-11-04-027, 460-15-01-017 and 460-15-01-027 (the “Property”); and
WHEREAS the City of Charleston plans to install and maintain a Stormwater Collection and Conveyance System (the “Stormwater System”) that connects a surface collection system to
a deep tunnel conveyance system serving the Spring/Fishburne Basin within the Charleston
Peninsula; and
WHEREAS, the Stormwater System will serve as the main source for the conveyance of
stormwater for a portion of the Charleston Peninsula identified as the Spring/Fishburne Basin; and
WHEREAS, the City of Charleston desires to route a portion of the Stormwater System so
as to locate it on and beneath the Property; and
WHEREAS, the City of Charleston has requested rights-of-way and utility easements
under and across the Property as described in Attachment A – Easement Plat, which the Medical
University of South Carolina has agreed to grant under the following terms and conditions.
NOW, THEREFORE, KNOW ALL MEN BY THESE PRESENTS, that the MEDICAL
UNIVERSITY OF SOUTH CAROLINA (“Grantor”), in consideration of the sum of One dollar
and 0/100ths ($1.00) to the Grantor in hand paid for the right-of-way and utility easements granted
hereunder, at and before the sealing of these presents, by the CITY OF CHARLESTON the receipt
of which is hereby acknowledged, has, subject to all matters of record in the Register of Deeds
1 Office for Charleston County, South Carolina and to all matters that an inspection of the Property
and/or a true and correct survey of the Property would show (collectively, the “Permitted
Exceptions”) granted, bargained, sold and released, and by these presents does grant, bargain, sell and release unto the CITY OF CHARLESTON (the “City” or “Grantee”), its successors and assigns forever, the following rights-of-way and easements:
(1) Permanent, transferable subsurface tunnel easements as described in Attachment
A – Easement Plat (collectively, the “Subsurface Tunnel Easement”) for a public
purpose under and across those certain portions of the Property designated as
“NEW PERMANENT 40’ COC SUBSURFACE TUNNEL EASEMENT, 0.32
ACRE (13,938 SF),” “NEW PERMANENT 40’ COC SUBSURFACE TUNNEL
EASEMENT, 0.06 ACRE (2,736 SF),” and “NEW PERMANENT 40’ COC
SUBSURFACE TUNNEL EASEMENT: 0.002 ACRE (81 SF),” on a plat entitled
“EASEMENT PLAT SHOWING TMS# 460-15-01-(017 & 027), TMS# 460-11-04-
027, PROPERTY OF THE MEDICAL UNIVERSITY OF SOUTH CAROLINA &
TMS# 460-15-01-(023, 024 & 026) PROPERTY OF THE HEALTH SCIENCE
FOUNDATION OF THE MEDICAL UNIVERSITY OF SC CREATING A
PERMANENT 40’ SUBSURFACE TUNNEL EASEMENT, PERMANENT
EXCLUSIVE DRAINAGE EASEMENT & TEMPORARY CONSTRUCTION
EASEMENT AS SHOWN TO BE ACQUIRED BY THE CITY OF CHARLESTON
LOCATED CITY OF CHARLESTON, CHARLESTON COUNTY, SOUTH
CAROLINA, D&F JOB #: 031874.00,” by Kevin Thewes (S.C.R.L.S. No. 21627)
of Davis & Floyd, Inc., dated March 11, 2020 and recorded on
______, in Plat Book ___ at Page ____ in the Register
2 of Deeds Office for Charleston County, South Carolina (the “Plat”).
Said Subsurface Tunnel Easement is shown as being contained within a portion of
the Property designated as “NEW PERMANENT 40’ COC SUBSURFACE
TUNNEL EASEMENT” on said Plat and has such size, shape, dimensions,
buttings and boundings as by reference to said Plat will more fully appear.
Together with the right to lay, construct, locate, install, operate, maintain, inspect
repair and replace an underground stormwater conveyance tunnel within the
Subsurface Tunnel Easement below the surface of the Property as described in
Attachment A – Easement Plat.
(2) A permanent and transferable stormwater drainage easement (the “Drainage
Easement”) for a public purpose over, under, and across that certain portion of the
Property designated as “NEW PERMANENT VARIABLE WIDTH COC
EXCLUSIVE DE: 0.04 ACRE (1,844 SF)” on the Plat. It is understood and agreed
that this easement is not to be construed as an easement granted to the exclusion of
Grantor or to others later granted a similar right. The Drainage Easement is shown
as being contained within a portion of the Property designated as “TMS# 460-15-
01-017” on said Plat and has such size, shape, dimensions, buttings and boundings
as by reference to said Plat will more fully appear.
(3) A temporary construction easement (the “Temporary Construction Easement”)
for a public purpose (as specified in Paragraph 4 below) over, under, and across
that certain portion of the Property designated as “NEW TEMPORARY
VARIABLE WIDTH COC CONSTRUCTION EASEMENT: 0.14 ACRE (6,225
SF)” on the Plat. The Temporary Construction Easement is shown as being
3 contained within a portion of the Property designated as “TMS# 460-15-01-017”
on said Plat and has such size, shape, dimensions, buttings and boundings as by
reference to said Plat will more fully appear.
(4) The City, its agents and independent contractors shall have, during the duration
of the Temporary Construction Easement, the right of ingress and egress to the
land contained within the Temporary Construction Easement as shown on the Plat
and described in Paragraph 3 above for purposes of construction, periodic
inspection, maintenance, repair and replacement as necessary to construct the
drop shaft, vortex box, deep tunnel, and associated surface drainage system
components for the Stormwater System. The Temporary Construction Easement
shall terminate upon the earlier of the completion of the portion of the drainage
project designated as “Ehrhardt Drainage Improvement Project” by the City or
______. The termination of such authorization shall be
automatic and without the necessity of any further documentation or action by the
Parties hereto; provided, however, that upon reasonable request of any one of the
Parties, a written agreement in recordable form prepared at the cost of the Party
so requesting shall be executed by the Parties hereto to evidence such termination.
(5) The easement areas contained within the Subsurface Tunnel Easement, Drainage
Easement, and Temporary Construction Easement shall collectively be identified
as the Easement Area.
IT IS FURTHER AGREED between the parties that the CITY OF CHARLESTON shall be responsible for the following:
(1) All landscape shrubs, trees and surface improvements that were removed to
4 requirements set forth below are in addition to types and limits of insurance the Architect normally maintains, the Architect shall purchase such coverage(s) prior to commencement of the project.
B.2.5.1 Commercial General Liability Insurance (CGL): The CGL shall provide coverage on an “occurrence” basis with bodily injury and property damage, including products-completed operations, personal injury, advertising injury, with limits no less than $1,000,000 per occurrence. If a general aggregate limit applies, either the general aggregate limit shall apply separately to the project or the general aggregate shall be twice the required occurrence limit. The contract shall be considered an “insured Contract” as defined in the policy.
B.2.5.2 Automobile Liability Insurance: Any auto owned by the Architect, or if they have no owned vehicle, but utilize non-owned vehicles, those vehicles will have limits of not less than $1,000,000 per accident for bodily injury and property damage.
B2.5.3. The Architect may achieve the required limits and coverage for Commercial General Liability and Automobile Liability through a combination of primary and excess or umbrella liability insurance, provided such primary and excess or umbrella liability insurance policies result in the same or greater coverages required under Sections B2.5.1 and B2.5.2, and in no event shall any excess or liability insurance provide narrower coverage than the primary policy. The excess policy shall not require the exhaustion of underlying limits only through the actual payment by the underlying insurers.
B2.5.4 Worker’s Compensation Insurance as required by the State of South Carolina with statutorily limits.
B.2.5.5 Employer’s liability with policy limits of not less than $100,000 each accident.
B.2.5.6 Professional Liability Insurance covering negligent acts and omissions in the performance of professional services with policy limits of not less than $1,000,000 per claim and $3,000,000 in the aggregate.
B2.5.6.1 If Professional Liability policy provides coverage on a claims-made and reported basis:
1. The Retroactive Date must be shown and must be before the date of this Contractor the beginning of the Architect’s work, whichever is earlier. 2. The insurance must be maintained, and evidence of insurance must be provided to the City, for at least 5 years after completion of the Architect’s work under the Agreement with the City. 3. If coverage is cancelled or non-renewed, and not replaced with another claims-made policy form with a Retroactive Date before the date of this agreement or the beginning of the Architect’s work, whichever is earlier, the Architect must purchase “extended reporting” coverage for a minimum of five (5) years after the completion of the Architect’s work under its agreement with the City. 4. The Architect shall give prompt written notice to the Grantor of all claims made against the policy during the period in which the policy is required to be maintained.
B.2.5.7 Additional Insured Obligations
To the fullest extent permitted by law, the Architect shall cause the primary and excess or umbrella policies for Commercial General Liability and Automobile Liability to include Grantor, its officers, officials, employees and volunteers, as additional insureds for claims cased in whole or in party by the Architect’s negligent acts or omissions. The additional insured coverage shall be primary and non-contributory to any of the Grantor’s insurance policies and shall apply to ongoing and completed operations.
6
construct the temporary laydown yard contained in the Temporary Construction
Easement area and as shown on the Plat will be promptly replaced with shrubs,
trees of equivalent size to that which was removed, provided they are compatible
with being placed within close proximity to a storm drain. All existing lawn that
has been disturbed during construction will be promptly replaced with sod. All
existing landscaping materials, barriers and fences will be replaced or restored as
it was prior to construction. All irrigation system components will be promptly
replaced, connected into the existing irrigation system and restored to full
operation, as it was prior to construction. Once the plants, shrubs, trees and/or sod,
as needed, have been placed within the Temporary Construction Easement by the
City, the Grantor shall be responsible for maintaining the materials placed in the
Temporary Construction Easement.
(2) Construction activities within the Temporary Construction Easement will
commence no earlier than ______and will be completed no later than
______. The City will strive to complete all identified work and return the
Temporary Construction Easement area to Grantor at the earliest feasible
opportunity.
(3) The City shall cause each contractor, architect, engineer and professional
consultants which shall provide materials, labor or services within the Easement
Area to purchase and maintain commercial general liability insurance as described
in the attached insurance addendum which is incorporated herein by reference as
Insurance Addendum to Permanent & Temporary Utility Easements (attached
hereto as Exhibit B).
5 (4) Evidence of Contractor’s insurance, to include but not be limited to certificates of
insurance and policies shall be provided to Grantor as follows via first class mail
to:
Office of General Counsel, MUSC
C/O MUSC Health
22 WestEdge, Suite 300
Charleston, SC 29403
TOGETHER with all the rights and privileges, if and to the extent the same do not
materially and negatively impact the Property, necessary or convenient for the full enjoyment or use of said Subsurface Tunnel Easement, Drainage Easement, and Temporary Construction
Easement.
AND it is further agreed between the parties that:
(1) The Grantor and its successors and assigns shall have the right to construct a
structure within the portion of the Property subject to the Subsurface Tunnel
Easement. Provided however, the Grantor agrees for itself and its successors and
assigns that, in the event a structure is constructed within the portion of the
Property subject to the Subsurface Tunnel Easement, no portion of said structure,
including but not limited to the foundation and pilings, will penetrate the
Subsurface Tunnel Easement to depths exceeding negative ninety-five feet (-
95.0'), referenced to the North American Vertical Datum of 1988 (NAVD88). See
“ Easement Section View (TYP)” on said Plat, which is incorporated herein by
reference.
(2) The Subsurface Tunnel Easement and Drainage Easement will run with the land
6 and continue to exist so long as they are used for utility purposes. And, in the
event the City should abandon or not use the Subsurface Tunnel Easement and
Drainage Easement for a consecutive period of (2) years, with or without written
notice to the Grantor, the City will have given up all rights to such easements.
The Subsurface Tunnel Easement, Drainage Easement, and/or Temporary
Construction Easement may also be terminated by Grantor in the event of the
City’s failure to comply with the terms and conditions of this instrument.
(3) The Subsurface Tunnel Easement and Drainage Easement granted herein are for
a public purpose and may be transferred and assigned by the City and its
successors and assigns with authorized Grantor approval.
(4) The agreements contained herein shall be binding upon the City of Charleston
and Grantor and their respective successors and assigns.
(5) The Grantee shall ensure that all of its activities involving the easements are in
compliance with all existing, and any future, applicable environmental, historical,
cultural protection and all other laws, statutes and regulations, including, but not
limited to: the Federal Water Pollution Control Act (a.k.a. the Clean Water Act),
33 U.S.C § 1251 et seq.; the Safe Drinking Water Act, 42 U.S.C § 300f et seq.;
The Clean Air Act, 42 U.S.C §7401 et seq.; the Resource Conservation and
Recovery Act, 42 U.S.C §6901 et seq.; the Toxic Substances Control Act, 15
U.S.C §2601 et seq.; the Coastal Zone Management Act, 16 U.S.C § 1451 et
seq.; the Federal Insecticide, Fungicide, and Rodenticide Act 7 U.S.C § 136 et
seq.; National Historic Preservation Act, 16 U.S.C §470 et seq.; and the
Endangered Species Act, 16 U.S.C §1531 et seq.; as well as any applicable
7 state or local laws or regulations.
(6) The Grantee may not unlawfully pollute the air, ground, or water, nor create a
public nuisance. The Grantee shall, at no cost to the Grantor, promptly comply
with all applicable federal, state, and local laws, regulations, or directives
regulating the quality of the environment and use of the Property for the purposes
set forth herein. This does not affect the Grantee’s right to contest the validity
of such laws, regulations, or directives or to try to enjoin their applicability.
(7) The Grantee shall use all required means to protect the environment, natural
resources and the balance of the Property from any damage arising from the
Grantee’s use of the Property and activities incident to such use.
(8) Grantee acknowledges responsibility for the torts and environmental and other
liabilities of Grantee and Grantee’s employees in the same manner and to the same
extent as a private individual under like circumstances, subject to the limitations
upon liability and damages, and exemptions from liability and damages, contained
in the South Carolina Tort Claims Act (the “Act”), codified at sections 15-78-10 to
-220 of the South Carolina Code, as the Act as applicable and as may be amended
from time to time.
(9) If any damage results to the environment or natural resources or to any portion of
the Property as a result of the rights granted herein, the Grantee shall promptly
restore the environment, damaged resources and/or Property at Grantee’s sole
cost and expense. The Grantee shall be solely responsible for all environmental
cleanup costs, any claims for damage done to any natural resources or to any
portion of the Property resulting from the Grantee’s use of the Property
8 and activities incident to such use.
(10) Notwithstanding the foregoing, the Grantor may be liable for the costs of any
environmental cleanup required for contamination which existed prior to the
execution of this agreement (except to the extent such existing contamination is
exacerbated or made evident by the actions of the Grantee or the existence of this
Easement, in which event the same shall be the sole responsibility of the Grantee),
or which Grantor causes after the execution of this document (except to the extent
resulting from the presence of this Easement , in which event the same shall be the
sole responsibility of the Grantee except to the extent caused by the negligent acts
of Grantor). “Environmental cleanup” as used herein means the remediation of any
environmental damage as required by any federal, state, or local regulatory agency
having jurisdiction over the area.
(11) The Grantee shall obtain any and all required federal, state and local environmental
permits, licenses and/or approvals prior to commencement of construction.
(12) The Subsurface Tunnel Easement, Drainage Easement, and Temporary
Construction Easement are conveyed without interference with, or prejudice to, the
rights of the Grantor, except so far as is reasonably necessary in the exercise of the
rights-of-way and easements hereby granted, and there are reserved to the Grantor
all its respective rights in, and to, the use of its land lying within said rights-of-
way and easements for all lawful purposes not inconsistent with the City’s use of
such easements for the purposes mentioned herein.
TO HAVE AND TO HOLD subject to the Permitted Exceptions, all and singular, the easement rights and privileges above described unto the CITY OF CHARLESTON, its successors
9 and assigns, forever.
IN WITNESS WHEREOF, the MEDICAL UNIVERSITY OF SOUTH CAROLINA has set its hand and seal this ____ day of ______2020.
THE MEDICAL UNIVERSITY OF SOUTH CAROLINA
By: ______(SIGNATURE)
Printed Name: ______
Its: ______TITLE Date
Witness: ______Printed Name
______Signature Date
Witness: ______Printed Name
______Signature Date
STATE OF SOUTH CAROLINA ) ) ACKNOWLEDGEMENT COUNTY OF CHARLESTON )
I, ______, Notary Public for the State of South Carolina, do hereby certify the MEDICAL UNIVERSITY OF SOUTH CAROLINA, by ______, its ______, personally appeared before me this day and acknowledged the due execution of the foregoing instrument.
Subscribed to and sworn before me this _____ day of ______2020.
______Notary Public for the State of South Carolina My commission expires: ______
In accordance with provision of §10-1-130 Code of Laws by South Carolina, as amended, at its meeting held on _____ day of ______, 2020, approval was given by the STATE
10 FISCAL ACCOUNTABILITY AUTHORITY to the easement herein.
11
DTCGS 1281-04-RP-0003E
IN WITNESS WHEREOF, the City of Charleston has caused these presents to be executed as of the date set forth below.
Signed, Sealed and Delivered in the CITY OF CHARLESTON Presence of:
______By: ______First Witness Name: John J. Tecklenburg Print Name: ______Its: Mayor
______Date: ______Second Witness Print Name: ______
STATE OF SOUTH CAROLINA ) ) ACKNOWLEDGEMENT COUNTY OF CHARLESTON )
I, ______, a Notary Public for South Carolina, do hereby certify that the CITY OF CHARLESTON, by John J. Tecklenburg, its Mayor, personally appeared before me this day and acknowledged the due execution of the foregoing instrument.
Witness my hand and seal this _____ day of ______, 2020.
______Notary Public for South Carolina Print Name: ______My Commission Expires: ______
12
Insurance Addendum to Permanent & Temporary Utility Easements:
Article A.1 General
City shall cause each general Contractor to purchase and maintain insurance as set forth herein.
Article A.2 General
Prior to commencement of the work, the Contractor shall secure the insurance and provide the Grantor with evidence of the coverage required under this Contract with the City for the stormwater project, and upon the Grantor’s request, provide a copy of the policies required herein. The copy of the policy or polices provided shall contain all applicable conditions, definition, exclusions, and endorsements.
Liability Insurance
The Contractor shall be responsible for purchasing and maintaining the usual general liability insurance.
A.3.1 Certificates of Insurance.
The Contractor shall provide certificates of insurance to the Grantor evidencing compliance with the requirements of this Contract at the following times: 1) prior to commencement of the work; 2) upon renewal or replacement of each required policy of insurance; and 3) upon Grantor’s written request. An additional certificate evidencing the continuation of commercial liability coverage, including coverage for completed operations, shall be submitted to the Grantor with the final Application for Payment submitted to the City and thereafter upon renewal or replacement of such coverage until the expiration of the required herein in section A.3.2.1. The Certificates will show the Grantor as an additional insured on the Contractor’s Commercial General Lability and excess or umbrella liability policy or policies. Information concerning the reduction of coverage on account of revised limits or claims paid under the general aggregate, or both shall be furnished by the Contractor to Grantor with reasonable promptness.
A.3.1.2 Deductibles and Self-Insured Retentions.
The Contractor shall disclose to the Grantor any deductible or self-insured retentions applicable to any insurance required to be provided by the Contractor.
A.3.1.3 Additional Insured Obligations.
To the fullest extent permitted by law, the Contractor shall cause the commercial general liability coverage to include (1) the Grantor, the Architect/Engineer or their consultant as additional insured for the claims caused in whole or in part by the Contractor’s negligent acts or omissions during the Contractor’s operations; and 2) the Grantor as an additional insured for claims caused in whole or in part by the Contractor’s negligent acts or omissions for which loss occurs during completed operations. The additional insured coverage shall be primary and non-contributory to any of the Grantor’s general liability insurance policies and shall apply to both ongoing and completed operations, whether such operations be by the Contractor or by the Subcontractor or by anyone directly or indirectly employed by any of them, or by anyone for whose acts any of them may be liable. To the extent commercially available, the additional insured coverage shall be no less than that provided to the City for the Work referenced in this Contract, with respect to the Architect and the Architect’s and or design consultants.
1
A.3.1.4 A failure by the City to either i) demand a certificate of insurance or written endorsement required by section A.3, or ii) reject a certificate or endorsement on the grounds it fails to comply with Section A.3, shall not be considered a waiver of Contractor’s obligation to obtain the required insurance.
A.3.2 Contractor’s Required Insurance Coverage
The Contractor shall purchase and maintain the following types and limits of insurance from an insurance company or companies lawfully authorized to issue insurance in the jurisdiction where the Project is located. The Contractor shall maintain the required insurance until the expiration of the period for correction of work as set forth in this Contract, for such other period for maintenance of completed operations coverage as specified in the Contract documents, or unless different duration as below:
COMMERCIAL GENERAL LIABILITY: (Including premises or operations and contractual liability)
• Bodily Injury and Property Damage: o $1,000,000 Each Occurrence o $2,000,000 Aggregate (per project) • Products and Completed Operations coverage shall be maintained for (three) 3 years after final payment: $2,000,000 Aggregate
CONTRACTOR'S EXCESS (UMBRELLA) LIABILITY INSURANCE policy covering excess over the limits specified for all employer's liability, commercial general liability, and business auto liability with minimum limits of $5,000,000 aggregate per policy year.
A.3.2.1 Commercial General Liability
Commercial General Liability insurance for the Project written on an occurrence form with policy limits of as described in A.3.2 and not less than $1,000,000 each occurrence, $2,000,000 general aggregate, $1,000,000 aggregate for products completed operations hazard, $1,000,000 personal advertising injury, $50,000 fire damage (any one fire, and $5,000 medical expense (any one person) providing coverage for claims including:
1. Damages because of bodily injury, sickness, disease, including occupational sickness or disease, and death of any person; 2. Personal injury and advertising injury; 3. Damages because of physical damage to destruction of tangible property including loss of use of such property; 4. Bodily injury or property damage arising out of completed operations; and 5. The Contractor’s indemnity obligations to the City for the Contract re: installing a Stormwater System that connects the surface collection systems to a deep tunnel conveyance system servicing the Spring/Fisburne Basin within the Charleston Peninsula.
A.3.2.2 The Contractor’s Commercial General Liability policy under this Section A.3.2.2 shall not contain an exclusion or restriction of coverage for the following:
2
1. Claims by one insured against another insured, if the exclusion or restriction is based solely on the fact that the claimant is an insured, and there would otherwise be coverage for the claim. 2. Claims for property damage to the Contractor’s Work arising out of the products-completed operations hazard where the damaged work or the work out of which the damage arises was performed by a subcontractor. 3. Claim for bodily injury other than to employees of the insured. 4. Claims for indemnity under Contractor’s indemnity obligations to the City under its Contract re: installing a Stormwater System that connects the surface collection systems to a deep tunnel conveyance system servicing the Spring/Fisburne Basin within the Charleston Peninsula. 5. Claims or loss excluded under a prior work endorsement or other similar exclusionary language. 6. Claims or loss due to physical damage under a prior injury endorsement or similar exclusionary language 7. Claims related to residential, multifamily, or other habitational projects, if the work is to be performed on such a project, 8. Claims related to roofing, if the work involves roofing, 9. Claims related to exterior insulation finishing systems (EIFS), synthetic stucco or similar exterior coatings or surfaces if the work involves such coatings or surfaces. 10. Claims related to earth subsidence or movement, where the work involves such hazards. 11. Claims related to explosion, collapse and underground hazards, where the work involves such hazards.
A.3.2.3
Automobile Liability covering vehicles owned, and non-owned vehicle(s) used, by the Contractor, with policy limits of not less than $1,000,000 per accident, for bodily injury, death of a person, and property damage arising out of the ownership, maintenance, and use of those motor vehicles with any other statutorily required automobile coverage.
A.3.2.4 The Contractor may achieve required limits and coverage for Commercial Lability, Employers Liability, and Automobile Liability through a combination of primary and excess or umbrella liability insurance, provided such primary and excess umbrella insurance policies result in the same or greater coverages required under section A.3.2.2 and A .3.2.3, and in no event shall any excess or umbrella liability insurance provide narrower coverage that then primary policy. The excess policy shall not require the exhaustion of the underlying limits only through the actual payment by the underlying insurers. The umbrella policy limits shall not be less than $5,000,000.
A3.2.5 Worker’s Compensation Insurance as required by the State of South Carolina with statutorily limits.
A.3.2.6 Employer’s liability with policy limits of not less than $100,000 each accident; $100,000 each employee, and $500,000 policy limits for claims, disability benefit and other similar employee benefit acts that are applicable to the work to be performed.
A.3.2.7 Jones Act and Longshore &Harbor Worker’s Compensation Act, as required, if the work involves hazards arising from work on or near navigable waterways, including vessels and docks.
3
A.3.2.8 Insurance maritime liability risks associated with the operation of a vessel, if the work requires such activities, with policy limits of not less than $100,000 each accident, 100,000 each employee, and $500,000 policy limits for claims.
A.3.2.9 Insurance for the use or operation of a manned or unmanned aircraft, if the work requires such activities, with policy limits of not less than less than $100,000 each accident, 100,000 each employee, and $500,000 policy limits for claims.
A.3.3 Required Property Insurance
A.3.3.1 The Contractor shall purchase and maintain, from an insurance company or insurance companies lawfully authorized to issue insurance in the jurisdiction where the Project is located, property insurance written on a builder’s risk “all-risks” completed value or equivalent policy form and sufficient to cover the total value of the entire project on a replacement cost basis. The Contractor’s property insurance coverage shall not be less than the amount of the initial Contract Sum of the Contract with the City for the Stormwater Project, plus the value of subsequent modifications and labor performed and material for equipment supplied by others. The property insurance shall be maintained until substantial completion and thereafter as provided in Section A.3.3.1.3, unless otherwise provided in the Contract Documents or otherwise agreed to by all the parties to this agreement. The insurance shall include the interests of the Grantor, Contractor, and Subcontractors in the Project as insured.
A.3.3.2. Causes of Loss. The insurance required by this Section A.3.3.1 shall provide coverage for direct physical loss or damage and shall include the risks of fire (with extended coverage), explosion, theft , vandalism, malicious mischief, collapse, earthquake, flood, or windstorm. The insurance shall also provide coverage for ensuring loss or resulting damage from error, omission, or deficiency in construction methods, workmanships or materials.
A.3.3.3. Specific required Coverages. The insurance required by this Section A.3.3.1 shall provide coverage for loss of damage to falsework and other temporary structures, and to building systems from testing and startup. The insurance shall also cover debris removal, including demolition occasioned by enforcement of any applicable legal requirements, and reasonable compensation for the Architect’s and Contractor’s services and expenses required as a result of such insured loss, including claim preparations expenses.
A.3.3.4 Unless the parties agree otherwise, upon substantial completion, the City shall replace the insurance policy required under Section A.3.3.1 with property insurance written for the total value of the project.
A.3.3.5 If insurance required by this Section is subject to deductibles or self-insured retentions, the Contractor shall be responsible for all loss not covered because of such deductible or retentions.
A.3.3.6. If the Grantor requests in writing that insurance or risks other than those described herein or other special causes of loss be included in the property insurance policy, the Contractor, if possible, will include such insurance, and the cost thereof shall be charged to the City by appropriate Change Order.
A.3.3.7 Before an exposure to loss may occur, the Contractor shall file with Grantor a copy of each policy that includes insurances as required by this section A.3.3. Each policy shall contain all generally applicable conditions, definitions, exclusions and endorsements related to this Project.
A.3.4. Contractor’s Other Insurance Coverage
4
A.3.4.1 Insurance selected and described in this section A.3.4, if applicable to the project, shall be purchased from an insurance shall company or insurance companies lawfully authorized to issue insurance in the jurisdiction where the Project is located. The Contractor shall maintain the required insurance until the expiration of the period for correction of work as set forth in the Contract with the City for the Stormwater Project and beyond the state of limitations.
A.3.4.2 The Contractor shall purchase and maintain the following types and limits of insurance.
A.3.4.2.1 Reserved
A.3.4.2.2 Insurance for physical damage to property while it is in storage and in transit to the construction site on an “all-risks” completed value form.
A.3.4.2.3 Property insurance on an “all-risks” completed value form, covering property owned by the Contractor and used on the Project, including scaffolding and other equipment.
A.3.4.2.4 Boiler and Machinery Insurance
The Contractor shall purchase and maintain boiler and machinery insurance as required, which shall specifically cover such injured objects during installation and until final acceptance by the City; this insurance shall include the interests of the Grantor, Contractor, Sub-Contractors and Sub-sub Contractors in the Work, and the Grantor and City shall be named insureds.
A.3.5 Third Party Indemnification
Without limitation and notwithstanding any provision in this agreement, the Contractor shall indemnify and hold harmless the Indemnitees for and against claims, damages, losses, expenses (including attorney’s fees) asserted by a third party against an Indemnitee arising or resulting from negligent acts or omissions of the Contractor, a consultant, or anyone directly or indirectly employed by them or anyone for whose acts they may be liable, regardless of whether or not such claim, damage, loss or expense is attributable to bodily injury, sickness, disease or death, or to injury to or destruction of tangible properly (other than the Work itself). The Contractor shall not be required to indemnify an Indemnitee to the extent of the Indemnitee’s damages result from Indemnitee’s own negligence. Such obligation shall not be construed to negate, abridge, reduce any other rights, including any other obligations of indemnity, which would otherwise exist as to a party or person described in this Section A.3.5. As used in this paragraph, “Indemnitees” means the State (including its instrumentalities, agencies, departments, boards, political subdivisions), the Contractor, the subcontractors at all tiers, and the officers, agents and employees of all the forgoing.
B. Architect/Engineer/Design Expert (hereinafter “Architect”) Insurance Coverages
B 2.5 The Architect and all other professional consultants for the Stormwater System that connects a surface collection system to a deep tunnel conveyance system serving the Spring/Fishburne Basin within the Charleston Peninsula shall procure and maintain in effect during the term of the Work the professional insurance coverages described below, which insurance shall be placed with insurance companies authorized to do business in the State of South Carolina and rated A minus VII or better by the current edition of Best’s Key rating Guide or otherwise approved by City and Grantor. If any of the
5 requirements set forth below are in addition to types and limits of insurance the Architect normally maintains, the Architect shall purchase such coverage(s) prior to commencement of the project.
B.2.5.1 Commercial General Liability Insurance (CGL): The CGL shall provide coverage on an “occurrence” basis with bodily injury and property damage, including products-completed operations, personal injury, advertising injury, with limits no less than $1,000,000 per occurrence. If a general aggregate limit applies, either the general aggregate limit shall apply separately to the project or the general aggregate shall be twice the required occurrence limit. The contract shall be considered an “insured Contract” as defined in the policy.
B.2.5.2 Automobile Liability Insurance: Any auto owned by the Architect, or if they have no owned vehicle, but utilize non-owned vehicles, those vehicles will have limits of not less than $1,000,000 per accident for bodily injury and property damage.
B2.5.3. The Architect may achieve the required limits and coverage for Commercial General Liability and Automobile Liability through a combination of primary and excess or umbrella liability insurance, provided such primary and excess or umbrella liability insurance policies result in the same or greater coverages required under Sections B2.5.1 and B2.5.2, and in no event shall any excess or liability insurance provide narrower coverage than the primary policy. The excess policy shall not require the exhaustion of underlying limits only through the actual payment by the underlying insurers.
B2.5.4 Worker’s Compensation Insurance as required by the State of South Carolina with statutorily limits.
B.2.5.5 Employer’s liability with policy limits of not less than $100,000 each accident.
B.2.5.6 Professional Liability Insurance covering negligent acts and omissions in the performance of professional services with policy limits of not less than $1,000,000 per claim and $3,000,000 in the aggregate.
B2.5.6.1 If Professional Liability policy provides coverage on a claims-made and reported basis:
1. The Retroactive Date must be shown and must be before the date of this Contractor the beginning of the Architect’s work, whichever is earlier. 2. The insurance must be maintained, and evidence of insurance must be provided to the City, for at least 5 years after completion of the Architect’s work under the Agreement with the City. 3. If coverage is cancelled or non-renewed, and not replaced with another claims-made policy form with a Retroactive Date before the date of this agreement or the beginning of the Architect’s work, whichever is earlier, the Architect must purchase “extended reporting” coverage for a minimum of five (5) years after the completion of the Architect’s work under its agreement with the City. 4. The Architect shall give prompt written notice to the Grantor of all claims made against the policy during the period in which the policy is required to be maintained.
B.2.5.7 Additional Insured Obligations
To the fullest extent permitted by law, the Architect shall cause the primary and excess or umbrella policies for Commercial General Liability and Automobile Liability to include Grantor, its officers, officials, employees and volunteers, as additional insureds for claims cased in whole or in party by the Architect’s negligent acts or omissions. The additional insured coverage shall be primary and non-contributory to any of the Grantor’s insurance policies and shall apply to ongoing and completed operations.
6
B.2.5.7.1. Prior to performing services, and thereafter upon replacement of each required policy of insurance, the Architect shall provide to the Grantor a written endorsement to the Architect’s general Liability Insurance Policy that (i) names the Grantor, its officials, employers, and volunteers, as additional insureds, and states ii) that coverage shall not be cancelled, except with notice to Grantor.
B2.5.7.2 Information concerning the reduction of coverage on account of revised limits or claims paid under the General Aggregate, or both, shall be furnished by the Architect with reasonable promptness.
B.2.5.8 Insurance Requirements for Consultants
The Architect agrees to require its consultants and sub-consultants to comply with the insurance provisions required of the Architect pursuant to this agreement unless the Architect, the City and the Grantor mutually agree to modify these requirements for the consultants whose work is relatively small scope. The Architect agrees that it will contractually obligate its consultants to advise the Architect promptly of any changes or lapses if the requisite insurance coverages and the Architect agrees to promptly advise the City and the Grantor of any such notices the Architect receives form its consultants. The Architect agrees that it will contractually obligate its consultants to indemnify and hold harmless the Grantor for consultant’s negligent acts or omissions.
B.2.5.9 Additional Requirements
The Architect shall not make changes in or allow the required insurance coverages to lapse without the Grantor’s prior written approval thereto. Should notice of cancellation be issued for non-payment of premiums or any part thereof, or should the Architect fail to provide and maintain certificates as set forth herein, the City and or Grantor shall have the right, but not the obligation to pay such premium to the insurance company or to obtain such coverage and seek reimbursement for said payments from the Architect. Any sums paid by the Grantor shall be due and payable immediately by the Architect upon notice from the Grantor. Receipt and Review by the City of any copies of insurance policies or insurance certificates shall not relieve the Architect of his obligation to comply with the insurance provisions of this Agreement. The insurance provisions of this Agreement shall not be construed as a limitation on the Architect’s responsibilities and liabilities pursuant to the terms and conditions of its Agreement with the City.
B2.5.10 Certificates of Insurance
B2.5.10.1 The Architect shall provide certificates of insurance to the Grantor that evidence compliance with the requirements in this Section B 2.5.
B2.5.10.2 Prior to performing services, and thereafter upon renewal or replacement of each required policy of insurance, the Architect shall provide to the Grantor a signed, original certificate of liability (if applicable ACORD 25). The certificate shall identify the types of insurance, state the limits of liability for each type of coverage, include a provision for written notice prior to cancellation as set forth in Section B2.5.7(ii), name the Grantor as a Certificate Holder, provide the general aggregate limit applies per project, and provide that coverage is written on a occurrence basis. Both the certificates and the endorsements must be received directly from with the Architect’s insurance agent or the insurance company.
B.3.5 Third Party Indemnification
7
Without limitation and notwithstanding any provision in this agreement, the Architect shall indemnify and hold harmless the Indemnitees for and against claims, damages, losses, expenses (including attorney’s fees) asserted by a third party against an Indemnitee arising or resulting from negligent acts or omissions of the Architect, a consultant, or anyone directly or indirectly employed by them or anyone for whose acts they may be liable, regardless of whether or not such claim, damage, loss or expense is attributable to bodily injury, sickness, disease or death, or to injury to or destruction of tangible properly (other than the Work itself). The Architect shall not be required to indemnify an Indemnitee to the extent of the Indemnitee’s damages result from Indemnitee’s own negligence. Such obligation shall not be construed to negate, abridge, reduce any other rights, including any other obligations of indemnity, which would otherwise exist as to a party or person described in this Section B.3.5. As used in this paragraph, “Indemnitees” means the State (including its instrumentalities, agencies, departments, boards, political subdivisions), the Contractor, the subcontractors at all tiers, and the officers, agents and employees of all the forgoing.
8
MEDICAL UNIVERSITY OF SOUTH CAROLINA (MUSC) BOARD OF TRUSTEES REGULAR AGENDA December 11, 2020 101 Colcock Hall/Via Teleconference
Members of the Board of Trustees
Dr. James Lemon, Chairman Dr. Richard M. Christian, Jr. Mr. Charles Schulze, Vice-Chairman Dr. Paul T. Davis Ms. Terri R. Barnes Dr. Donald R. Johnson II The Honorable James A. Battle, Jr. Ms. Barbara Johnson-Williams Mr. William H. Bingham, Sr. Dr. G. Murrell Smith, Sr. Dr. W. Melvin Brown III Mr. Michael E. Stavrinakis Dr. Henry F. Butehorn III Thomas L. Stephenson, Esq. Dr. C. Guy Castles III Dr. Bartlett J. Witherspoon, Jr.
Trustees Emeriti Mrs. Margaret M. Addison Dr. Charles B. Thomas, Jr. Mr. Allan E. Stalvey Dr. James E. Wiseman, Jr.
Item 1. Call to Order ...... Dr. James Lemon Chairman
Item 2. Roll Call ...... Jane Scutt Assistant Board Secretary
Item 3. Date of Next Meeting – February 12, 2021 ...... Jane Scutt Assistant Board Secretary
Item 4. Approval of Meeting Minutes of October 9, 2020 ...... Dr. James Lemon Chairman
Recommendations and Informational Report of the President: Dr. David Cole
Item 5. Other Business ...... Dr. David Cole President
Research and Institutional Advancement Committee: Ms. Terri Barnes, Chair
Item 6. Institutional Advancement Report ...... Kate Azizi Vice President for Institutional Advancement
Item 7. MUSC Foundation Report ...... Stuart Ames CEO, MUSC Foundation
Item 8. Research Report...... Dr. Kathleen Brady Vice President for Research
Item 9. Foundation for Research Development Report ...... Michael Rusnak Executive Director, Foundation for Research Development
Item 10. Other Committee Business ...... Terri Barnes Committee Chair
Education, Faculty & Student Affairs Committee: Ms. Barbara Johnson-Williams, Chair
Item 11. Graduate Medical Education (GME) Update ...... Dr. Benjamin Clyburn Associate Dean for Graduate Medical Education
Item 12. Provost Report ...... Dr. Lisa Saladin Executive Vice President for Academic Affairs and Provost
Item 13. Appointment of Vice President for Research ...... Dr. Lisa Saladin Associate Dean for Graduate Medical Education
Item 14. Other Committee Business ...... Barbara Johnson-Williams Committee Chair
Finance and Administration Committee: Mr. Jim Battle, Chair
Item 15. MUSC Financial Report ...... Patrick Wamsley Chief Financial Officer, MUSC
Item 16. MUSC Physicians Financial Report...... Eva Greenwood Chief Financial Officer, MUSC Physicians
Item 17. Other Committee Business ...... Jim Battle Committee Chair
Other Business for the Board of Trustees: Dr. James Lemon, Chair
Item 18. Approval of Consent Agenda ...... Dr. James Lemon Chairman
Item 19. Executive Session ...... Dr. James Lemon Chairman
Upon proper motion and vote, the Board may convene a closed session pursuant to SC Code Ann. §30-4-70. Although the Board will not vote on any items discussed in closed session, the Board may return to public session to vote on items discussed.
Item 20. New Business for the Board of Trustees ...... Dr. James Lemon Chairman
Item 21. Report from the Chairman ...... Dr. James Lemon Chairman
MUSC Office of Development and Alumni Affairs MUSC Board of Trustees Update November 2020
As of Nov. 18, 2020, the Office of Development and Alumni Affairs had received $17,268,104 in gifts and pledges. We are pleased to share the following highlights, which have taken place since the last meeting of the Board of Trustees.
• The Beemok Family Foundation has made a three-year commitment totaling $2,250,000 to underwrite the Lowvelo fundraising event for MUSC Hollings Cancer Center.
• Alfred and Janet Lombardi have made a planned gift of $2 million to MUSC. Of this amount, $1 million is dedicated to Storm Eye Institute’s general fund and $1 million to MUSC’s general fund.
• The MUSC College of Nursing has received $1,580,000 in grants from the Duke Endowment to support the following projects:
o To promote diversity in the South Carolina health care work force by training underrepresented minority students. ($313,000) o To expand a trauma resilience and recovery program across the Carolinas. ($585,000) o To develop, test and implement a post-graduate psychiatric mental health nurse practitioners’ residency program that will exclusively use a virtual telehealth model to reach underserved communities. ($685,000)
• The College of Medicine received an estate gift of $510,000 from Mrs. Linda Belk to benefit the Dr. H. Dean Belk Endowed Fund for Education in Occupational Medicine.
• Dr. and Mrs. Jonathan Kil have made a $500,000 pledge to support the Chairman's Endowed Chair in Otolaryngology-Head and Neck Surgery
• The Patterson Barclay Memorial Foundation made a $500,000 pledge payment to the Transplant Research Institute, the second of 3 towards their $1.5 million commitment.
• Anita Zucker has made a $357,000 payment toward a $5 million pledge to the Zucker Family Atrium in the MUSC Shawn Jenkins Children’s Hospital.
• The Boeing Company has made a $200,000 gift to support the Boeing Center for Promotion of Healthy Lifestyles in Children and Families.
• Gary Cooper made a $200,000 pledge commitment in support of the Elliott-Robison Endowed Chair in Vascular Surgery.
• Susan Flanagan made a $200,000 pledge commitment in support of the Elliott-Robison Endowed Chair in Vascular Surgery in the MUSC Heart & Vascular Center.
• SEGRA has made a $200,000 gift to support the MUSC Shawn Jenkins Children’s Hospital building.
• Leigh Walker Sherman made an additional planned gift commitment of $200,000 to the Davis Walker Heart Fund in the Heart & Vascular Center.
• Mrs. Harriet McDougal made a $103,331 gift of stock to support Dr. Daniel Judge and the amyloid program at the Heart & Vascular Center.
• Dr. Christopher Clare has made a $100,000 gift to support the College of Nursing.
• Dr. Felicia Goins contributed $100,000 to establish the Dr. Felicia L. Goins Endowed Scholarship Fund in the College of Dental Medicine. The purpose of the fund is to provide a scholarship to a minority dental student who is interested in becoming a pediatric dentist. Dr. Goins is a graduate of Howard University and practices pediatric dentistry in Columbia. She serves as a volunteer and member of the college’s Friends of MUSC Minority Scholarship Committee.
• The MUSC Health Heart & Vascular Center has launched a $100,000 matching gift campaign in support of the Global Health for Cardiology – Tanzania Fund during a virtual event which raised commitments of $26,200, including a $5,000 gift from Mr. and Mrs. Douglas Bolton.
• Dr. Robert Sade made an $81,500 payment to the Robert M Sade Endowed Chair in Pediatric Cardiac Surgery and a new gift of $8,100 to the Dr. William H. Lee, Jr. Memorial Fund.
• The estate of Fabian X. Schupper has made a gift of $78,617 to the Fabian X. Schupper Fund in the Department of Medicine. This is in addition to a previous pledge of $140,000.
• Medtronic has made a commitment of $75,000 for the Neuro Endovascular Surgery (NES) Department to be used for the purpose of educational activities and events.
• TD Charitable Foundation has made a $75,000 gift to support MUSC Hollings Cancer Center.
• Dentsply Sirona has donated a Primescan Intraoral Scanner, valued at $69,995, for use in the dental school’s Department of Oral Rehabilitation. The state-of-the-art technology captures more data in higher resolution and quicker processing time, with increased sharpness and with better precision, which allows indications from single-tooth to full-arch treatments. The unit also has enhanced connectivity which allows easier communication with labs and other partners.
• Blue Cross Blue Shield of South Carolina Foundation has donated $65,000 for support of the College of Dental Medicine’s existing Duke Endowment grant entitled “School-based Oral Health Expansion Initiative – Readiness and Planning Project.” The grant will help develop care delivery and business plans of school-based, prevention-oriented programs.
• Patrick and Maureen Marr have pledged $60,000 to endow the Patrick and Maureen Marr Scholarship in the College of Nursing. • The estate of Arthur L. Haisten has made a final distribution of $50,000 to the Arthur L. Haisten Fund in the James B. Edwards College of Dental Medicine. The late Dr. Haisten, who served as dean of the college, and his wife, Wanda, left half of their entire estate, more than $1 million to the college.
• Harriett Daughtridge Harris made a gift commitment of $50,000 to the Seinsheimer Cardiovascular Disease Prevention Program in support of Dr. Pamela Morris.
• Robert J. Lukey of Myrtle Beach pledged $50,000 to establish the John L. Covington and Robert J. Lukey Scholarship Fund in the College of Dental Medicine, in memory of his late spouse, John Covington, Dental Class of ’88, who passed away in January.
• Dr. Julian McGill, a former faculty member in the MUSC College of Pharmacy, has committed to endowing the Julian E. and Ann M. McGill Scholarship at the $50,000 level. Scholarship support remains a top priority for the college, including increasing the number of endowed scholarships.
• The South Carolina Academy of Pediatric Dentistry has pledged $50,000 to establish the South Carolina Academy of Pediatric Dentistry Faculty Endowment for the Postgraduate Program in Pediatric Dentistry to supplement faculty salaries in the program.
• Ron Stokes has made an additional contribution to his planned gift in the amount of $50,000 to the Murray Center for Research on Parkinson's Disease & Related Disorders.
• An anonymous benefactor has made a $50,000 gift in support of Dr. Norris' EDS lab.
• Dr. and Mrs. Richard Sanders donated $45,000 to the Richard J. Sanders, M.D., and Dorothy M. Sanders Endowed Scholarship in the College of Medicine.
• Mr. and Mrs. David Wallace made a $37,500 pledge commitment in support of the Elliott- Robison Endowed Chair in Vascular Surgery.
• Mr. and Mrs. James Ramich made two gifts: a $10,309 gift of stock to the MUSC Heart & Vascular Fund and another $25,278.96 gift of stock in support of the Elliott-Robison Endowed Chair in Vascular Surgery.
• Capers H. Poulnot has given $30,000 to support the Sandra Hayes Poulnot Nursing Scholarship in the College of Nursing
• William and Karyn Hewitt gave a one-time gift of $29,886.92 towards the Laura M. and William B. Hewitt Endowed Chair in Ophthalmology at the Storm Eye Institute.
• Ruth and Bill Baker gave a one-time $25,000 towards the Grady Lyman Fund that supports the work of Dr. Edward Wilson and Dr. Rupil Travidi in the Storm Eye Institute.
• The MUSC Arboretum has launched a $20,000 matching gift campaign in celebration of its 10th Anniversary. Dr. Jerry Reves, former dean of the College of Medicine, made a pledge commitment of $5,000 in support of the campaign.
• John Ray has given $20,000 in unrestricted funding to the General University Fund.
• Acteon, North America donated a Piezotome Cube and related surgical items valued at nearly $17,000 to the graduate periodontics program in the College of Dental Medicine. The Piezotome Cube is an ultrasonic surgical system that supply utilities to and serve as a base for dental tips. The Piezotome Cube consists of a control unit and handpiece designed for use in intraoral surgery procedures including osteotomy, osteoplasty, periodontics and implantology.
• Dr. and Mrs. Dennis Feinberg made a verbal commitment of $15,000 in support of the Seinsheimer Cardiovascular Disease Prevention Program in support of Dr. Pamela Morris.
• Sonny Rao has made a contribution of $6,500, which was matched by an employer gift from Google, for a total of $13,000 to the Sushma Rao Memorial Scholarship.
• Spiro C. Vallis has given $12,250 to the Olympia "Bia" Vallis Nursing Scholarship in the College of Nursing.
• John Winthrop made two gifts totaling $11,000 in support of the 10th Anniversary Celebration of the MUSC Arboretum.
• Hyman Bielsky, a donor dedicated to research and innovation, donated $10,000 to the Zucker Institute for Applied Neurosciences (ZIAN).
• Mr. and Mrs. Theodore Levin made a $10,000 gift to the Heart & Vascular Fund.
• Matt Prisby made a contribution of $10,000 to his late wife’s memorial fund in the MUSC Hollings Cancer Center, the Sheryl Prisby Scholarship in Gynecological Oncology.
• Kendra Scott, M.D., made a $10,000 gift to the Underrepresented in Medicine Endowed Scholarship in the College of Medicine.
• Bruce Switzer, M.D., made a $10,000 gift to the Underrepresented in Medicine Endowed Scholarship.
• An anonymous donor gave $10,000 to the John A. Siegling, M.D., Endowed Chair in Orthopedics in the College of Medicine
THE MEDICAL UNIVERSITY OF SOUTH CAROLINA Monthly Financial Reports Table of Contents For the Four (4) Month Period Ended October 31, 2020
Page
Statement of Net Position 1
University Budgeted Funds Comparison to Budget 2
Direct Expenditures on Federal Grants and Contracts (By Responsibility Center) 3
Notes to the Financial Statements 4-5
Summary of Current Debt Obligations and Analysis of Available Bonded Debt Capacity 6
Statement of Revenues, Expenses and Changes in Net Position For Affiliated Organizations 7 The Medical University of South Carolina and Affiliated Organizations Statement of Net Position As of October 31, 2020 Area Health CHS Education Development University Consortium Company
Assets & Deferred Outflows
Cash and Cash Equivalents$ 370,077,129 $ 9,473,578 $ - Cash and Cash Equivalents - Restricted 27,348,344 - 623,323 State Appropriation Receivable 63,594,997 5,576,292 - Student Tuition and Fees Receivable 1,898,819 - - Student Loan Receivable 11,487,090 - - Grants and Contracts Receivable 45,560,727 132,406 - Capital Improvement Bond Proceeds Receivable - - - Capital Lease Receivable - - 7,400,063 Other Receivables 3,197,359 - - Investments - - 1,452,822 Prepaid Items 15,846,857 - 499,645 Capital Assets, net of Accumulated Depreciation 384,731,457 - - Due from Hospital Authority 5,889,781 - - Due from Other Funds 107,482,579 - - Bond Issue Costs - - - Derivative Instruments Fair Value / Deferred Outflows - - - Deferred loss on Debt Refinancing 47,351 - 96,900 Deferred Outflows-Pensions 72,357,229 - - Deferred Outflows-OPEB 79,853,552 Other Assets - - -
Total Assets & Deferred Outflows $ 1,189,373,271 $ 15,182,276 $ 10,072,753 Liabilities & Deferred Inflows
Accounts Payable $ 12,029,968 $ - $ - Accrued Payroll and Other Payroll Liabilities 17,621,523 - - Accrued Compensated Absences 29,743,454 180,710 - Deferred Revenue 96,491,260 7,439,752 - Retainages Payable 42,865 - - Long-Term Debt 135,702,437 - 8,840,000 Interest Payable 1,111,367 - 66,300 Deposits Held for Others 4,332,787 94,921 - Due to Hospital Authority - - - Due to Other Funds 4,826,676 - - Federal Loan Program Liability 12,411,194 - - Derivative Instruments Fair Value / Deferred Inflows - - - Net Pension Liability 514,712,234 - - Net OPEB Liability 509,768,131 Deferred Inflows-Pensions 4,309,649 - - Deferred Inflows-OPEB 51,092,898 Other Liabilities 38,070,721 - -
Total Liabilities & Deferred Inflows $ 1,432,267,164 $ 7,715,383 $ 8,906,300
Net Position (242,893,893) 7,466,893 1,166,453
Total Liabilities & Deferred Inflows and Net Position $ 1,189,373,271 $ 15,182,276 $ 10,072,753
1 of 7 The Medical University of South Carolina Budgeted Funds Comparison to Budget (Expenses Classified by Category) For the period ending October 31, 2020 Prorated Budget Budget (Note) Actual Variance Revenues Federal Grants & Contracts$ 136,128,555 $ 45,376,185 $ 46,758,378 $ 1,382,193 F Federal Grants Indirect Cost Recoveries 40,139,244 13,379,748 13,189,506 (190,242) U State Grants & Contracts 9,773,003 3,257,668 3,487,881 230,213 F Private Grants & Contracts 24,342,418 8,114,139 7,737,538 (376,601) U Private Grants Indirect Cost Recoveries 5,033,996 1,677,999 1,522,266 (155,733) U Total Grants & Contracts 215,417,216 71,805,739 72,695,569 889,830 F State Appropriations 71,816,999 23,939,000 23,939,000 - F Tuition and Fees 107,213,434 35,249,912 35,090,395 (159,517) U Pass-Through Revenues 87,328,707 29,109,569 29,751,363 641,794 F Gifts 21,776,671 7,258,890 3,566,017 (3,692,873) U Transfers from (to) MUSC Physicians 85,098,905 28,366,302 25,830,762 (2,535,540) U Sales and Services of Educational Departments 14,072,069 4,690,690 4,913,120 222,430 F Sales and Services of Auxiliary Enterprises 14,840,354 4,946,785 3,755,619 (1,191,166) U Interest and Investment Income 12,741 4,247 (29,723) (33,970) U Endowment Income 4,025,898 1,341,966 1,335,905 (6,061) U Miscellaneous 14,849,539 4,949,846 6,052,276 1,102,430 F Miscellaneous - Residents 7,800,000 2,600,000 2,730,000 130,000 F Authority Revenue 89,164,598 29,721,533 23,393,545 (6,327,988) U Authority Revenue - Residents 66,922,788 22,307,596 22,068,493 (239,103) U Intra-Institutional Sales 45,186,778 15,062,259 9,707,039 (5,355,220) U Total Other 630,109,481 209,548,595 192,103,811 (17,444,784) U Total Revenues 845,526,697 281,354,334 264,799,380 (16,554,954) U Expenditures Salaries$ 328,504,153 $ 109,501,386 $ 100,535,262 $ 8,966,124 F Miscellaneous Personnel Expenditures 4,918,805 1,639,602 1,884,814 (245,212) U Fringe Benefits 126,098,343 42,032,781 39,421,653 2,611,128 F Total Personnel $ 459,521,301 $ 153,173,769 $ 141,841,729 $ 11,332,040 F Contractual Services$ 150,669,252 $ 50,223,085 $ 44,631,759 $ 5,591,326 F Pass-through Expenditures 87,328,707 29,109,569 29,751,363 (641,794) U Supplies 53,071,849 17,690,616 14,720,614 2,970,002 F Fixed Charges 53,138,469 17,712,823 15,160,169 2,552,654 F Equipment 8,649,609 2,883,203 2,070,377 812,826 F Travel 5,232,848 1,744,283 72,515 1,671,768 F Trainee / Scholarships 20,737,403 6,912,468 6,727,428 185,040 F Other Expenses 5,030,944 1,676,981 301,138 1,375,843 F Debt Service 5,564,630 1,854,877 1,854,877 - F Total Other$ 389,423,711 $ 129,807,905 $ 115,290,240 $ 14,517,665 F Total Expenditures$ 848,945,012 $ 282,981,674 $ 257,131,969 $ 25,849,705 F Other Additions (Deductions) Transfers from(to) Plant Funds (14,062,292) (4,687,431) (8,525,822) (3,838,391) U Other Transfers (47,611) (15,870) (404,319) (388,449) U Prior Year Fund Balance Usage 18,213,517 6,071,172 4,144,737 (1,926,435) U Total Other Additions (Deductions)$ 4,103,614 $ 1,367,871 $ (4,785,404) $ (6,153,275) U NET INCREASE (DECREASE) in Fund Balance $ 685,299 $ (259,469) $ 2,882,007 $ 3,141,476 F
Non-Budgeted Items Net Unfunded Pension Expense (9,970,385) Net Unfunded OPEB Expense (3,717,875) Depreciation (12,039,671) Endowment Gains/Losses 4,846,373 Gain (Loss) on Disposition of Property 13,103 Other Non-Budgeted Items 3,405,984 SRECNP Bottom Line (14,580,464)
2 of 7 The Medical University of South Carolina Direct Expenditures on Federal Grants and Contracts (By Responsibility Center) For the 4 Month Period Ending October 31, 2020
Administration 1,034,202
College of Dental Medicine 641,193
College of Graduate Studies 365,209
College of Health Professions 1,867,611
College of Medicine 39,943,824
College of Nursing 1,489,228
College of Pharmacy 343,095
Hollings Cancer Center 867,237
Library 196,227
Office of Sponsored Programs 10,552
$46,758,378
NOTE: The federal direct expenditures shown above were incurred by the University. The federal grant and contract revenue earned to cover these direct expenditures was $46,758,378.
In addition to this federal grant and contract revenue, the University received $13,189,506 in federal monies to reimburse it for Facilites and Administration (F+A) costs incurred to administer the above federal grants and contracts. $13,093,715 of the F+A recoveries received is unrestricted which means the University can use it for any of its operating needs. The remaining $95,791 represents the F+A recoveries on non-research federal grants and contracts. This amount is required to be remitted to the State.
University direct federal expenditures $46,758,378 Facilites and Administration costs $13,189,506
Federal operating grants and contracts $59,947,884
3 of 7 THE MEDICAL UNIVERSITY OF SOUTH CAROLINA NOTES TO THE FINANCIAL STATEMENTS October 31, 2020
Note 1. Basis of Presentation This financial statement provides summarized information for The Medical University of South Carolina (MUSC) and its affiliated organizations in discrete columns on the same page. The purpose of this financial report is to provide information that will be helpful to those who must make decisions about MUSC.
Note 2. State Appropriations State appropriations revenue is prorated evenly over the twelve month period for which the funds are to be spent.
Note 3. Cash and Cash Equivalents - Restricted Cash and cash equivalents - restricted include bond proceeds, the debt service reserve accounts, and the debt service fund accounts.
Note 4. Capital Assets, Net of Accumulated Depreciation The University's capital assets, net of accumulated depreciation consists of the following:
Construction in progress$ 11,521,568 Land/Bldgs/Equipment/Accumulated depreciation 373,209,889 Capital Assets, Net of Accumulated Depreciation$ 384,731,457
Note 5. Construction in Progress Construction in progress consists of the following projects and expenditures to date and is included in Capital Assets, Net of Accumulated Depreciation on the Statement of Net Position.
Jun 30, 2020Fiscal Year 2021 Oct 31, 2020 Balance Added Capitalized Balance
Energy Performance Contract$ 3,144,870 $ 2,228,812 $ - $ 5,373,682 BSB Exterior Envelope Repairs 970,235 599,245 - 1,569,480 SEI Chiller Replacement 901,645 129,166 - 1,030,811 New College of Pharmacy Addition 3,258,353 15,241 - 3,273,594 Others less than $1,000,000 (ending balance) 1,129,897 (855,896) - 274,001 Total construction in progress$ 9,405,000 $ 2,116,568 $ - $ 11,521,568
Note 6. Deferred Revenue The University's deferred revenue consists of the following:
State appropriations $ 62,732,587 Grants and contracts 12,525,725 Student tuition and fees 18,738,547 Other 2,494,401 Total Deferred Revenue$ 96,491,260
4 of 7 THE MEDICAL UNIVERSITY OF SOUTH CAROLINA NOTES TO THE FINANCIAL STATEMENTS October 31, 2020
Note 7. Long Term Liabilities The University's long term liabilities consist of the following:
Obligations under capital leases$ 47,021,301 Higher Ed Refunded Revenue bond payable 19,465,000 State Institution bonds payable 35,095,000 Energy Performance Note Payable 30,881,657 Premium on State Institution bonds payable 1,979,172 Premium on Refunding Revenue Bonds 1,260,307 Total Long Term Liabilities$ 135,702,437
Note 8. Summary of Net Position The University implemented GASB Statement No. 68, Accounting and Financial Reporting for Pensions in fiscal year 2015 and GASB Statement No. 75, Accounting and Financial Reporting for Post Employment Benefits Other Than Pensions (OPEB) in fiscal year 2018. These statements require participating employers to report their proportionate share of the plans' net pension liability and OPEB liabilities, pension and OPEB expense and deferred outflows and inflows. In fiscal year 2020, excluding the GASB 68 and GASB 75 impact, the University's unrestricted net position decreased $14.8 million for a total of $150.6 million. In fiscal year 2019, excluding the GASB 68 and GASB 75 impact, the University's net position increased $28.2 million for a total of $165.4 million. In fiscal year 2018, excluding the GASB 68 and GASB 75 impact, the University's unrestricted net position increased $0.6 million for at total of $137.2 million. In fiscal year 2017, excluding the GASB 68 impact, the University's unrestricted net position increased $10.5 million for a total of $136.7 million.
Per annual CAFR FY2020 FY2019 FY2018 FY2017
Net investment in capital assets $ 281,488,661 $ 290,960,785 $ 318,787,398 $ 335,952,501 Restricted Nonexpendable 92,884,333 91,997,286 91,314,812 90,977,372 Expendable 119,736,905 113,211,622 99,701,424 93,054,368 Unrestricted (exclusive of GASB 68 and 75 liabilities) 150,579,907 165,423,830 137,210,133 136,658,030 Unrestricted (including GASB 68 and 75 liabilities) (868,396,874) (841,631,771) (812,662,227) (346,845,010) Total net position $ (223,707,068) $ (180,038,248) $ (165,648,460) $ 309,797,261
5 of 7 Medical University of South Carolina Summary of Current Debt Obligations
($$ in thousands)
Outstanding & Original Authorized as of Issue Purpose 31-Oct-2020
State Institution Bonds (SIB) SIB 2011D 18,950 Deferred maintenance projects 12,005 SIB 2012B refunding 12,645 Refunding SIB 2001C, 2003D, & 2003J 3,150 SIB 2016D 30,095 Refunding SIB 2005A & convert BAN 19,940 $ 122,735
Current SIB Debt Authorized and Issued $ 35,095
Construction of College Health Notes Payable - JEDA $ 32,985 Health Profession facilities $ 8,840
Refunding Revenue Bonds, Series 2017 2017$ 25,115 Refunding of Higher Ed Revenue Bonds$ 19,465
Energy Performance Note Payable EPNP 02-27-19$ 30,000 Energy Savings$ 30,882
6 of 7 MUSC Affiliated Organizations Statement of Revenues, Expenses and Changes in Net Position For the Four (4) Month Period Ending October 31, 2020 Area Health CHS Education Development Consortium Company
Operating Revenues Student Tuition and Fees$ - $ - Federal Grants and Contracts 227,574 - State Grants and Contracts 30,107 - Local Government Grants and Contracts - - Nongovernmental Grants and Contracts 50,000 - Sales and Services to Hospital Authority 130,000 - Sales and Services of Educational and Other Activities 240 - Sales and Services of Auxiliary Enterprises - - Interest Income - 112,333 Other Operating Revenues 54,893 - Total Operating Revenues 492,814 112,333
Operating Expenses Compensation and Employee Benefits 936,389 - Pension Benefits OPEB Expense Services and Supplies 409,090 - Utilities - - Scholarships and Fellowships 7,500 - Refunds to Grantors - - Interest Expense - 73,059 Depreciation and Amortization - 52,116 Total Operating Expenses 1,352,979 125,175
Operating Income (Loss) (860,165) (12,842)
Nonoperating Revenues (Expenses) State Appropriations 3,719,876 - State Appropriations - MUHA - - Gifts and Grants Received - - Investment Income - - Interest Expense 292 - Gain (Loss) on Disposal of Capital Assets - - Transfers From (To) Other State Agencies - - Other Nonoperating Revenues (Expenses), net - - Net Nonoperating Revenues (Expenses) 3,720,168 -
Income (Loss) Before Other Revenues, Expenses, Gains, Losses and Transfers 2,860,003 (12,842)
Capital Appropriations - - Capital Grants and Gifts - - Additions to Permanent Endowments - - Transfers From (To) MUSC Physicians (UMA) - - Transfers From (To) AHEC 539 - Transfers From (To) CHS Development - (2,804) Transfers From (To) Facilities Corporation - - Increase (Decrease) In Net Position $ 2,860,542 $ (15,646)
7 of 7 Dh^WŚLJƐŝĐŝĂŶƐĂŶĚ Carolina Family Care /ŶƚĞƌŝŵ&ŝŶĂŶĐŝĂů^ƚĂƚĞŵĞŶƚƐ &ŽƌƚŚĞfour ŵŽŶƚŚƉĞƌŝŽĚĞŶĚŝŶŐ October 31͕ϮϬ20
Dh^W džĞĐƵƚŝǀĞ^ƵŵŵĂƌLJ ϭ
Dh^WĐƚƵĂůƚŽƵĚŐĞƚsĂƌŝĂŶĐĞ Ϯ
Dh^W^ƚĂƚĞŵĞŶƚŽĨEĞƚWŽƐŝƚŝŽŶ ϯͲϰ
CFC džĞĐƵƚŝǀĞ^ƵŵŵĂƌLJ ϱ
CFCĐƚƵĂůƚŽƵĚŐĞƚsĂƌŝĂŶĐĞ ϲ
CFC^ƚĂƚĞŵĞŶƚŽĨEĞƚWŽƐŝƚŝŽŶ ϳͲϴ
CFC^ƚĂƚĞŵĞŶƚŽĨZĞǀĞŶƵĞƐ͕ džƉĞŶƐĞƐ͕ĂŶĚ ϵ ŚĂŶŐĞƐŝŶEĞƚWŽƐŝƚŝŽŶͲĚĞƚĂŝůĞĚ
CFC^ƚĂƚĞŵĞŶƚŽĨZĞǀĞŶƵĞƐ͕ džƉĞŶƐĞƐ͕ĂŶĚ 10 ŚĂŶŐĞƐŝŶEĞƚWŽƐŝƚŝŽŶͲZ,E
ŽŶƐŽůŝĚĂƚĞĚƵĞdŽĂŶĚƵĞ&ƌŽŵ ϭ1
Unaudited–ForManagementUse Medical University of South Carolina Physicians Executive Summary For the four month period ending October 31, 2020
Charges: YTD‐5% over budget and 4% over last year Month of October: 6% over budget and 1% over last year Top 5 clinical departments: Dermatology, Medicine, Ophthalmology, Radiology, Orthopedics Bottom 5 clinical departments: Psychiatry, Radiation Oncology, Pediatrics, Otolaryngology, Neurology
Payments YTD‐6% over budget and 2% over last year Month of October: 3% over budget and 5% under last year Strong revenue cycle performance in 35 Days in AR and $89 per wRVU
Income/(Loss): $14.9M Operating Income; 8% Operating Margin o $19.4M favorable variance to budget . $6.8M favorable net clinical service revenue . $6.3M favorable salaries, wages and benefits ‐ Higher than expected vacancies, delays of projects . $2.3M favorable R‐Transfers . $3.6M favorable in various expense accounts
$14.7M Net Income; 7.9% Net Margin o $16.3M favorable variance to budget . $7.7M unrealized/realized gain on investments . ($9.8M) accrued reversal of 2020 CARES Act Funds
Balance Sheet: Days cash on hand: 236 days Current ratio: 4.4 Net Position: $369.2M; increased by $10.5M compared to October 2019
Pension: YTD expense: $12.3M; decreased by 10.1% compared to YTD October 2019
1 MUSC Physicians (A Component Unit of MUSC) Statement of Revenues, Expenses and Changes in Net Position For the Period Ending October 31, 2020
Oct‐2020 Oct‐2020 Actual Budget Variance Var %
Operating revenues Net clinical service revenue $ 125,008,631 $ 118,178,682 $ 6,829,949 6% Supplemental medicaid 17,417,508 16,933,333 484,174 3% Other operating revenue 4,693,943 2,184,790 2,509,153 115% MUHA reimbursement for ambulatory and revenue cycle 1,918,471 1,646,596 271,875 17% Purchased services 32,997,079 33,468,994 (471,915) (1%) Grant salary reimbursement from MUSC 4,849,629 4,668,181 181,448 4%
Total operating revenues 186,885,261 177,080,576 9,804,685 6%
Operating expenses Salaries, wages and benefits 118,378,884 124,702,722 6,323,838 5% MUSCP reimbursement for education and research 26,106,968 28,366,302 2,259,334 8% Supplies 13,373,899 12,416,506 (957,393) (8%) Contractual services 4,523,156 5,516,116 992,959 18% Facility cost and equipment 2,729,790 3,641,146 911,356 25% Professional liability insurance 2,099,359 2,356,479 257,120 11% Depreciation 1,782,939 2,099,101 316,162 15% Meals and travel 85,049 1,373,768 1,288,720 94% Other expenses 2,678,041 283,229 (2,394,812) (846%) Faculty and staff recruitment 122,542 477,234 354,692 74% Donations ‐ transfer to MUSC Foundation and others 100,200 371,944 271,744 73%
Total operating expenses 171,980,827 181,604,548 9,623,721 5%
Operating income (loss) $ 14,904,434 $ (4,523,972) $ 19,428,405 429%
Nonoperating revenue (expenses) CARES Act Provider Relief Fund (9,790,814) ‐ (9,790,814) 0% MUHA reimbursement for equipment ‐ GRTC ‐ 267,234 (267,234) (100%) Investment income 8,578,479 1,670,321 6,908,158 414% Interest expense (929,161) (1,158,554) 229,392 20% Rental income 2,451,053 2,689,940 (238,887) (9%) Rent expense (541,679) (541,679) ‐ 0% Gain (loss) on disposal of assets ‐ (28,597) 28,597 100%
Total Nonoperating revenue (expenses) (232,122) 2,898,665 (3,130,787) (108%)
Change in net position $ 14,672,312 $ (1,625,306) $ 16,297,618 1003%
Notes: Other operating revenue variance due to: CMMI Program Funds $2.6M Salaries, wages and benefits: Salaries under budget due to higher than expected vacancies and project delays MUSCP reimbursement for education and reimbursement (R‐transfers): timing differences, but intent to transfer full budget by YE Other expenses variance due to CMMI Program Funds $2.6M transfer to MHA CARES Act Provider Relief Fund: accrued reversal of 2020 income Investment income gain includes unrealized/realized gain on investment of $7.7M Rental income: Parkshore retro rent adjustment
2 MUSC Physicians (A Component Unit of the Medical University of South Carolina)
Statement of Net Position
ASSETS
Current assets: October 31, 2019 October 31, 2020 Variance Cash and cash equivalents $ 92,870,523 $ 81,238,265 $ (11,632,258) Investments 157,280,979 202,218,651 44,937,672 Receivables: Patient services ‐ net of allowances for contractual adjustments of $107,276,601 bad debts of $19,154,279 40,281,439 39,728,772 (552,667) Due from the Medical University of South Carolina 1,366,192 6,580,149 5,213,957 Due from the Medical University Hospital Authority 6,401,279 3,024,953 (3,376,326) Due from the Medical University Foundation 1,246,944 1,083,509 (163,435) Due from Carolina Family Care, Inc. 4,979,581 12,328,991 7,349,410 Note receivable UMA/MHP 209,000 166,859 (42,141) Investment / Advancements consolidated CFC 32,270,000 32,270,000 ‐ Due from Comprehensive Psychiatric Services 303,106 19,228 (283,878) Due from MSV 65,857 16,165 (49,692) Prepaid rent ‐ MUSC Foundation 338,226 338,226 ‐ Other current assets 10,928,066 18,862,992 7,934,926
Total Current Assets $ 348,541,192 $ 397,876,760 $ 49,335,568 Noncurrent assets: Capital assets: Land 26,096,521 22,999,986 (3,096,535) Buildings 50,882,068 51,518,876 636,808 Furniture and equipment 18,121,281 25,314,755 7,193,474 Leasehold improvements 50,643,833 59,177,338 8,533,505 Rental buildings under capital lease 13,989,600 13,989,600 ‐ Computer software 13,593,123 13,593,123 ‐ Less: accumulated depreciation and amortization (80,889,744) (86,124,423) (5,234,679) Prepaid rent ‐ MUSC Foundation 5,734,665 5,734,117 (548) Other assets 6,800,000 8,450,000 1,650,000 Investment in partnerships 3,468,609 4,963,972 1,495,363
Total noncurrent assets $ 108,439,956 $ 119,617,344 $ 11,177,388 Total Assets $ 456,981,148 $ 517,494,104 $ 60,512,956
Deferred outflows of resources Deferred refunding cost 10,276,125 8,801,197 (1,474,928) Deferred outflows‐OPEB ‐ 35,614 35,614 Total deferred outflows$ 10,276,125 $ 8,836,811 $ (1,439,314) Total Assets and Deferred Outflows$ 467,257,273 $ 526,330,915 $ 59,073,642
3 MUSC Physicians (A Component Unit of the Medical University of South Carolina)
Statement of Net Position LIABILITIES October 31, 2019 October 31, 2020 Variance Current Liabilities Accounts payable$ 1,647,896 $ 6,767,802 $ (5,119,906) Accrued payroll 8,267,067 8,877,767 (610,700) Accrued payroll withholdings 7,881,964 11,989,820 (4,107,856) Accrued pension contribution 4,204,169 4,489,043 (284,874) Unapplied cash ‐ patient services 3,954,801 5,531,843 (1,577,042) Other accrued liabilities 2,426,003 28,169,482 (25,743,479) Due to Medical University of South Carolina 17,379 15,693 1,686 Due to Medical University Hospital Authority 4,995,619 12,100,438 (7,104,819) Due to MUSC Health Alliance (17,000) 4,569,342 (4,586,342) Accrued compensated absences 1,897,692 2,332,023 (434,331) Capital leases 190,917 457,388 (266,471) Bonds payable 4,890,000 4,360,000 530,000
Total current liabilities $ 40,356,507 $ 89,660,641 $ (49,304,134)
Noncurrent liabilities: Accrued compensated absences 1,648,002 2,015,468 (367,466) Capital leases ‐ 242,941 (242,941) Bonds payable 60,555,000 56,755,000 3,800,000 Net OPEB liability 18,606 ‐ 18,606 Deferred inflows‐OPEB 85,799 59,638 26,161 Fair value of derivative instruments 5,847,995 8,373,477 (2,525,482)
Total noncurrent liabilities $ 68,155,402 $ 67,446,524 $ 708,878
Total liabilities $ 108,511,909 $ 157,107,165 $ (48,595,256)
NET POSITION
Invested in capital assets, net of related debt 58,712,466 68,397,600 (9,685,134) Unrestricted (deficit) 300,032,898 300,826,150 (793,252) Total Net Position $ 358,745,364 $ 369,223,750 $ (10,478,386)
Total Liabilities, Inflows, & Net Position $ 467,257,273 526,330,915 (59,073,642)
Notes: Cash & cash equivalents, Investments have increased due to Supplemental Medicaid payments, COVID‐19 mitigtaion strategies: Advanced Medicare Payments, CARES Act Stimulus , Deferral of Employer FICA portion, Investments have been subject to market value adjustment Due from MUSC variance is due to timing of collection of Supplemental Medicaid funds, Grant salary reimbursement $1.6M not received in October Other Assets ‐ (Current) is the accrual for Supplemental Medicaid payments; in October 2019 DHHS payment received reducing the receivable by $7M Land decreased due the sale of Porcher's Bluff $3.2M Other Assets ‐ (Noncurrent) increase in collateral deposit for Swap Accounts payable includes $1.5M compliance refund accrual; $2.7M corporate credit card payable advance payment in 2019; $525K Professional Liability Insurance accrual Accrued payroll withholdings includes FICA Employer Withholding being deferred Other accrued liabilities includes Deferred Revenue from receipt of Advanced Medicare Payments $16M, accrual for CARES Act return of funds received in 2020 $9.8M Due to MUHA: funds owed for West Campus project $2.9M to be paid in December Due to MHA: CMMI Program funds to be transferred from UMA to MHA Fair value of derivative instruments are adjusted to actuals quarterly
4 Carolina Family Care, Inc. Including Carolina Primary Care Physicians & MUSC Health Partners Executive Summary For the four month period ending October 31, 2020
Charges: YTD‐1% over budget and 8% under last year Month of October: 11% over budget
Payment: YTD‐7% under budget and 2% under last year Month of October: 5% under budget 35 Days in AR and $66 per wRVU
Income/(Loss): Year to Date: $1.9M Operating Income; 4.8% Operating Margin o $2.8M favorable variance to budget . $1.0M favorable other operating revenue ‐ $.8M RHN 2020 shared services . $1.3M favorable salaries, wages and benefits due to higher than expected vacancies Balance Sheet: Current ratio: .7 Net Position: ($4.8M); decreased by ($3.8M) compared to October 2019 Assets increased $10.5M compared to October 2019 o ($5.1M) decrease in patient receivables due to Unbilled RHN receivables at YE 2019 o $11.0M increase in Due from MUHA – RHN o $3.7M increase in other current assets related to Supplemental Medicaid Liabilities increased $14.0M compared to October 2019 o $4.6M increase in other accrued liabilities ‐ $1.3M deferred revenue from receipt of Advanced Medicare payments ‐ $1.2M IBNR liability ‐ $2.3M increase in RHN salaries accrued o $7.3M increase in due to UMA: approximately $5M due to UMA paying RHN revenue on behalf of CFC during Q4 2020 and Q1 2021. o $1.0M increase in accrued payroll withholdings primarily due to FICA employer withholding being deferred
5 Carolina Family Care, Inc. (Including Carolina Primary Care Physicians and MUSC Health Partners) Statement of Revenues, Expenses and Changes in Net Position For the Period Ending October 31, 2020
Oct‐2020 Oct‐2020 Actual Budget Variance Var %
Operating revenues Net clinical service revenue $ 22,554,691 $ 24,143,958 $ (1,589,267) (7%) Supplemental medicaid 1,066,667 1,066,667 ‐ 0% Other operating revenue 2,401,767 1,369,324 1,032,443 75% RHN provider practice strategic support 9,286,749 8,222,702 1,064,047 13% Salary reimbursment for RHN Emergency Dept 1,356,366 ‐ 1,356,366 0% Salary reimbursment for RHCs 1,109,611 1,298,606 (188,995) (15%) Purchased services 1,543,499 1,009,210 534,289 53%
Total operating revenues 39,319,351 37,110,466 2,208,884 6%
Operating expenses Salaries, wages and benefits 29,005,960 30,278,852 1,272,892 4% Supplies 1,585,305 1,896,726 311,420 16% Contractual services 2,221,671 1,054,918 (1,166,753) (111%) Depreciation 86,858 93,328 6,470 7% Facility cost and equipment 2,442,949 2,649,202 206,253 8% Professional liability insurance 926,990 837,893 (89,098) (11%) Meals and travel 3,479 38,046 34,567 91% Faculty and staff recruitment 12,620 2,846 (9,774) (343%) MUSCP corporate shared services 929,925 988,208 58,282 6% Other expenses 229,498 148,534 (80,964) (55%)
Total operating expenses 37,445,257 37,988,552 543,295 1%
Operating income (loss) $ 1,874,094 $ (878,086) $ 2,752,179 313%
Nonoperating revenue (expenses) Investment income 41 ‐ 41 100% Rental income 9,598 10,081 (483) (5%)
Nonoperating revenue (expenses) 9,638 10,081 (443) (4%)
Change in net position $ 1,883,732 $ (868,004) $ 2,751,737 317%
Notes: Net Clinical Service Revenue: $1.7M RHN underbudget Other operating revenue variance related to 2020 Q1‐3 RHN Shared Services $824K; CMMI Program Funds $154K Purchased Services: Hampton Regional $195K unbudgeted, RHN reimbursements $200K Salaries and benefits includes: $343K RHN salary favorable, other favorability due to higher than expected vacancies Contractual Services: $1.2M related to Chester and Lancaster Emergency Departments Physician services unbudgeted Other expenses: CMMI Program Funds ($154K) transferred to MHA
6 Carolina Family Care, Inc. including Carolina Primary Care Physicians and MUSC Health Partners
Statement of Net Position
ASSETS
Current assets: October 31, 2019 October 31, 2020 Variance Cash and cash equivalents$ 4,086,553 $ 5,080,033 $ 993,480 Receivables: Patient services ‐ net of allowances for contractual adjustments of $23,997,354 bad debts of $5,057,964 12,983,583 7,925,534 (5,058,049) Due from the Medical University of South Carolina 63,894 32,387 (31,507) Due from the Medical University Hospital Authority 582,884 615,210 32,326 Due from MUHA ‐ RHN / RHN Settlement (7,999,201) 2,908,667 10,907,868 Due from MSV (289,287) 311,096 600,383 Other current assets (1,330,504) 2,340,768 3,671,272
Total Current Assets $ 8,097,922 $ 19,213,695 $ 11,115,773 Noncurrent assets: Capital assets: Furniture and equipment 1,361,934 1,361,934 ‐ Leasehold improvements 2,862,009 2,641,766 (220,243) Computer software 46,563 46,563 ‐ Less: accumulated depreciation and amortization (2,252,995) (2,360,541) (107,546) Investment in partnerships 989,223 737,845 (251,378)
Total noncurrent assets $ 3,006,734 $ 2,427,567 $ (579,167)
Total Assets $ 11,104,656 $ 21,641,262 $ 10,536,606
7 Carolina Family Care, Inc. including Carolina Primary Care Physicians and MUSC Health Partners
Statement of Net Position
LIABILITIES October 31, 2019 October 31, 2020 Variance Current Liabilities Accounts payable$ 638,640 $ 602,341 $ 36,299 Accrued payroll 712,779 1,310,982 (598,203) Accrued payroll withholdings 448,762 1,449,872 (1,001,110) Unapplied cash ‐ patient services (153,170) 208,757 (361,927) Other accrued liabilities 4,194,547 8,838,715 (4,644,168) Due to Medical University of South Carolina ‐ 96,939 (96,939) Due to Medical University Hospital Authority 61,760 34,518 27,242 Due to UMA 4,979,581 12,328,991 (7,349,410) Note Payable UMA/MHP 209,000 166,859 42,141 Due to MUSC Health Alliance ‐ 198,524 (198,524) Accrued compensated absences 476,756 635,000 (158,244)
Total current liabilities $ 11,568,655 $ 25,871,498 $ (14,302,843)
Noncurrent liabilities: Accrued compensated absences 451,540 529,837 (78,297)
Total noncurrent liabilities $ 451,540 $ 529,837 $ (78,297)
Total liabilities $ 12,020,195 $ 26,401,335 $ (14,381,140)
NET POSITION Capital stock and Additional paid‐in capital 32,270,000 32,270,000 ‐ Invested in capital assets, net of related debt 2,145,707 1,776,580 (369,127) Unrestricted (deficit) (35,331,246) (38,806,653) (3,475,407) Total Net Position $ (915,539) $ (4,760,073) $ (3,844,534)
Total Liabilities & Net Position $ 11,104,656 $ 21,641,262 $ 10,536,606
Notes: Patient Receivables significantly higher in 2019 due to Unbilled RHN receivables at end of year Other Current assets in 2019 included early receipt of DHHS funds $3.2M Accrued payroll withholdings includes FICA Employer Withholding being deferred Other accrued liabilities includes $1.3M Deferred Revenue from receipt of Advanced Medicare Payments; $1.2M IBNR liability ‐ related to Group Health Insurance; $2.3M increase in RHN salaries accrued Due to MUHA ‐ RHN includes the net advance from MUHA for RHN expenses and write‐off of FY19 RHN shared services Due to MHA: CMMI Program funds to be transferred from CFC to MHA
8 Carolina Family Care, Inc. (Including Carolina Primary Care Physicians and MUSC Health Partners) Statement of Revenues, Expenses and Changes in Net Position For the Period Ending October 31, 2020
East Cooper Tidelands Regional Health Other Carolina CFC Radiology GRTC Neuro Network MHP entities Family Care Total (1) (2) (3) (4) (5) (6) Sum of (1)‐(6) Operating revenues Net clinical service revenue $ 487,384 $ ‐ $ 196,037 $ 15,248,505 $ 18,102 $ 6,604,663 $ 22,554,691 Supplemental medicaid ‐ ‐ ‐ ‐ ‐ 1,066,667 1,066,667 Other operating revenue 123 ‐ ‐ ‐ 824,343 1,577,302 2,401,767 RHN provider practice strategic support ‐ ‐ ‐ 9,286,749 ‐ ‐ 9,286,749 Salary reimbursment for Emergency Depts ‐ ‐ ‐ 1,356,366 ‐ ‐ 1,356,366 Salary reimbursment for RHCs ‐ ‐ ‐ 1,109,611 ‐ ‐ 1,109,611 Purchased services 90,779 195,864 65,204 330,563 591,687 269,400 1,543,498
Total operating revenues 578,286 195,864 261,241 27,331,795 1,434,132 9,518,032 39,319,350
Operating expenses Salaries, wages and benefits 315,609 189,418 304,094 21,674,719 603,443 5,918,677 29,005,960 Supplies ‐ ‐ 511 949,246 1,213 634,336 1,585,305 Contractual services 184,629 125 ‐ 1,754,028 6,412 276,478 2,221,671 Depreciation ‐ ‐ ‐ ‐ ‐ 86,858 86,858 Facility cost and equipment ‐ ‐ 19,311 1,760,555 23,514 639,568 2,442,949 Professional liability insurance 52,154 5,629 27,857 718,100 11,731 111,520 926,990 Meals and travel ‐ ‐ ‐ ‐ 1,783 1,696 3,479 Faculty and staff recruitment ‐ ‐ ‐ 11,941 ‐ 679 12,620 MUSCP corporate shared services ‐ ‐ ‐ 421,992 ‐ 507,933 929,925 Other expenses 25,894 1,708 14,605 41,214 1 146,075 229,497
Total operating expenses 578,286 196,881 366,378 27,331,795 648,097 8,323,820 37,445,257
Operating income (loss) $ ‐ $ (1,017) $ (105,137) $ ‐ $ 786,035 $ 1,194,212 $ 1,874,093
Nonoperating revenues (expenses) Investment income ‐ ‐ ‐ ‐ ‐ 41 41 Rental income ‐ ‐ ‐ ‐ ‐ 9,598 9,598
Total Nonoperating revenues (expenses) ‐ ‐ ‐ ‐ ‐ 9,638 9,638
Change in net position $ ‐ $ (1,017) $ (105,137) $ ‐ $ 786,035 $ 1,203,850 $ 1,883,732
Notes: (1) East Cooper Radiology income/losses are transferred to MSV where billings are made to East Cooper Hospital ($220,176 per year) and MUHA. $91K in reimbursement from MSV YTD. (2) Georgetown Hospital pays 18.5% of total collections to cover operating expenses of provider at GRTC (3) MUHA and Tidelands have each been billed 50% of FY20 losses related to Tidelands Neurosciences. Total loss YTD is $170K. (4) MUHA funds 100% of deficit related to Regional Health Network (5) Other non‐Primary Care entities: ‐ ($12K) Manager of Occupational Safety and Health ‐ MUHA, MUSC and UMA provide support ‐ ($3K) Institutional Advancement ‐ lobbying costs ‐ ($23K) Group Health Insurance ‐ $824K Shared Services Writeoff (Q1‐3 2020 RHN shared services)
9 Carolina Family Care, Inc. (Including Carolina Primary Care Physicians and MUSC Health Partners) Regional Health Network Statement of Revenues, Expenses and Changes in Net Position For the Period Ending October 31, 2020
Florence Marion Chester Lancaster Integ. Costs RHN Consol. RHN Consol. RHN Consol. Actual Actual Actual Actual Actual Actual Budget Variance (1) (2) (3) (4) (5) Sum of (1)‐(5) Operating revenues Net clinical service revenue $ 10,859,087 $ 777,699 $ 1,669,894 $ 1,941,411 415$ $ 15,248,505 $ 16,930,701 $ (1,682,195) Purchased services (29,313) (26,656) (27,546) 166,022 248,056 330,563 127,003 203,560
Total operating revenues 10,829,774 751,043 1,642,347 2,107,433 248,471 15,579,069 17,057,704 (1,478,635)
Operating expenses Salaries, wages and benefits 13,321,960 1,902,158 2,142,209 4,084,866 223,526 21,674,719 22,018,107 343,388 Supplies 501,288 99,102 144,401 204,122 333 949,246 1,098,338 149,093 Contractual services 221,271 35,024 850,059 623,061 24,612 1,754,028 403,113 (1,350,915) Facility cost and equipment 1,000,817 183,860 215,846 360,033 ‐ 1,760,555 1,845,114 84,558 Professional liability insurance 442,288 93,553 67,482 114,777 ‐ 718,100 662,854 (55,246) Meals and travel ‐ ‐ ‐ ‐ ‐ ‐ 7,211 7,211 Faculty and staff recruitment 11,165 ‐ 108 669 ‐ 11,941 1,680 (10,261) MUSCP corporate shared services 259,779 43,839 45,640 72,734 ‐ 421,992 480,275 58,282 Other expenses 5,765 1,225 910 33,314 ‐ 41,214 62,320 21,106
Total operating expenses 15,764,333 2,358,760 3,466,656 5,493,575 248,471 27,331,795 26,579,012 752,783
Operating income (loss) $ (4,934,559) $ (1,607,717) $ (1,824,309) $ (3,386,141) $ ‐ $ (11,752,726) $ (9,521,308) $ (2,231,419)
RHN provider practice strategic support 4,934,559 498,106 1,186,184 2,667,900 ‐ 9,286,749 8,222,702 1,064,047 Salary reimbursment for RHN Emergency ‐ ‐ 638,125 718,241 ‐ 1,356,366 ‐ 1,356,366 Salary reimbursment for RHCs ‐ 1,109,611 ‐ ‐ ‐ 1,109,611 1,298,606 (188,995)
Change in net position $ ‐$ ‐ $ ‐ $ ‐ $ ‐ $ ‐ $ ‐ $ ‐
Notes: Purchased services in operating revenues includes Medical Directorships, FCALL payments, other salary reimbursements Salary Reimbursement for RHCs: 4 Regional Health Clinics in the Marion region are fully reimbursed for salaries and other expenses by MUHA. Income is not recognized but reimbursed directly to MUHA. Salary Reimbursement for Emergency Departments: fully reimbursed for salaries and other expenses by MUHA. Income is not recognized but reimbursed directly to MUHA
10 FY2021 MUSCP Due to/Due From As of 10/31/20
Outstanding Balance Notes 1. MUSCP/MUHA
MUSCP is due to pay MUHA $11,466,465 $2.9M for Siemen's equipment to be paid in December MUHA is due to pay MUSCP $3,024,953 Balance consists of monthly recurring activity Net: MUSCP is due to pay MUHA $8,441,512
2. MUSCP/MUSC
MUSC is due to pay MUSCP $6,580,149 Balance consists of monthly recurring activity MUSCP is due to pay MUSC $15,693 $10K agency funds offset by monthly recurring activity Net: MUSC is due to pay MUSCP $6,564,456
3. CFC/MUHA
CFC is due to pay MUHA $18,497 Includes $38K owed for MHP‐MUHA MSA reconciliation MUHA is due to pay CFC $645,090 Balance consists of monthly recurring activity Net: MUHA is due to pay CFC $626,592
4. CFC/MUHA ‐ RHN Net Advance from MUHA for RHN expenses. Also includes AR, salary, Total RHN accounts‐Due to MUHA ($2,908,667) AP accruals (non‐cash); rent agreements
5. CFC/MUSC
CFC is due to pay MUSC $96,939 Centerspace ‐ TPC Salary Reimbursements
6. MHP/MUHA
MUHA is due to pay MHP $3,989 Balance consists of monthly recurring activity MHP is due to pay MUHA $4,121 Balance consists of monthly recurring activity Net: MUHA is due to pay MHP ($131)
7. MHP/MUSC
MUSC is due to pay MHP $32,387 Occupational Practice Manager Salary Reimbursement
8. MSV
MSV is due to pay CFC $518,452 FY20 outsanding balance plus FY21 July‐October activity MSV is due to pay MUSCP $16,165 Balance consists of monthly recurring activity Total due from MSV $534,617
11 MEDICAL UNIVERSITY HOSPITAL AUTHORITY (MUHA) BOARD OF TRUSTEES CONSENT AGENDA December 11, 2020 101 Colcock Hall/Via Teleconference
Authority Operations, Quality and Finance Committee: Dr. Murrell Smith, Chair
Consent Agenda for Approval
Item 26. Appointments, Reappointments and Delineation of Privileges...... Dr. Phillip Warr Chief Medical Officer, MUHA
Consent Agenda for Information
Item 27. MEC Minutes ...... Dr. Phillip Warr Chief Medical Officer, MUHA
Item 28. Contracts and Agreements ...... David McLean Director, MUHA Legal Affairs
MUHA and MUSC Physical Facilities Committee: Mr. Bill Bingham, Chair
Consent Agenda for Information
Item 29. MUHA and MUSC FY2021 Active Projects >$250,000 ...... Brad Taylor Chief Facilities Officer, MUSC
Item 30. MUSC Facilities Contracts Awarded ...... Brad Taylor Chief Facilities Officer, MUSC 0HGLFDO([HFXWLYH&RPPLWWHH2FWREHU 7KH&UHGHQWLDOV&RPPLWWHHUHYLHZHGWKHIROORZLQJDSSOLFDQWVRQ2FWREHU DQGUHFRPPHQGVDSSURYDOE\WKH0HGLFDO([HFXWLYH&RPPLWWHH 0HGLFDO6WDII,QLWLDO$SSRLQWPHQWDQG&OLQLFDO3ULYLOHJHV DĂƌLJďĞů͕D͘͘ ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů WĞĚŝĂƚƌŝĐƐ ZĂŚŽƵůŚƵũĂ͕D͘͘ ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů DĞĚŝĐŝŶĞ :ŽƐŚƵĂƌŽǁŶ͕D͘͘ ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů EĞƵƌŽůŽŐLJ ĂǀŝĚŚĞŶ͕D͘͘ ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů KƚŽůĂƌLJŶŐŽůŽŐLJ <ĂƐĞLJŽůůŝŶƐ͕D͘͘ ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů WƐLJĐŚŝĂƚƌLJ tŝůůLJsĂůĞŶĐŝĂ͕D͘͘ ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů DĞĚŝĐŝŶĞ EĂŶĐLJtĞƐƚŵĂƌŬ͕͘D͘͘ ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů KƌĂůΘDĂdž^ƵƌŐĞƌLJ <ĂƚŚĞƌŝŶĞ,ŝůůĞƌŝĐŚ͕͘E͘W͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ WƐLJĐŚŝĂƚƌLJ <ĂŝƚůŝŶ^ĞĂƌƐ͕E͘W͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ ^ƵƌŐĞƌLJ ůĞĐŝĂŶLJŝŵ͕D͘͘ WƌŽǀŝƐŝŽŶĂůĨĨŝůŝĂƚĞͲŽůůĞĂŐƵĞͲKƚŚĞƌ DĞĚŝĐŝŶĞ LJĂĚEĂnjĞƌ͕D͘͘ WƌŽǀŝƐŝŽŶĂůĨĨŝůŝĂƚĞͲŽůůĞĂŐƵĞͲKƚŚĞƌ DĞĚŝĐŝŶĞ >LJŶŶĂƌƌ͕D͘͘ WƌŽǀŝƐŝŽŶĂůĨĨŝůŝĂƚĞͲŽůůĞĂŐƵĞͲKƚŚĞƌ ŵĞƌŐĞŶĐLJDĞĚŝĐŝŶĞ DĂƌŬĂƌƌŽůů͕D͘͘ WƌŽǀŝƐŝŽŶĂůĨĨŝůŝĂƚĞͲŽůůĞĂŐƵĞͲKƚŚĞƌ ŵĞƌŐĞŶĐLJDĞĚŝĐŝŶĞ ^ĂŶĚLJŽŽƉĞƌ͕D͘͘ WƌŽǀŝƐŝŽŶĂůĨĨŝůŝĂƚĞͲŽůůĞĂŐƵĞͲKƚŚĞƌ ŵĞƌŐĞŶĐLJDĞĚŝĐŝŶĞ ŚƌŝƐƚŽŽƵƌďĂŶ͕D͘͘ WƌŽǀŝƐŝŽŶĂůĨĨŝůŝĂƚĞͲŽůůĞĂŐƵĞͲKƚŚĞƌ ŵĞƌŐĞŶĐLJDĞĚŝĐŝŶĞ ĂŶĂ'ŝĂƌƌŝnjnjŝ͕͘K͘ WƌŽǀŝƐŝŽŶĂůĨĨŝůŝĂƚĞͲŽůůĞĂŐƵĞͲKƚŚĞƌ DĞĚŝĐŝŶĞ ^ŽůŽŵŽŶ:ĂŶ͕D͘͘ WƌŽǀŝƐŝŽŶĂůĨĨŝůŝĂƚĞͲŽůůĞĂŐƵĞͲKƚŚĞƌ DĞĚŝĐŝŶĞ ŽŶĂůĚEŽƌĚƐƚƌŽŵ͕D͘͘ WƌŽǀŝƐŝŽŶĂůĨĨŝůŝĂƚĞͲŽůůĞĂŐƵĞͲKƚŚĞƌ ZĂĚŝĂƚŝŽŶKŶĐŽůŽŐLJ ^ƚƵĂƌƚ^ŵŝƚŚ͕D͘͘ WƌŽǀŝƐŝŽŶĂůĨĨŝůŝĂƚĞͲŽůůĞĂŐƵĞͲKƚŚĞƌ ŵĞƌŐĞŶĐLJDĞĚŝĐŝŶĞ <ĞŶŶĞƚŚ^ƚĂƉůĞƐ͕:ƌ͕͘͘K͘ WƌŽǀŝƐŝŽŶĂůĨĨŝůŝĂƚĞͲŽůůĞĂŐƵĞͲKƚŚĞƌ ŵĞƌŐĞŶĐLJDĞĚŝĐŝŶĞ 0HGLFDO6WDII5HDSSRLQWPHQWDQG&OLQLFDO3ULYLOHJHV ŶĚƌĞĂďďŽƚƚ͕D͘͘ ĐƚŝǀĞ ^ƵƌŐĞƌLJ DŝůƚŽŶƌŵƐƚƌŽŶŐ͕D͘͘ ĐƚŝǀĞ ^ƵƌŐĞƌLJ WƌĂďŚĂŬĂƌĂůŝŐĂ͕D͘͘ ĐƚŝǀĞ ^ƵƌŐĞƌLJ DĂƌŝƐƐĂ<ŶŽǁůƚŽŶ͕D͘͘ ĐƚŝǀĞ WĞĚŝĂƚƌŝĐƐ ŚƌŝƐƚŝŶĂŽƵƌŶĞ͕D͘͘ ĐƚŝǀĞ ŵĞƌŐĞŶĐLJDĞĚŝĐŝŶĞ DĂƌLJƌLJĂŶ͕D͘͘ ĐƚŝǀĞ WƐLJĐŚŝĂƚƌLJ ŚƌŝƐƚŝŶĞĂƌƌ͕D͘͘ ĐƚŝǀĞ ŵĞƌŐĞŶĐLJDĞĚŝĐŝŶĞ <ĂƚŚƌLJŶƌŝƐƚĂůĚŝ͕D͘͘ ĐƚŝǀĞ WĞĚŝĂƚƌŝĐƐ ^ĂŶĚƌĂ&ŽǁůĞƌ͕D͘͘ ĐƚŝǀĞ WĞĚŝĂƚƌŝĐƐ <ƌŝƐƚŝŶĂ'ƵƐƚĂĨƐŽŶ͕D͘͘ ĐƚŝǀĞ WĞĚŝĂƚƌŝĐƐ ĂŶŝĞů:ƵĚŐĞ͕D͘͘ ĐƚŝǀĞ DĞĚŝĐŝŶĞ ĚǁĂƌĚ<ŝůď͕///͕D͘͘ ĐƚŝǀĞ DĞĚŝĐŝŶĞ DĂƚƚŚĞǁ<ŽŚůĞƌ͕D͘͘ ĐƚŝǀĞ KďƐƚĞƚƌŝĐƐΘ'LJŶĞĐŽůŽŐLJ ŝƉƉŽƌĂŚ<ƌŝƐŚŶĂƐĂŵŝ͕D͘͘ ĐƚŝǀĞ DĞĚŝĐŝŶĞ :ŽŚŶZŚŽĚĞƐ͕:ƌ͕͘D͘͘ ĐƚŝǀĞ WĞĚŝĂƚƌŝĐƐ ĞďŽƌĂŚZŽŵĞŽ͕D͘͘ ĐƚŝǀĞ ŶĞƐƚŚĞƐŝŽůŽŐLJ ůũŽĞƐŽŶtĂůŬĞƌ͕D͘͘ ĐƚŝǀĞ EĞƵƌŽůŽŐLJ :ŽŚŶtĂůƚŽŶ͕D͘͘ ĐƚŝǀĞ ŶĞƐƚŚĞƐŝŽůŽŐLJ ƉƉůŝĐĂƚŝŽŶdLJƉĞ͗ZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͖^ƚĂƚƵƐ͗ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů <ŚŝůĞŶWĂƚĞů͕D͘͘ ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů KďƐƚĞƚƌŝĐƐΘ'LJŶĞĐŽůŽŐLJ ZĂŚŶZĂǀĞŶĞůů͕͘W͘D͘ ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů KƌƚŚŽƉĂĞĚŝĐƐ ƉƉůŝĐĂƚŝŽŶdLJƉĞ͗ZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͖^ƚĂƚƵƐ͗ĚŵŝŶŝƐƚƌĂƚŝǀĞͬ,ŽŶŽƌĂƌLJ &ƌĞĚƌĂǁĨŽƌĚ͕:ƌ͕͘D͘͘ ĚŵŝŶŝƐƚƌĂƚŝǀĞͬ,ŽŶŽƌĂƌLJ ^ƵƌŐĞƌLJ ƉƉůŝĐĂƚŝŽŶdLJƉĞ͗ZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͖^ƚĂƚƵƐ͗ĨĨŝůŝĂƚĞ tŝůůŝĂŵ>ŝǀĞƐĂLJ͕:ƌ͕͘͘K͘ ĨĨŝůŝĂƚĞ EĞƵƌŽƐƵƌŐĞƌLJ 0HGLFDO6WDII5HDSSRLQWPHQWDQG&KDQJHLQ&OLQLFDO3ULYLOHJHV EŽŶĞ 0HGLFDO6WDII&KDQJHLQ3ULYLOHJHV ƌŝĂŶKƌƌ͕D͕͘͘D͘^͘ ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů KďƐƚĞƚƌŝĐƐΘ'LJŶĞĐŽůŽŐLJ :ĞƌůŝŶĚĂ'ůĂĚLJƐĂŵŝůůĞZŽƐƐ͕D͕͘͘ ĐƚŝǀĞWƌŽǀŝƐŝŽŶĂů KďƐƚĞƚƌŝĐƐΘ'LJŶĞĐŽůŽŐLJ 3URIHVVLRQDO6WDII,QLWLDO$SSRLQWPHQWDQG&OLQLFDO3ULYLOHJHV EŝĐŚŽůĞ ǀĂŶƐ͕&͘E͘W͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚͲŽůůĞĂŐƵĞͲKƚŚĞƌ DĞĚŝĐŝŶĞ ƵƐƚŝŶ,ĂLJĞƐ͕W͘͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚͲŽůůĞĂŐƵĞͲKƚŚĞƌ ŵĞƌŐĞŶĐLJDĞĚŝĐŝŶĞ <ŝŵ:ĂŵĞƐ͕͘͘E͘W WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚͲŽůůĞĂŐƵĞͲKƚŚĞƌ DĞĚŝĐŝŶĞ ĂƌůŽŶ:ĞŶŬŝŶƐ͕E͘W͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚͲŽůůĞĂŐƵĞͲKƚŚĞƌ DĞĚŝĐŝŶĞ ĂŶŝĞů^<ŽĞůĞ͕W͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚͲŽůůĞĂŐƵĞͲKƚŚĞƌ ŵĞƌŐĞŶĐLJDĞĚŝĐŝŶĞ ĂŶĚŝĚĂ>ŽŝƐĞůůĞ͕&͘E͘W͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚͲŽůůĞĂŐƵĞͲKƚŚĞƌ DĞĚŝĐŝŶĞ dŽŶLJ>ƵĐĂƐ͕E͘W͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚͲŽůůĞĂŐƵĞͲKƚŚĞƌ DĞĚŝĐŝŶĞ ŚĂĚtĂƚƚƐ͕W͘͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚͲŽůůĞĂŐƵĞͲKƚŚĞƌ ŵĞƌŐĞŶĐLJDĞĚŝĐŝŶĞ 3URIHVVLRQDO6WDII5HDSSRLQWPHQWDQG&OLQLFDO3ULYLOHJHV sĂŶĞƐƐĂĚĂŵƐ͕D͘^͘E͘ ůůŝĞĚ,ĞĂůƚŚ WĞĚŝĂƚƌŝĐƐ ůůĞŶĂůĚŝŶŽ͕W͘͘͘ ůůŝĞĚ,ĞĂůƚŚ DĞĚŝĐŝŶĞ DĂƌLJĂƌƌŽǁ͕W͘͘ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ >ĞŝŐŚĞĐŬ͕͘W͘Z͘E͘ ůůŝĞĚ,ĞĂůƚŚ WĞĚŝĂƚƌŝĐƐ ƌŝƚƚĂŶLJĞŶƐŽŶ͕͘Z͘E͘͘ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ ^ŚĂŶŶĂůĂĐŬ͕͘Z͘E͘͘ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ ĞďŽƌĂŚƌŽŽŬƐ͕͘E͘W͘ ůůŝĞĚ,ĞĂůƚŚ DĞĚŝĐŝŶĞ DĞŐĂŶƵŶĐŚ͕W͘͘ ůůŝĞĚ,ĞĂůƚŚ &ĂŵŝůLJDĞĚŝĐŝŶĞ <ĂƚŝĞĂƌĚǁĞůů͕W͘͘ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ <ĂƚŚĞƌŝŶĞ,ĂƌƌŝƐ͕͘E͘W͘ ůůŝĞĚ,ĞĂůƚŚ WĞĚŝĂƚƌŝĐƐ DĂƚƚŚĞǁĂLJůĂŵŝ͕͘Z͘E͘͘ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ DĂƌŝĂŶŶĞ&ŝƵƚĞŵ͕͘Z͘E͘͘ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ ůĞdžĂŶĚƌĂ'ĂƌĐŝĂ͕͘Z͘E͘͘ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ :ĞŶŶŝĨĞƌ,ĂůĞ͕͘Z͘E͘͘ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ dĞŶĞůůĞ:ŽŶĞƐ͕>D&d ůůŝĞĚ,ĞĂůƚŚ WƐLJĐŚŝĂƚƌLJ <ŝŵďĞƌůLJ<ŝƌďLJ͕͘Z͘E͘͘ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ <LJŵďĞƌůĞLJ<ŝƚƚůĞ͕W͘͘͘ ůůŝĞĚ,ĞĂůƚŚ /ŶƚĞƌĚŝƐĐŝƉůŝŶĂƌLJ,ŽƐƉŝƚĂů^ƚĂĨĨ :ĞŶŶŝĨĞƌDŽLJůĂŶ͕͘Z͘E͘͘ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ <ĞƌƌŝĞDƵƌƉŚLJ͕WŚ͘͘ ůůŝĞĚ,ĞĂůƚŚ WƐLJĐŚŝĂƚƌLJ ZŽƐĂƵƌĂKƌĞŶŐŽͲŐƵĂLJŽ͕WŚ͘͘ ůůŝĞĚ,ĞĂůƚŚ WƐLJĐŚŝĂƚƌLJ DĂƌŝĂŶŶĂZŽƐƐ͕͘Z͘E͘͘ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ ůĂŶŶĂ^ŚŝĨůĞƚƚ͕E͘E͘W͘ ůůŝĞĚ,ĞĂůƚŚ WĞĚŝĂƚƌŝĐƐ :ĞŶŶŝĨĞƌsŽůůŵĞƌ͕W͘͘͘ ůůŝĞĚ,ĞĂůƚŚ KƌƚŚŽƉĂĞĚŝĐƐ DĞŐĂŶtĂůƚĞƌƐ͕W͘͘͘ ůůŝĞĚ,ĞĂůƚŚ ^ƵƌŐĞƌLJ ZĂLJŵŽŶtŚŝƚĞ͕///͕E͕ ůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ :ĂŵĞƐtŝůĚĞƌ͕D͘^͘t͘ ůůŝĞĚ,ĞĂůƚŚ WƐLJĐŚŝĂƚƌLJ ƉƉůŝĐĂƚŝŽŶdLJƉĞ͗ZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͖^ƚĂƚƵƐ͗WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ KůŐĂ:ƵŶŬƵůŝƐ͕͘Z͘E͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ ^ĂƌĂŚ<ŝŶŐ͕W͘͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ WĞĚŝĂƚƌŝĐƐ ŵŝůLJ<ƵĞƐĞƌ͕W͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ KƚŽůĂƌLJŶŐŽůŽŐLJ <ĂƚŚĞƌŝŶĞ<LJůĞ͕͘W͘Z͘E͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ DĞĚŝĐŝŶĞ ZĂĐŚĞůůĞDĐ>ĞĞƐ͕͘Z͘E͕͘͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ DĞŐĂŶDĐDĂŶƵƐ͕W͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ <ĂƚĞůLJŶDŝƐƚƌĞƚƚĂ͕͘Z͘E͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ <ĂƌĞŶDŽŚƌǁŝŶŬĞů͕͘Z͘E͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ ZŝĐŚĞůůĞWĞǀĞůĞƌ͕D͘^͘E͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ DĞĚŝĐŝŶĞ ^ƵnjĂŶŶĞZƵĚĂ͕͘Z͘E͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ DĞŐĂŶ^ůĂƉƉĞ͕D͘^͘E͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ DĞĚŝĐŝŶĞ <ĂLJĚĞĞ^ŵŝƚŚ͕W͘͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ EĞƵƌŽůŽŐLJ ƌĂĚLJdŚŽŵĂƐ͕͘Z͘E͘͘ WƌŽǀŝƐŝŽŶĂůůůŝĞĚ,ĞĂůƚŚ ŶĞƐƚŚĞƐŝŽůŽŐLJ 3URIHVVLRQDO6WDII&KDQJHLQ3ULYLOHJHV EŽŶĞ EZK^d Z Board of Trustees Credentialing Subcommittee Nov 2020 The Medical Executive Committee reviewed the following applicants on Nov 18, 2020 and recommends approval by the Board of Trustees Credentialing Subcommittee effective 11.28.20 Medical Staff Initial Appointment and Clinical Privileges Natalie Barnett, M.D. Active Provisional Anesthesiology Neena Champaigne, M.D. Active Provisional Pediatrics Joshua Coney, M.D. Active Provisional Medicine Oleksandra Lupak, M.D. Active Provisional Medicine Grace Berlin Suppa, D.O. Active Provisional Medicine Alexei Zhadkevich, M.D. Active Provisional Medicine Celia Aguilar, M.D. Provisional Affiliate‐ Emergency Medicine RHN Steven Halus, M.D. Provisional Affiliate‐ Emergency Medicine RHN Marion Douglas Holt, M.D. Provisional Affiliate‐ Emergency Medicine RHN Medical Staff Reappointment and Clinical Privileges Kathleen Brady, M.D. Active Psychiatry Howard Brilliant, M.D. Active Orthopaedics Brandon Brown, M.D. Active Family Medicine Thomas Byrne, M.D. Active Surgery Nicole Cain, M.D. Active Pediatrics William Creasman, M.D. Active Obstetrics & Gynecology Stephen Fann, M.D. Active Surgery James Glenn, M.D. Active Medicine Lakshmi Katikaneni, M.D. Active Pediatrics David Lewin, M.D. Active Pathology & Lab. Med. Louis Luttrell, M.D. Active Medicine John Maize , Sr., M.D. Active Dermatology Sandi McKenzie, M.D. Active Pediatrics Pamela Morris, M.D. Active Medicine Arni Nutting, M.D. Active Pediatrics Wing‐Kin Syn, M.B.,Ch.B., Active Medicine Bruce Thiers, M.D. Active Dermatology Marion Wilson, Jr., M.D. Active Ophthalmology William Haley, M.D. Active Provisional Neurology Lauren Robinson, M.D. Active Provisional Pediatrics Thomas Werth, M.D. Active Provisional Medicine Erin Sparks, M.D. Affiliate Neurology Paul Everman, Jr., M.D. Affiliate ‐ Colleague Psychiatry John McDonald, M.D. Affiliate CFC ‐ Medicine Medical Staff Reappointment and Change in Clinical Privileges None Medical Staff Change in Privileges adding Moderate Colston Edgerton, M.D. Active Provisional Surgery Sedation Priv Professional Staff Initial Appointment and Clinical Privileges Aminah Rahim, A.P.R.N. Provisional Allied Pediatrics Julie Hughes, M.S.N. Provisional Allied Pediatrics Kimbi Marenakos, D.N.P. Provisional Allied Psychiatry Samantha Parker, M.P.A.S. Provisional Allied Medicine Sarah Peglow, P.A.C. Provisional Allied Medicine Bree Romecki, M.S.N. Provisional Allied Medicine Rachel Wildman‐Dellos, Provisional Allied Pediatrics Rebecca Miller, F.N.P. Provisional Allied Urology RHN Florence Professional Staff Reappointment and Clinical Privileges Jeanne Barreira, C.N.M. Allied Health Obstetrics & Gynecology Robert Black, O.D. Allied Health Ophthalmology Ali Burnette, F.N.P. Allied Health Pediatrics Mary Chalk, F.N.P. Allied Health Medicine Rebecca Cumbee, P.A. Allied Health Urology Rona Cushman, N.N.P. Allied Health Pediatrics Joseph Davis, A.T.C. Allied Health Orthopaedics Matthew Ewald, P.A.C. Allied Health Emergency Medicine Amanda Fowler, N.P. Allied Health Medicine Hwajoo Haynes, A.N.P. Allied Health Medicine Elizabeth Hudson, M.A. Allied Health Psychiatry Carla Newman, LMSW Allied Health Psychiatry Crystal Reynolds, A.T.C. Allied Health Orthopaedics Jennifer Ridgeway, P.A.C. Allied Health Surgery Whitney Savino, N.N.P., Allied Health Pediatrics Jane Swing, C.R.N.A. Allied Health Anesthesiology Molly Valerio, M.S.W. Allied Health Psychiatry Karen van Bakergem, LISW‐CP Allied Health Pediatrics Nicole Cagle‐Richardson, Provisional Affiliate Pediatrics Orlando Valdez, M.D. Provisional Affiliate Pediatrics Shannon Cornell, N.P. Provisional Allied Medicine Chad Davis, M.S.N. Provisional Allied Medicine Rachel Fox, C.R.N.A. Provisional Allied Anesthesiology Jessica Gardner, M.S.N. Provisional Allied Pediatrics Joy Lauerer, D.N.P. Provisional Allied Department of Nursing Amanda Watts , P.A. Provisional Allied Pediatrics Cristy Blackmon, F.N.P. Provisional Allied Obstetrics & Gynecology Professional Staff Reappointment and Change in Privileges None Professional Staff Change in Privileges Emily Dudleck, P.A.C. Allied Health Neurosurgery adding 2nd dept. Amber Thompson, P.A. Allied Health Neurosurgery adding 2nd dept. Laura Lybarger, N.P. Allied Health Family Medicine Dept. Chg from MED END of ROSTER 0HGLFDO([HFXWLYH&RPPLWWHH DĞĚŝĐĂů džĞĐƵƚŝǀĞŽŵŵŝƚƚĞĞ DĞŵďĞƌƐƉƌĞƐĞŶƚ͗ƌ͘ŶĚƌĞǁƐ͕ƌ͘ĂůŝŐĂ͕ƌ͘ĂƐĐŽ͕ƌ͘ŽLJůĂŶ͕EŽƌĂƌĂŚŶĞLJ͕ƌ͘ƌĞŶĚůĞ͕ƌ͘ƵŶĚLJ͕ƌ͘ĂƌƌŽůů͕ƌ͘ŝŶĂ͕ WƌĞƐŝĚŝŶŐ͗ƌ͘ZŽďĞƌƚŝŶĂ ƌ͘ůĂƌŬ͕ƌ͘ůLJďƵƌŶ͕ƌ͘ƌĂǁĨŽƌĚ͕ƌ͘ŝ^ĂůǀŽ͕ƌ͘ ĂƐƚĞƌůŝŶŐ͕ƌ͘ ĚǁĂƌĚƐ͕ƌ͘,Ăďŝď͕ƌ͘,Ăƌƚ͕ƌ͘<ŽǁĂůĞŶŬŽ͕>͘<Ğƌƌƌ͘ ĂƚĞ͗:ƵůLJϭϱ͕ϮϬϮϬ <ŽĐŚĞƌ͕͘DĐ>ĞĂŶ ƐƋ͕͘ƌ͘DĐ^ǁĂŝŶ͕ƌ͘ZĞĞǀĞƐ͕ƌ͘ZƵƐƐĞůů͕^ƌ͘^ĂůŐĂĚŽ͕^ĐĂƌďƌŽƵŐŚ͕ƌ͘͘^ĐŚĞƵƌĞƌ͕ƌ͘D͘^ĐŚĞƵƌĞƌ͕ƌ͘ DĞĞƚŝŶŐWůĂĐĞ͗tĞď dž tĂƌƌ ZĞĐŽƌĚŝŶŐ͗D͘ĂƌƌŽůů DĞŵďĞƌƐĞdžĐƵƐĞĚ͗ƌ͘ƚnj͕͕ƌ͘ůĂƌŬ͕ƌ͘ŽƐƚĞůůŽ͕ƌ͘ƵŽŝƐ͕D͘&ƵůƚŽŶ͕Z͘ ůůŝƐ͕ƌ͘,ŽŶŐ͕ƌ͘>ĞĚĚLJ͕ƌ͘WĂŽůŝŶŝ͕ƌ͘^ƚƌĞĐŬ͕ƌ͘ DĞĞƚŝŶŐdŝŵĞ͗ϳ͗ϯϬĂŵ ǁĞƌŶĞƌ͖ƌ͘ĂĂƐ ĚũŽƵƌŶŵĞŶƚ͗ϴ͗ϰϱĂŵ 'ƵĞƐƚƐ͗ ZĞĐŽŵŵĞŶĚĂƚŝŽŶͬ ŐĞŶĚĂͬdŽƉŝĐ ĞďĂƚĞΘŝƐĐƵƐƐŝŽŶ ŽŶĐůƵƐŝŽŶƐ &ŽůůŽǁͲhƉ tŚĂƚͬtŚĞŶͬtŚŽ džĞĐƵƚŝǀĞ^ĞƐƐŝŽŶ ŶͬĂ ŶͬĂ ZĞǀŝĞǁŽĨDŝŶƵƚĞƐ DŝŶƵƚĞƐĨƌŽŵDĂLJD ŵĞĞƚŝŶŐĂƉƉƌŽǀĞĚ /ŶĨŽƌŵĂƚŝŽŶ ƉƉƌŽǀĞĚ EŽƌĂƌĂŚŶĞLJƌĞƉŽƌƚĞĚƚŚĞĨŽůůŽǁŝŶŐĨŽƌƌ͘ ĚǁĂƌĚƐ͗ DĞĚŝĐĂů^ƚĂĨĨ/ŶŝƚŝĂůƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗ϯϮ ZĞŐŝŽŶĂůWƌŽǀŝĚĞƌƐ/ŶŝƚŝĂůƉƉŽŝŶƚŵĞŶƚƐ͗ϱ D DĞĚŝĐĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗ϳϰ ƌĞĐŽŵŵĞŶĚƐƚŚĞ DĞĚŝĐĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚŚĂŶŐĞŝŶůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗ϭ ĂƉƉŽŝŶƚŵĞŶƚƐ͕ ƌĞĚĞŶƚŝĂůƐŽŵŵŝƚƚĞĞ DĞĚŝĐĂů^ƚĂĨĨŚĂŶŐĞŝŶWƌŝǀŝůĞŐĞƐ͗Ϯ ƌĞĂƉƉŽŝŶƚŵĞŶƚƐ ĂŶĚĚĞůŝŶĞĂƚŝŽŶ ƌ͘ ĚǁĂƌĚƐ WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨ/ŶŝƚŝĂůƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗Ϯ ŽĨĐůŝŶŝĐĂů WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗ϮϮ ƉƌŝǀŝůĞŐĞƐĨŽƌ WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚŚĂŶŐĞŝŶWƌŝǀŝůĞŐĞƐ͗Ϭ ŽĂƌĚŽĨ WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨŚĂŶŐĞƐŝŶWƌŝǀŝůĞŐĞƐ͗Ϭ dƌƵƐƚĞĞƐ ƌĞĚĞŶƚŝĂůŝŶŐŽŵŵŝƚƚĞĞĚŝĚŶŽƚƌĞĐŽŵŵĞŶĚĞďŽƌĂŚ<ĞůůĞƌ͕D͘͘ĨŽƌĂƉƉƌŽǀĂů͘dŚĞŝƌ ĂƉƉƌŽǀĂů͘ ĚĞĐŝƐŝŽŶǁĂƐďƌŽƵŐŚƚƚŽD ĨŽƌǀŽƚĞ͕D ǀŽƚĞĚƵŶĂŶŝŵŽƵƐůLJƚŽƵƉŚŽůĚƌĞĚĞŶƚŝĂůŝŶŐ ŽŵŵŝƚƚĞĞ͛ƐƌĞĐŽŵŵĞŶĚĂƚŝŽŶ͘ sŝƌƚƵĂůůLJŽŶďŽĂƌĚĞĚŽǀĞƌϮϬϬƌĞƐŝĚĞŶƚƐĂŶĚĨĞůůŽǁƐ tĞŶƚƐŽǁĞůůƚŚĂƚƐŽŵĞĂƌĞĂƐŽĨƚŚĞŽŶďŽĂƌĚŝŶŐǁŝůůƌĞŵĂŝŶǀŝƌƚƵĂůŐŽŝŶŐĨŽƌǁĂƌĚ 'D ZĞƉŽƌƚ Ks/ƐƚƌĞƐƐĞƐĂƌĞŝŵƉĂĐƚŝŶŐWƵůŵŽŶĂƌLJ&ĞůůŽǁƐĂŶĚĨůŽŽƌƐĞƌǀŝĐĞƐĂƐƚŚĞLJĂƌĞ /ŶĨŽƌŵĂƚŝŽŶ ƌ͘ůLJďƵƌŶ ƐĞĞŝŶŐĂŶĐŽŶƚŝŶƵĂůŝŶĐƌĞĂƐŝŶŐĐĂƐĞůŽĂĚĂŶĚŝŶĐƌĞĂƐĞŝŶKs/ƉĂƚŝĞŶƚƐ͕ŝƚŝƐĂ ƐƚƌĞƐƐŽŶƚŚĞƚƌĂŝŶŝŶŐƉƌŽŐƌĂŵ KǀĞƌĂůůƐĐŽƌĞĐĂƌĚϯ͘ϴͲEĞǁŐŽĂůƐĨŽƌ&zϮϭƐŚŽƵůĚƌĞĨůĞĐƚĨŽƌƵŐƵƐƚŵĞĞƚŝŶŐ YƵĂůŝƚLJZĞƉŽƌƚ ƌĂĨƚŐƵŝĚĞůŝŶĞƐĨŽƌƌĞŵŽǀŝŶŐ/ƐŽůĂƚŝŽŶ^ƚĂƚƵƐĨŽƌŚŽƐƉŝƚĂůŝnjĞĚĂŶĚŶŽŶͲŚŽƐƉŝƚĂůŝnjĞĚ /ŶĨŽƌŵĂƚŝŽŶ ƌ͘ƵŶĚLJ BB0(& ƉĂƚŝĞŶƚƐǁŝůůďĞƉƌĞƐĞŶƚĞĚƚŚŝƐǁĞĞŬ %XQG\SSW[ ΎΎΎKE&/ Ed/>͗^^ddhd ^ϰϬͲϳϭͲϭϬΘϰϬͲϳϭͲϮϬƉƌŽƚĞĐƚƚŚŝƐĚŽĐƵŵĞŶƚĨƌŽŵ ͘͘͘͞ĚŝƐĐŽǀĞƌLJ͕ƐƵďƉŽĞŶĂ͕ŽƌŝŶƚƌŽĚƵĐƚŝŽŶŝŶƚŽĞǀŝĚĞŶĐĞŝŶĂŶLJĐŝǀŝůĂĐƚŝŽŶ͘͘͘͟ΎΎΎ WĂŐĞϭŽĨϯ 0HGLFDO([HFXWLYH&RPPLWWHH ŽŵŵƵŶŝĐĂƚŝŽŶ͛ƐZĞƉŽƌƚ EŽƌĞƉŽƌƚƚŚŝƐŵŽŶƚŚ /ŶĨŽƌŵĂƚŝŽŶ ƌ͘tĂƌƌ EĞǁƵƐŝŶĞƐƐ ŵƉůŽLJĞĞdĞƐƚŝŶŐͲZŽůůƵƉŽĨƉŽƐŝƚŝǀĞƚĞƐƚƐĨŽƌĞŵƉůŽLJĞĞƐďLJĂĨĨŝůŝĂƚŝŽŶ͕ƐƚĂƌƚƐ DĂƌĐŚϭ͕ŽǀĞƌŚĂůĨDh,͕hŶŝǀĞƌƐŝƚLJŶƵŵďĞƌƐĂƌĞŵŽƐƚůLJƐƚƵĚĞŶƚƐ͕ůĂƐƚƐŝĚĞ '%60(&-XO\ SSW[ ƌĞǀŝĞǁƐƉƌŽƚŽĐŽůĨŽƌĞŵƉůŽLJĞĞƐ WW hƉĚĂƚĞͲ^ƵƉƉůLJŚĂŝŶĚŽĞƐĂĚĂŝůLJĂƐƐĞƐƐŵĞŶƚƚŽŵŽŶŝƚŽƌWW ͕ŵŽŶŝƚŽƌƐWŝĐŬ 0(&&29,'6DIHW\ /ŶĨŽƌŵĂƚŝŽŶ ƚŝĐŬĞƚƐĨŽƌĂŶĂĐĐŽƵŶƚŝŶŐŽĨĂůůWW ƌĞƋƵĞƐƚĞĚĂŶĚĚŝƐƚƌŝďƵƚĞĚ͕ďƵƌŶƌĂƚĞŝƐĐůŽƐĞůLJ SSW[ ŵŽŶŝƚŽƌĞĚƚŽĞŶƐƵƌĞWW ŝƐĂǀĂŝůĂďůĞ
^ĂĨĞƚLJ'ƵŝĚĞůŝŶĞƐʹ'ŽĂůŝƐƚŽƉƌŽǀŝĚĞǁŽƌŬĂŶĚƚƌĞĂƚŵĞŶƚƐƉĂĐĞƐĂĨĞĨŽƌ 0(&6XSSO\&KDLQ ƉĂƚŝĞŶƚƐĂŶĚƐƚĂĨĨ͕ƚĞƐƚŝŶŐƉƌŽƚŽĐŽůƐ͕WW ƵƐĂŐĞ͕ƌĞĞǀĂůƵĂƚŝŽŶƉĂƚŝĞŶƚƐǁͬŽƐŝŐŶƐ 6&8SGDWHS ĂŶĚƐLJŵƉƚŽŵƐ͕ŚĂƐƵƉĚĂƚĞĚŐƵŝĚĂŶĐĞƚŽŝŶĐůƵĚĞĨĂĐĞƐŚŝĞůĚƐĂƐǁĞůůĂƐĞLJĞ ƉƌŽƚĞĐƚŝŽŶ͕ĐŽŶƚĂĐƚƚƌĂĐŝŶŐƐƵƌǀĞLJŝƐĂǀĂůƵĂďůĞƚŽŽůƚŽŚĞůƉŝĚĞŶƚŝĨLJƐŽƵƌĐĞƐ ŽŶƐĞŶƚ/ƚĞŵƐ WŽůŝĐŝĞƐĨŽƌƉƉƌŽǀĂů͗ WŽůŝĐŝĞƐ ͻWŽůŝĐLJͲϬϳϱ͗sĂƐĐƵůĂƌĐĐĞƐƐĂƌĞĂŶĚDĂŶĂŐĞŵĞŶƚ͕ŝŶĐůƵĚŝŶŐ/s /ŶĨŽƌŵĂƚŝŽŶ ;ŽŶƐĞŶƚͿ ĚŵŝŶŝƐƚƌĂƚŝŽŶ^ĞƚƐ͕/s/ŶĨƵƐŝŽŶĂŶĚ/sĚŵŝŶŝƐƚƌĂƚŝŽŶŽŶĞĂƚƚŚŝƐƚŝŵĞ ƉƉƌŽǀĞĚ ^ƚĂŶĚŝŶŐKƌĚĞƌƐ ^ƚĂŶĚŝŶŐKƌĚĞƌƐĨŽƌƉƉƌŽǀĂů͗ /ŶĨŽƌŵĂƚŝŽŶ ;ŽŶƐĞŶƚͿ ŶͬĂ KƚŚĞƌŽŶƐĞŶƚ/ƚĞŵƐ ŶͬĂ Eͬ ;ŽŶƐĞŶƚͿ ĂƚĂΘ^ĞƌǀŝĐĞZĞƉŽƌƚƐ ĂƚĂƌĞƉŽƌƚƐƌĞǀŝĞǁĞĚ͗ ^ĞƌǀŝĐĞƌĞƉŽƌƚƐƌĞǀŝĞǁĞĚ͗ ;ŽŶƐĞŶƚͿ ĚŵŝƚdƌĂŶƐĨĞƌZĞƉŽƌƚ ŝƐĐŚĂƌŐĞ^ƵŵŵĂƌLJdƵƌŶĂƌŽƵŶĚdŝŵĞ o ƉƉƌŽǀĞĚ ĚŵŝƚdƌĂŶƐĨĞƌZĞƉŽƌƚ&zϭϵ ŝƐĐŚĂƌŐĞĞƚĂŝůddďLJWŚLJƐŝĐŝĂŶ /ŶĨŽƌŵĂƚŝŽŶ o o zdĞŶƐƵƐZĞƉŽƌƚϮϬϭϴͲϮϬϭϵ o ,ĂŶĚ,LJŐŝĞŶĞ:ƵůLJϮϬϭϵ ^ƵďĐŽŵŵŝƚƚĞĞDŝŶƵƚĞƐ /ͬŽĚŝŶŐ ;ŽŶƐĞŶƚͿ ƌĞĚĞŶƚŝĂůŝŶŐŽŵŵŝƚƚĞĞ /ŶĨŽƌŵĂƚŝŽŶ ƉƉƌŽǀĞĚ 'D ŽŵŵŝƚƚĞĞ ,ĞĂůƚŚ/ŶĨŽƌŵĂƚŝŽŶDĂŶĂŐĞŵĞŶƚ WŚĂƌŵĂĐLJĂŶĚdŚĞƌĂƉĞƵƚŝĐƐŽŵŵŝƚƚĞĞ
ΎΎΎKE&/ Ed/>͗^^ddhd ^ϰϬͲϳϭͲϭϬΘϰϬͲϳϭͲϮϬƉƌŽƚĞĐƚƚŚŝƐĚŽĐƵŵĞŶƚĨƌŽŵ ͘͘͘͞ĚŝƐĐŽǀĞƌLJ͕ƐƵďƉŽĞŶĂ͕ŽƌŝŶƚƌŽĚƵĐƚŝŽŶŝŶƚŽĞǀŝĚĞŶĐĞŝŶĂŶLJĐŝǀŝůĂĐƚŝŽŶ͘͘͘͟ΎΎΎ WĂŐĞϮŽĨϯ 0HGLFDO([HFXWLYH&RPPLWWHH WĞĞƌZĞǀŝĞǁŽŵŵŝƚƚĞĞ ĚũŽƵƌŶŵĞŶƚ dŚĞŶĞdžƚŵĞĞƚŝŶŐŽĨƚŚĞDĞĚŝĐĂů džĞĐƵƚŝǀĞŽŵŵŝƚƚĞĞǁŝůůďĞƵŐƵƐƚ͕ϭϵϮϬϮϬĂƚϳ͗ϯϬĂŵsŝĂtĞď dž ϴ͗ϰϱĂŵ Prabhakar Baliga, MD ͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺ WƌĂďŚĂŬĂƌĂůŝŐĂ͕D͕^ĞĐƌĞƚĂƌLJŽĨƚŚĞDĞĚŝĐĂů^ƚĂĨĨ
ΎΎΎKE&/ Ed/>͗^^ddhd ^ϰϬͲϳϭͲϭϬΘϰϬͲϳϭͲϮϬƉƌŽƚĞĐƚƚŚŝƐĚŽĐƵŵĞŶƚĨƌŽŵ ͘͘͘͞ĚŝƐĐŽǀĞƌLJ͕ƐƵďƉŽĞŶĂ͕ŽƌŝŶƚƌŽĚƵĐƚŝŽŶŝŶƚŽĞǀŝĚĞŶĐĞŝŶĂŶLJĐŝǀŝůĂĐƚŝŽŶ͘͘͘͟ΎΎΎ WĂŐĞϯŽĨϯ 0HGLFDO([HFXWLYH&RPPLWWHH DĞĚŝĐĂů džĞĐƵƚŝǀĞŽŵŵŝƚƚĞĞ WƌĞƐŝĚŝŶŐ͗ƌ͘ůŝĐĞŽLJůĂŶ DĞŵďĞƌƐƉƌĞƐĞŶƚ͗ƌ͘ĂůŝŐĂ͕ƌ͘ĂƐĐŽ͕ƌ͘ŽLJůĂŶ͕EŽƌĂƌĂŚŶĞLJ͕ƌ͘ƌĞŶĚůĞ͕ƌ͘ƵŶĚLJ͕ƌ͘ĂƌƌŽůů͕ƌ͘ŝŶĂ͕ƌ͘ŝ^ĂůǀŽ͕ ĂƚĞ͗ƵŐƵƐƚϭϵ͕ϮϬϮϬ ƌ͘ƵŽŝƐĞ͕ƌ͘ ĂƐƚĞƌůŝŶŐ͕ƌ͘ ĚǁĂƌĚƐ͕D͘&ƵůƚŽŶ͕ƌ͘,Ăƌƚ͕ƌ͘<ŽĐŚĞƌ͕ƌ͘<ŽǁĂůĞŶŬŽ͕>͘<Ğƌƌ͕ƌ͘DĐ^ǁĂŝŶ͕ƌ͘ZĞĞǀĞƐ͕ƌ͘ DĞĞƚŝŶŐWůĂĐĞ͗tĞď dž ZƵƐƐĞůů͕ƌ͘^ĂůŐĂĚŽ͕^͘^ĐĂƌďƌŽƵŐŚ͕ƌ͘͘^ĐŚĞƵƌĞƌ͕ƌ͘tĂƌƌ ZĞĐŽƌĚŝŶŐ͗D͘ĂƌƌŽůů DĞŵďĞƌƐĞdžĐƵƐĞĚ͗ƌ͘ŶĚƌĞǁƐ͕ƌ͘ƚnj͕ƌ͘ůĂƌŬ͕ƌ͘ůLJďƵƌŶ͕ƌ͘ŽƐƚĞůůŽ͕ƌ͘ƌĂǁĨŽƌĚƌ͘ƵŽŝƐ͕Z͘ ůůŝƐ͕ƌ͘,Ăďŝď͕ƌ͘ DĞĞƚŝŶŐdŝŵĞ͗ϳ͗ϯϬĂŵ ,ŽŶŐ͕ƌ͘>ĞĚĚLJ͕͘DĐ>ĞĂŶ͕ ƐƋ͕͘ƌ͘WĂŽůŝŶŝ͕ƌ͘D^ĐŚĞƵƌĞƌ͕ƌ͘^ƚƌĞĐŬ͕ƌ͘ĂĂƐ͕ƌ͘ǁĞƌŶĞƌ ĚũŽƵƌŶŵĞŶƚ͗ϴ͗ϯϬĂŵ 'ƵĞƐƚƐ͗ƌ͘^ĐŽƚƚƌĂĚůĞLJ͕ŶƚŚŽŶLJ,ĂůĞ͕EŝĐŽůĞWŝůĐŚ ZĞĐŽŵŵĞŶĚĂƚŝŽŶͬ ŐĞŶĚĂͬdŽƉŝĐ ĞďĂƚĞΘŝƐĐƵƐƐŝŽŶ ŽŶĐůƵƐŝŽŶƐ &ŽůůŽǁͲhƉ tŚĂƚͬtŚĞŶͬtŚŽ džĞĐƵƚŝǀĞ^ĞƐƐŝŽŶ ŶͬĂ ŶͬĂ ZĞǀŝĞǁŽĨDŝŶƵƚĞƐ DŝŶƵƚĞƐĨƌŽŵ:ƵůLJD ŵĞĞƚŝŶŐĂƉƉƌŽǀĞĚ /ŶĨŽƌŵĂƚŝŽŶ ƉƉƌŽǀĞĚ ƌ͘ ĚǁĂƌĚƐƌĞƉŽƌƚĞĚƚŚĞĨŽůůŽǁŝŶŐ͗ D DĞĚŝĐĂů^ƚĂĨĨ/ŶŝƚŝĂůƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗Ϯϳ ƌĞĐŽŵŵĞŶĚƐƚŚĞ ZĞŐŝŽŶĂůWƌŽǀŝĚĞƌƐ/ŶŝƚŝĂůƉƉŽŝŶƚŵĞŶƚƐ͗Ϯ ĂƉƉŽŝŶƚŵĞŶƚƐ͕ DĞĚŝĐĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗ϲϬ ƌĞĚĞŶƚŝĂůƐŽŵŵŝƚƚĞĞ ƌĞĂƉƉŽŝŶƚŵĞŶƚƐ DĞĚŝĐĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚŚĂŶŐĞŝŶůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗Ϯ ĂŶĚĚĞůŝŶĞĂƚŝŽŶ ƌ͘ ĚǁĂƌĚƐ DĞĚŝĐĂů^ƚĂĨĨŚĂŶŐĞŝŶWƌŝǀŝůĞŐĞƐ͗Ϯ ŽĨĐůŝŶŝĐĂů WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨ/ŶŝƚŝĂůƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗ϭϭ ƉƌŝǀŝůĞŐĞƐĨŽƌ WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗Ϯϵ ŽĂƌĚŽĨ WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚŚĂŶŐĞŝŶWƌŝǀŝůĞŐĞƐ͗Ϭ dƌƵƐƚĞĞƐ ĂƉƉƌŽǀĂů͘ WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨŚĂŶŐĞƐŝŶWƌŝǀŝůĞŐĞƐ͗Ϭ 'D ZĞƉŽƌƚ KƌŝĞŶƚĂƚŝŽŶĂŶĚŽŶďŽĂƌĚŝŶŐǁĂƐǀŝƌƚƵĂůƚŚŝƐLJĞĂƌ͕ǁĞƌĞĂďůĞƚŽŐĞƚŝŶĚŝǀŝĚƵĂů /ŶĨŽƌŵĂƚŝŽŶ ƌ͘ůLJďƵƌŶ ŽŽŵůŝĐĞŶƐĞƐĨŽƌĞĂĐŚƉƌŽŐƌĂŵ͕ KǀĞƌĂůů^ĐŽƌĞϯ͘ϴ YƵĂůŝƚLJZĞƉŽƌƚ ZĞŵŽǀĂůŝĨŝƐŽůĂƚŝŽŶƐĨůĂŐƐĨŽƌKs/ͲϭϵƉĂƚŝĞŶƚƐ /ŶĨŽƌŵĂƚŝŽŶ ƌ͘ƵŶĚLJ ^LJŵƉƚŽŵďĂƐĞĚͬƚĞƐƚďĂƐĞĚͬƚŝŵĞďĂƐĞĚ BB 0(& %XQG\SSW[ ϵϬĚĂLJƌĞƉĞĂƚKs/WZƚŽĞŶĚƐŽŽŶ DKǁĞĞŬůLJŶĞǁƐůĞƚƚĞƌŝƐƵƉĂŶĚƌƵŶŶŝŶŐ͕ĨĞĞĚďĂĐŬǁĞůĐŽŵĞ WůĞĂƐĞƚĂŬĞĂŵŽŵĞŶƚƚŽƌĞǀŝĞǁƚŚĞKs/ŐƵŝĚŝŶŐƉƌŝŶĐŝƉůĞƐǁŝƚŚƚŚŽƐĞƌĞƚƵƌŶŝŶŐ ŽŵŵƵŶŝĐĂƚŝŽŶ͛ƐZĞƉŽƌƚ ƚŽĐĂŵƉƵƐ /ŶĨŽƌŵĂƚŝŽŶ ƌ͘tĂƌƌ tŽƌŬŝŶŐͲŽƵƚŚŽǁƚŽŽƉĞŶϱϬŽƌƐŽŵŽƌĞďĞĚƐŝŶ^ĞƉƚĞŵďĞƌĂŶĚKĐƚŽďĞƌ͕ǁŝůůďĞ ĚŽŶĞŝŶƉŚĂƐĞƐ
ΎΎΎKE&/ Ed/>͗^^ddhd ^ϰϬͲϳϭͲϭϬΘϰϬͲϳϭͲϮϬƉƌŽƚĞĐƚƚŚŝƐĚŽĐƵŵĞŶƚĨƌŽŵ ͘͘͘͞ĚŝƐĐŽǀĞƌLJ͕ƐƵďƉŽĞŶĂ͕ŽƌŝŶƚƌŽĚƵĐƚŝŽŶŝŶƚŽĞǀŝĚĞŶĐĞŝŶĂŶLJĐŝǀŝůĂĐƚŝŽŶ͘͘͘͟ΎΎΎ WĂŐĞϭŽĨϯ 0HGLFDO([HFXWLYH&RPPLWWHH EĞǁƵƐŝŶĞƐƐ s/hZĞƉŽƌƚKƵƚ ^ĐŽƉĞŽĨtŽƌŬ͗/ŶƚĞƌǀŝĞǁĐƵƌƌĞŶƚůLJƐƚĂŬĞŚŽůĚĞƌƐŝŶs/h͖DĂŬĞ &9,&8,QWHUQDO 5HYLHZ9SSW[ ƌĞĐŽŵŵĞŶĚĂƚŝŽŶƐĨŽƌĐĂƌĞŵŽĚĞů͖ZĞƐĞĂƌĐŚĐĂƌĞŵŽĚĞůƐĨŽƌŚŝŐŚůLJĨƵŶĐƚŝŽŶĂů s/hƐĂƌŽƵŶĚƚŚĞĐŽƵŶƚƌLJ EƵƌƐŝŶŐ͗ZĞƐŽƵƌĐĞŶƵƌƐĞ͕ǁĞĞŬĞŶĚƐŚŝĨƚƐ͕ĚĞĚŝĐĂƚĞĚĚĂLJĂŶĚŶŝŐŚƚƐŚŝĨƚƐ͖WK ƚĞƐƚŝŶŐ͕ŵŽǀĞůĂďĐůŽƐĞƚŽŽƌŝŶƐŝĚĞs/h WW^͗WĂŝĚƉŽƐŝƚŝŽŶĨŽƌWWůĞĂĚĞƌ͖ĞƐŝŐŶĂƚĞĚǁŽƌŬƐƉĂĐĞŶĞĂƌͬŝŶs/h͖DĞĚŝĐĂů /ŶĨŽƌŵĂƚŝŽŶ ŝƌĞĐƚŽƌĨŽƌWWƐ͖WWƐƚŽĞĂĐŚƐƉĞŶĚŽŶĞŵŽŶƚŚŽĨĚĞĚŝĐĂƚĞĚƚŝŵĞŽŶƚŚĞd ƐƵƌŐĞƌLJƐĞƌǀŝĐĞ >ŽŶŐͲƚĞƌŵ͗ƐƐĞƐƐĐĂƉĂĐŝƚLJĂŶĚƐƵƉƉŽƌƚ/hĨŽƌŵĞĚŝĐĂůƉĂƚŝĞŶƚƐĂŶĚs/hĂƐ ƐƵƌŐŝĐĂů/h͖ĂƌĚŝĂĐ/hĨƵŶĐƚŝŽŶƵŶĚĞƌƐĂŵĞĐŽůůĂďŽƌĂƚŝǀĞŵŽĚĞůǁŝƚŚĐƌŝƚŝĐĂů ĐĂƌĞƐĞƌǀŝĐĞĂƐƉƌŝŵĂƌLJƚĞĂŵ &ŽůůŽǁƵƉǁŝƚŚŽĨĨŝĐŝĂůD ƌĞĐŽŵŵĞŶĚĂƚŝŽŶ ŽŶƐĞŶƚ/ƚĞŵƐ WŽůŝĐŝĞƐĨŽƌƉƉƌŽǀĂů͗ x ͻ&9DVFXODU$FFHVV&DUHDQG0DQDJHPHQWLQFOXGLQJ,9 WŽůŝĐŝĞƐ $GPLQLVWUDWLRQ6HWV,9,QIXVLRQDQG,9$GPLQLVWUDWLRQ ƉƉƌŽǀĞĚ /ŶĨŽƌŵĂƚŝŽŶ ;ŽŶƐĞŶƚͿ x & 3DWLHQW)DPLO\1XWULWLRQ(GXFDWLRQ x &86*,93ROLF\ W ^ƚĂŶĚŝŶŐKƌĚĞƌƐĨŽƌƉƉƌŽǀĂů͗ x 'LDEHWHV&DUH3ODQ ^ƚĂŶĚŝŶŐKƌĚĞƌƐ x +HDUW)DLOXUH&$'&DUH3ODQ /ŶĨŽƌŵĂƚŝŽŶ ;ŽŶƐĞŶƚͿ x +\SHUWHQVLRQ&DUH3ODQ x 5[5HILOOV&KLOGUHQ¶V$PEXODWRU\ 7UDQVSRUW6WDQGDUGRI:RUN KƚŚĞƌŽŶƐĞŶƚ/ƚĞŵƐ ŶͬĂ Eͬ ;ŽŶƐĞŶƚͿ
ΎΎΎKE&/ Ed/>͗^^ddhd ^ϰϬͲϳϭͲϭϬΘϰϬͲϳϭͲϮϬƉƌŽƚĞĐƚƚŚŝƐĚŽĐƵŵĞŶƚĨƌŽŵ ͘͘͘͞ĚŝƐĐŽǀĞƌLJ͕ƐƵďƉŽĞŶĂ͕ŽƌŝŶƚƌŽĚƵĐƚŝŽŶŝŶƚŽĞǀŝĚĞŶĐĞŝŶĂŶLJĐŝǀŝůĂĐƚŝŽŶ͘͘͘͟ΎΎΎ WĂŐĞϮŽĨϯ 0HGLFDO([HFXWLYH&RPPLWWHH ĂƚĂΘ^ĞƌǀŝĐĞZĞƉŽƌƚƐ ĂƚĂƌĞƉŽƌƚƐƌĞǀŝĞǁĞĚ͗ ^ĞƌǀŝĐĞƌĞƉŽƌƚƐƌĞǀŝĞǁĞĚ͗ ;ŽŶƐĞŶƚͿ ĚŵŝƚdƌĂŶƐĨĞƌZĞƉŽƌƚ ŝƐĐŚĂƌŐĞ^ƵŵŵĂƌLJdƵƌŶĂƌŽƵŶĚdŝŵĞ o ƉƉƌŽǀĞĚ ĚŵŝƚdƌĂŶƐĨĞƌZĞƉŽƌƚ&zϭϵ ŝƐĐŚĂƌŐĞĞƚĂŝůddďLJWŚLJƐŝĐŝĂŶ /ŶĨŽƌŵĂƚŝŽŶ o o zdĞŶƐƵƐZĞƉŽƌƚϮϬϭϴͲϮϬϭϵ o ,ĂŶĚ,LJŐŝĞŶĞ:ƵůLJϮϬϭϵ ^ƵďĐŽŵŵŝƚƚĞĞDŝŶƵƚĞƐ ƌĞĚĞŶƚŝĂůŝŶŐŽŵŵŝƚƚĞĞ ;ŽŶƐĞŶƚͿ 'D ŽŵŵŝƚƚĞĞ /ŶĨŽƌŵĂƚŝŽŶ ƉƉƌŽǀĞĚ WΘdŽŵŵŝƚƚĞĞ YƵĂůŝƚLJ džĞĐƵƚŝǀĞŽŵŵŝƚƚĞĞ ĚũŽƵƌŶŵĞŶƚ dŚĞŶĞdžƚŵĞĞƚŝŶŐŽĨƚŚĞDĞĚŝĐĂů džĞĐƵƚŝǀĞŽŵŵŝƚƚĞĞǁŝůůďĞ^ĞƉƚĞŵďĞƌ͕ϭϲϮϬϮϬĂƚϳ͗ϯϬĂŵsŝĂtĞď dž ϴ͗ϯϬĂŵ Prabhakar Baliga, MD ͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺ WƌĂďŚĂŬĂƌĂůŝŐĂ͕D͕^ĞĐƌĞƚĂƌLJŽĨƚŚĞDĞĚŝĐĂů^ƚĂĨĨ
ΎΎΎKE&/ Ed/>͗^^ddhd ^ϰϬͲϳϭͲϭϬΘϰϬͲϳϭͲϮϬƉƌŽƚĞĐƚƚŚŝƐĚŽĐƵŵĞŶƚĨƌŽŵ ͘͘͘͞ĚŝƐĐŽǀĞƌLJ͕ƐƵďƉŽĞŶĂ͕ŽƌŝŶƚƌŽĚƵĐƚŝŽŶŝŶƚŽĞǀŝĚĞŶĐĞŝŶĂŶLJĐŝǀŝůĂĐƚŝŽŶ͘͘͘͟ΎΎΎ WĂŐĞϯŽĨϯ 0HGLFDO([HFXWLYH&RPPLWWHH DĞĚŝĐĂů džĞĐƵƚŝǀĞŽŵŵŝƚƚĞĞ WƌĞƐŝĚŝŶŐ͗ƌ͘ůŝĐĞŽLJůĂŶ DĞŵďĞƌƐƉƌĞƐĞŶƚ͗ƌ͘ĂůŝŐĂ͕ƌ͘ĂƐĐŽ͕ƌ͘ŽLJůĂŶ͕E͘ƌĂŚŶĞLJ͕ƌ͘ƌĞŶĚůĞ͕ƌ͘ƵŶĚLJ͕ƌ͘ĂƌƌŽůů͕ƌ͘ůLJďƵƌŶ͕ƌ͘ŝŶĂ͕ƌ͘ ĂƚĞ͗^ĞƉƚĞŵďĞƌϭϲ͕ϮϬϮϬ ƌĂǁĨŽƌĚ͕ƌ͘ŝ^ĂůǀŽ͕ƌ͘ƵŽŝƐĞ͕͕ƌ͘ ĚǁĂƌĚƐ͕D͘&ƵůƚŽŶ͕ƌ͘,Ăƌƚ͕ƌ͘,ŽŶŐ͕ƌ͘<ŽǁĂůĞŶŬŽ͕͕͘DĐ>ĞĂŶ͕ ƐƋ͕͕͘ƌ͘ DĞĞƚŝŶŐWůĂĐĞ͗tĞď dž ZĞĞǀĞƐ͕ƌ͘ZƵƐƐĞůů͕ƌ͘^ĂůŐĂĚŽ͕^͘^ĐĂƌďƌŽƵŐŚ͕ƌ͘D͘^ĐŚĞƵƌĞƌ͕ƌ͘tĂƌƌ ZĞĐŽƌĚŝŶŐ͗D͘ĂƌƌŽůů DĞŵďĞƌƐĞdžĐƵƐĞĚ͗ƌ͘ŶĚƌĞǁƐ͕ƌ͘ƚnj͕ƌ͘ůĂƌŬ͕ƌ͘ŽƐƚĞůůŽ͕ƌ͘ƵŽŝƐ͕ƌ͘ ĂƐƚĞƌůŝŶŐ͕Z͘ ůůŝƐ͕ƌ͘,Ăďŝď͕>͘<Ğƌƌƌ͘<ŽĐŚĞƌ DĞĞƚŝŶŐdŝŵĞ͗ϳ͗ϯϬĂŵ ƌ͘>ĞĚĚLJ͕ƌ͘DĐ^ǁĂŝŶƌ͘WĂŽůŝŶŝ͕ƌ͘^ĐŚĞƵƌĞƌ͕ƌ͘^ƚƌĞĐŬ͕ƌ͘ĂĂƐ͕ƌ͘ǁĞƌŶĞƌ ĚũŽƵƌŶŵĞŶƚ͗ϴ͗ϯϬĂŵ 'ƵĞƐƚƐ͗ĂƌŽůŝŶĞĞůŽŶŐĐŚĂŵƉƐĂŶĚ<ĞůůLJ>ŽLJĚ ZĞĐŽŵŵĞŶĚĂƚŝŽŶͬ ŐĞŶĚĂͬdŽƉŝĐ ĞďĂƚĞΘŝƐĐƵƐƐŝŽŶ ŽŶĐůƵƐŝŽŶƐ &ŽůůŽǁͲhƉ tŚĂƚͬtŚĞŶͬtŚŽ džĞĐƵƚŝǀĞ^ĞƐƐŝŽŶ ŶͬĂ ŶͬĂ ZĞǀŝĞǁŽĨDŝŶƵƚĞƐ DŝŶƵƚĞƐĨƌŽŵƵŐƵƐƚD ŵĞĞƚŝŶŐĂƉƉƌŽǀĞĚ /ŶĨŽƌŵĂƚŝŽŶ ƉƉƌŽǀĞĚ ƌ͘ ĚǁĂƌĚƐƌĞƉŽƌƚĞĚƚŚĞĨŽůůŽǁŝŶŐ͗ D DĞĚŝĐĂů^ƚĂĨĨ/ŶŝƚŝĂůƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗ϯϲ ƌĞĐŽŵŵĞŶĚƐƚŚĞ DĞĚŝĐĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗ϯϱ ĂƉƉŽŝŶƚŵĞŶƚƐ͕ ƌĞĚĞŶƚŝĂůƐŽŵŵŝƚƚĞĞ DĞĚŝĐĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚŚĂŶŐĞŝŶůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗ϭ ƌĞĂƉƉŽŝŶƚŵĞŶƚƐ ĂŶĚĚĞůŝŶĞĂƚŝŽŶ ƌ͘ ĚǁĂƌĚƐ DĞĚŝĐĂů^ƚĂĨĨŚĂŶŐĞŝŶWƌŝǀŝůĞŐĞƐ͗Ϯ ŽĨĐůŝŶŝĐĂů WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨ/ŶŝƚŝĂůƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗ϵ ƉƌŝǀŝůĞŐĞƐĨŽƌ WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚůŝŶŝĐĂůWƌŝǀŝůĞŐĞƐ͗ϯϳ ŽĂƌĚŽĨ WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨZĞĂƉƉŽŝŶƚŵĞŶƚĂŶĚŚĂŶŐĞŝŶWƌŝǀŝůĞŐĞƐ͗ϭ dƌƵƐƚĞĞƐ WƌŽĨĞƐƐŝŽŶĂů^ƚĂĨĨŚĂŶŐĞƐŝŶWƌŝǀŝůĞŐĞƐ͗Ϭ ĂƉƉƌŽǀĂů͘ dŚĞƌĞĂƌĞĚŝƐĐƵƐƐŝŽŶĐĞŶƚĞƌŝŶŐĂƌŽƵŶĚĂ'D ĐŽŶƐŽƌƚŝƵŵ͕ŵƵůƚŝƉůĞŵŽĚĞůƐĂƌĞ 'D ZĞƉŽƌƚ ďĞŝŶŐĚŝƐĐƵƐƐĞĚ͕ŽƵƌƌĞŐŝŽŶŝƐĚŝĨĨĞƌĞŶƚĂŶĚŵŽĚĞůƐǁŝůůŶĞĞĚƚŽƌĞĨůĞĐƚƚŚĂƚĨŽƌ /ŶĨŽƌŵĂƚŝŽŶ ƌ͘ůLJďƵƌŶ ƌĞĐƌƵŝƚŵĞŶƚ KǀĞƌĂůů^ĐŽƌĞsŝnjŝĞŶƚ͗ϰϬ͘ϳϰdǁŽƐƚĂƌƐĂŶĚŽǀĞƌĂůůƌĂŶŬŽĨϴϱ YƵĂůŝƚLJZĞƉŽƌƚ ,ŝŐŚƐĐŽƌĞƐŝŶƉĂƚŝĞŶƚĐĞŶƚĞƌĞĚŶĞƐƐĂŶĚĞƋƵŝƚLJ /ŶĨŽƌŵĂƚŝŽŶ ƌ͘ƵŶĚLJ >ŽǁĞƐƚĐŽƌĞƐŝŶŵŽƌƚĂůŝƚLJĂŶĚƐĂĨĞƚLJ B B0(& %XQG\SSW[ 'ŽĂů͗dŽďĞƚŽƉϭϱƌĂŶŬŝŶŐĂŵŽŶŐĂĐĂĚĞŵŝĐŚĞĂůƚŚƐLJƐƚĞŵƐ tŽƌŬŝŶŐŽŶŝŶĐƌĞŵĞŶƚĂůůLJŽƉĞŶŝŶŐďĞĚƐĂŶĚŽďƐĞƌǀĂƚŝŽŶĂůďĞĚƐĂƚZdĂŶĚDĂŝŶ tŽƌŬŝŶŐŽŶŽƉĞŶŝŶŐŵŽƌĞ/hďĞĚƐ͕ĐƵƌƌĞŶƚůLJϱĂƌĞŽƉĞŶ WĂƚƚŝ,ĂƌƚǁŽƌŬŝŶŐƚŽƌĞĐƌƵŝƚŶƵƌƐĞƐĨŽƌƚŚŽƐĞĂƌĞĂƐ ŽŵŵƵŶŝĐĂƚŝŽŶ͛ƐZĞƉŽƌƚ tŽƌŬŝŶŐŽŶŚŝƌŝŶŐWW^ĨŽƌƚŚĞƐĞĂƌĞĂƐĂƐǁĞůůŝŶŽƌĚĞƌƚŽďĞŵŽƐƚĞĨĨĞĐƚŝǀĞ /ŶĨŽƌŵĂƚŝŽŶ ƌ͘tĂƌƌ ZĞƋƵĞƐƚĂƐƐŝƐƚĂŶĐĞŝŶƉƌŝŽƌŝƚŝnjŝŶŐƌĞƋƵĞƐƚƐƚŽDĞĚdƌĂŶƐĨĞƌĞŶƚĞƌƚŽďĞƐƚƵƚŝůŝnjĞ ƌĞƐŽƵƌĐĞƐ ŽŶƚŝŶƵĞƚŽƉůĂŶĨŽƌĂŶLJƉŽƚĞŶƚŝĂůKs/ƐƵƌŐĞΕϮϬϬ͕ǁĞĐĂŶŵĞĞƚƚŚĂƚĚĞŵĂŶĚ ΎΎΎKE&/ Ed/>͗^^ddhd ^ϰϬͲϳϭͲϭϬΘϰϬͲϳϭͲϮϬƉƌŽƚĞĐƚƚŚŝƐĚŽĐƵŵĞŶƚĨƌŽŵ ͘͘͘͞ĚŝƐĐŽǀĞƌLJ͕ƐƵďƉŽĞŶĂ͕ŽƌŝŶƚƌŽĚƵĐƚŝŽŶŝŶƚŽĞǀŝĚĞŶĐĞŝŶĂŶLJĐŝǀŝůĂĐƚŝŽŶ͘͘͘͟ΎΎΎ WĂŐĞϭŽĨϯ 0HGLFDO([HFXWLYH&RPPLWWHH EĞǁƵƐŝŶĞƐƐ 'ƵŝĚŝŶŐWƌŝŶĐŝƉůĞƐĨŽƌDh^ŚĂƌůĞƐƚŽŶZŽƵŶĚŝŶŐ dŚĞtŚLJ͗/ŶƉĂƚŝĞŶƚƌŽƵŶĚŝŶŐŵĂŝŶƚĂŝŶƐƚŚĞŚŝŐŚĞƐƚƋƵĂůŝƚLJŽĨĐĂƌĞĚĞůŝǀĞƌLJĂŶĚ ĐŽŶƚŝŶƵĞƐŽƵƌĐŽŵŵŝƚŵĞŶƚƚŽƉĂƚŝĞŶƚĂŶĚĨĂŵŝůLJĐĞŶƚĞƌĞĚĐĂƌĞ͕ĂŵƵůƚŝͲ ĚŝƐĐŝƉůŝŶĂƌLJĂƉƉƌŽĂĐŚƐƵƉƉŽƌƚDh^͛ƐŝĚĞĂůƐĂŶĚĞĚƵĐĂƚŝŽŶĂůŵŝƐƐŝŽŶ dŚĞ,Žǁ͗ĂŝůLJƌŽƵŶĚŝŶŐďLJƚŚĞĂƚƚĞŶĚŝŶŐĂŶĚŝŶĐůƵƐŝŽŶŽĨƚŚĞƉĂƚŝĞŶƚ͕ĨĂŵŝůLJĂŶĚ ŵƵůƚŝͲĚŝƐĐŝƉůŝŶĂƌLJƚĞĂŵŝŶƚŚĞĚŝƐĐƵƐƐŝŽŶŽĨĐĂƌĞƉůĂŶƐ WĂƚŝĞŶƚĂŶĚĨĂŵŝůLJĂƌĞĐƌŝƚŝĐĂůƉĂƌƚŶĞƌƐŽŶƚŚĞĐĂƌĞƉůĂŶ /ŶĨŽƌŵĂƚŝŽŶ ĚŝƚƐǁŝůůďĞŵĂĚĞĂŶĚƐĞŶƚďĂĐŬƚŽD ƚŽǀŽƚĞ WĂƚŝĞŶƚŝƐŵŝƐƐĂůƉƌŽĐĞƐƐ KŶŽĐĐĂƐŝŽŶŝƚŝƐŶĞĐĞƐƐĂƌLJĨŽƌĂƉŚLJƐŝĐŝĂŶƚŽĚŝƐŵŝƐƐĂƉĂƚŝĞŶƚ tĞŵƵƐƚĨŽůůŽǁƚŚĞƉƌŽƉĞƌƉƌŽĐĞĚƵƌĞƚŽĞŶƐƵƌĞƚŚĞƉĂƚŝĞŶƚŝƐŶŽƚĂďĂŶĚŽŶĞĚĂŶĚ ƚŚĂƚǁĞĂƌĞŝŶĐŽŵƉůŝĂŶĐĞ WŚLJƐŝĐŝĂŶƐƐŚŽƵůĚĐŽŶƚĂĐƚZŝƐŬDĂŶĂŐĞŵĞŶƚĨŽƌĂƐƐŝƐƚĂŶĐĞŝŶĚŽĐƵŵĞŶƚĂƚŝŽŶĂŶĚ ƉƌŽĐĞĚƵƌĞ ŽŶƐĞŶƚ/ƚĞŵƐ WŽůŝĐŝĞƐĨŽƌƉƉƌŽǀĂů͗ x & 3DWLHQWDQG)DPLO\1XWULWLRQ(GXFDWLRQ WŽůŝĐŝĞƐ x &86*,93ROLF\ ƉƉƌŽǀĞĚ /ŶĨŽƌŵĂƚŝŽŶ ;ŽŶƐĞŶƚͿ x :73RLQWRI&DUH7HVWLQJ x 3&6SHFLPHQ&ROOHFWLRQDQG5HTXLVLWLRQ W ^ƚĂŶĚŝŶŐKƌĚĞƌƐ ^ƚĂŶĚŝŶŐKƌĚĞƌƐĨŽƌƉƉƌŽǀĂů͗ /ŶĨŽƌŵĂƚŝŽŶ ;ŽŶƐĞŶƚͿ 1RQHDWKLVWLPH KƚŚĞƌŽŶƐĞŶƚ/ƚĞŵƐ ŶͬĂ Eͬ ;ŽŶƐĞŶƚͿ ĂƚĂΘ^ĞƌǀŝĐĞZĞƉŽƌƚƐ ĂƚĂƌĞƉŽƌƚƐƌĞǀŝĞǁĞĚ͗ ^ĞƌǀŝĐĞƌĞƉŽƌƚƐƌĞǀŝĞǁĞĚ͗ ;ŽŶƐĞŶƚͿ ĚŵŝƚdƌĂŶƐĨĞƌZĞƉŽƌƚ ŝƐĐŚĂƌŐĞ^ƵŵŵĂƌLJdƵƌŶĂƌŽƵŶĚdŝŵĞ o ƉƉƌŽǀĞĚ ĚŵŝƚdƌĂŶƐĨĞƌZĞƉŽƌƚ&zϭϵ ŝƐĐŚĂƌŐĞĞƚĂŝůddďLJWŚLJƐŝĐŝĂŶ /ŶĨŽƌŵĂƚŝŽŶ o o zdĞŶƐƵƐZĞƉŽƌƚϮϬϭϴͲϮϬϭϵ o ,ĂŶĚ,LJŐŝĞŶĞ:ƵůLJϮϬϭϵ ^ƵďĐŽŵŵŝƚƚĞĞDŝŶƵƚĞƐ /ͬŽĚŝŶŐYW/ŽŵŵŝƚƚĞĞ /ŶĨŽƌŵĂƚŝŽŶ ƉƉƌŽǀĞĚ ;ŽŶƐĞŶƚͿ ůŝŶŝĐĂů>ĂďĚǀŝƐŽƌLJŽŵŵŝƚƚĞĞ ƌĞĚĞŶƚŝĂůŝŶŐŽŵŵŝƚƚĞĞ ΎΎΎKE&/ Ed/>͗^^ddhd ^ϰϬͲϳϭͲϭϬΘϰϬͲϳϭͲϮϬƉƌŽƚĞĐƚƚŚŝƐĚŽĐƵŵĞŶƚĨƌŽŵ ͘͘͘͞ĚŝƐĐŽǀĞƌLJ͕ƐƵďƉŽĞŶĂ͕ŽƌŝŶƚƌŽĚƵĐƚŝŽŶŝŶƚŽĞǀŝĚĞŶĐĞŝŶĂŶLJĐŝǀŝůĂĐƚŝŽŶ͘͘͘͟ΎΎΎ WĂŐĞϮŽĨϯ 0HGLFDO([HFXWLYH&RPPLWWHH 'D ŽŵŵŝƚƚĞĞ ,D/ WΘdŽŵŵŝƚƚĞĞ WĞƌŝŶĂƚĂůYƵĂůŝƚLJŽŶĨĞƌĞŶĐĞ YƵĂůŝƚLJ džĞĐƵƚŝǀĞŽŵŵŝƚƚĞĞ ĚũŽƵƌŶŵĞŶƚ dŚĞŶĞdžƚŵĞĞƚŝŶŐŽĨƚŚĞDĞĚŝĐĂů džĞĐƵƚŝǀĞŽŵŵŝƚƚĞĞǁŝůůďĞKĐƚŽďĞƌϮϭ͕ϮϬϮϬĂƚϳ͗ϯϬĂŵsŝĂtĞď dž ϴ͗ϯϬĂŵ Prabhakar Baliga, MD ͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺͺ WƌĂďŚĂŬĂƌĂůŝŐĂ͕D͕^ĞĐƌĞƚĂƌLJŽĨƚŚĞDĞĚŝĐĂů^ƚĂĨĨ
ΎΎΎKE&/ Ed/>͗^^ddhd ^ϰϬͲϳϭͲϭϬΘϰϬͲϳϭͲϮϬƉƌŽƚĞĐƚƚŚŝƐĚŽĐƵŵĞŶƚĨƌŽŵ ͘͘͘͞ĚŝƐĐŽǀĞƌLJ͕ƐƵďƉŽĞŶĂ͕ŽƌŝŶƚƌŽĚƵĐƚŝŽŶŝŶƚŽĞǀŝĚĞŶĐĞŝŶĂŶLJĐŝǀŝůĂĐƚŝŽŶ͘͘͘͟ΎΎΎ WĂŐĞϯŽĨϯ Medical Executive Committee
Medical Executive Committee Presiding: Dr. Alice Boylan Members present: Dr. Andrews, Dr. Baliga, Dr. Basco, Dr. Boylan, N. Brahney, Dr. Bundy, Dr. Carroll, Dr. Clyburn, Dr. Cina Dr. Date: October 21, 2020 Clark, Dr. Crawford, Dr. DiSalvo, Dr. DuBoise, Dr. Easterling, M. Fulton, Dr. Hart, Dr. Kowalenko, L. Kerr; Dr. Kocher, D. Meeting Place: WebEx McLean, Esq, Dr. Reeves, Dr. Russell Dr. McSwain, S. Scarbrough, Dr. D. Scheurer, Dr. Warr Recording: M. Carroll Members excused: Dr. Atz, Dr. Brendle, Dr. Costello, Dr. Edwards, R. Ellis, Dr. Habib, Dr. Hong; Dr. Leddy, Dr. Paolini, Dr. Salgado Meeting Time: 7:30 am Dr. M Scheurer, Dr. Streck, Dr. Zaas, Dr. Zwerner Adjournment: 8:30 am Guests: Allison Fabick Recommendation/ Agenda/Topic Debate & Discussion Conclusions Follow-Up What/When/Who Executive Session n/a n/a Review of Minutes Minutes from September MEC meeting approved Information Approved Dr. Edwards reported the following: Medical Staff Initial Appointment and Clinical Privileges: 20 MEC Medical Staff Reappointment and Clinical Privileges: 18 recommends the Application Type: Reappointment and Clinical Privileges: Status Active Provisional:2 appointments, Application Type: Reappointment and Clinical Privileges: Status Administrative / Honorary 1 Credentials Committee reappointments Application Type: Reappointment and Clinical Privileges: Status: Affiliate:1 Dr. Edwards and delineation Medical Staff Reappointment and Change in Clinical Privileges: 0 of clinical
Medical Staff Change in Privileges: 2 privileges for Professional Staff Initial Appointment and Clinical Privileges: 8 Board of Professional Staff Reappointment and Clinical Privileges: 26 Trustees approval. Application Type: Reappointment and Clinical Privileges: Status: Provisional Allied Health: 13 Professional Staff Changes in Privileges: 0 GME Report 10 year ACGME self-study is completed. Site visit will happen in 2023 Information Dr. Clyburn Resident’s concerns with work load in CVICU- CVICU improvement team notified Overall Score 2.1 COVID: 180-day bar on repeat PRC testing; Saliva testing on the horizon; staff Quality Report continues to self-monitor and screen for symptoms; if they have any symptoms, Information 20_10_21 MEC Dr. Bundy Bundy.pptx should not report to work and seek testing Quality department reorganization – New Ethics Director Grant Goodrich CVICU group is meeting; Medical Directors are taking action; meeting monthly;
expanding group and adding senior leaders to discussion; will continue to report Communication’s Report out Information Dr. Warr
***CONFIDENTIAL: SC STATUTE S40-71-10 & 40-71-20 protect this document from “...discovery, subpoena, or introduction into evidence in any civil action...”*** Page 1 of 3 Medical Executive Committee
New Business Annual Staff Meeting being held Via Web Ex 11/19/2020 5:30 pm; Membership invited; time to elect new Secretary; Nominations requested from membership and will be forwarded to Nomination Committee MEC endorses the attached Guiding Principles for MUSC rounding; Patient and Guiding Principles for MUSC Charleston Family focused; speaks to core values and will be adopted Policy Change standing and Verbal orders: Information 1. In patient observational encounters signed in 96 hours; 14days for ambulatory
encounter. Rules and Regs 2. Delinquent notes will be forwarded to administrator for review; if no Revision - Standing resolution the issue will be forwarded to peer review
Consent Items Policies for Approval: Policies C-144B Pediatric Parenteral Nutrition - PN - and Intravenous Lipid Emulsion – IL Information (Consent) C-014 Emergency Medical Response Approved
Standing Orders for Approval: Standing Orders GI Medicine and GI Surgery Prescription Refill Standing orders was approved by Information Approved (Consent) MEC email vote between the October and November meeting Other Consent Items n/a N/A (Consent) Data & Service Reports Data reports reviewed: Service reports reviewed: (Consent) Admit Transfer Report Discharge Summary Turnaround Time o Approved Admit Transfer Report FY19 Discharge Detail TAT by Physician Information o o YTD Census Report 2018-2019 o Hand Hygiene July 2019 Subcommittee Minutes Credentialing Committee (Consent) HMIC Information Approved P&T Committee
Peer Review Committee Sedation Committee Adjournment The next meeting of the Medical Executive Committee will be November 18, 2020 at 7:30 am Via WebEx 8:30 am
***CONFIDENTIAL: SC STATUTE S40-71-10 & 40-71-20 protect this document from “...discovery, subpoena, or introduction into evidence in any civil action...”*** Page 2 of 3 Medical Executive Committee
Prabhakar Baliga, MD ______Prabhakar Baliga, MD, Secretary of the Medical Staff
***CONFIDENTIAL: SC STATUTE S40-71-10 & 40-71-20 protect this document from “...discovery, subpoena, or introduction into evidence in any civil action...”*** Page 3 of 3 AGREEMENTS ENTERED INTO SINCE THE OCTOBER 2020 MEETING OF THE BOARD OF TRUSTEES
Hospital Services - Any contract involving the exchange of Hospital services either for money or other services.
Managed Care – Th e Medical Center has entered a Managed Care Agreement with the following:
Humana Choice Care VA United Healthcare Insurance Blue Cross and Blue Shield of South Carolina BCBSSC – State Health Plan (PEBA) BlueChoice Medicaid_ branches of DHHS BCBSSC – Preferred Blue
Transplant Agreements - For the institution(s) listed below, the Medical Center Transplant Unit agrees to provide tissue typing and transplantation to those patients who are medically suitable and to follow those patients in the transplant clinic at MUSC.
Transfer Agreements - MUHA agrees to accept the admission of individuals requiring specialized care and meet certain criteria from the following facilities:
MUHA d/b/a MUSC Health Marion Medical Center MUHA d/b/a MUSC Health Florence Medical Center MUHA d/b/a MUSC Health Marion Medical Center MUSC Health Marion Medical Center (x4) The Eye and Laser Center
Affiliation Agreements –
Weber State University Graceland University Excelsior College Queens University at Charlotte Eastern Virginia Medical School The George Washington University South Carolina Midlands Emergency Medical Service Management Association Simmons University (x2) Massachusetts College of Pharmacy and Health Sciences The Board of Trustees of The University of Alabama for The University of Alabama at Birmingham
Shared Services Agreements –
MUHA FY21 Capital Projects December 2020
Proj # Description Total Project Budget FY21 Funding FY 21 Invoiced FY 21 Balance A/E Contractor Status Projected Final Completion
200035 EH Phase 2 Lab Renovation $2,000,000 $1,290,000 $0 $1,290,000 GMC Stenstrom Construction April 2021 170047 ART ECRP Phase 2 & Holding $925,000 $925,000 $0 $925,000 TBD 180112 UH 4th Floor Burn Clinic $500,000 $375,000 $172,500 $202,500 C5P Redan Construction Complete 200033 EH 6th Floor NIR Room 1 $700,000 $650,000 $141,569 $508,431 JSA MBK Construction January 2021 190064 ART CPC $3,000,000 $1,144,000 $60,000 $1,084,000 MPS CSG Construction January 2021 190085 ART EP 6/7 $900,000 $810,000 $512,000 $298,000 Liollio Medpro Construction November 2020 190071 UH 377 MRI Replacement $600,000 $489,000 $4,000 $485,000 C5P Satchell Construction March 2021 190093 RT Memory Care (Donor Funded Project) $900,000 900000 $567,000 $333,000 Doyle Medpro Construction Complete 210016 Cath Lab 10 $475,000 $475,000 $0 $475,000 Liollio Design June 2021 210016 Cath Lab 13 $475,000 $475,000 $0 $475,000 Liollio Design June 2021 210026 ART Gamma camera room $250,000 $250,000 $0 $250,000 Liollio Design June 2021 EH-VIR 5th Floor (Room 3) $250,000 $250,000 $0 $250,000 3rd Qtr StartTBD EH-IR Angio 5th Floor (Room 2) $250,000 $250,000 $0 $250,000 TBD 190067 Parkshore 3rd Floor Reno East (Sute 350) $1,323,972 $1,323,972 $91,000 $1,232,972 MPS Construction March 2021 Parkshore 1st Floor Renovation $335,141 $335,141 $0 $335,141 TBD Parkshore 3rd Floor West Renovation $337,792 $150,000 $0 $150,000 TBD Sleeplab $1,000,000 $850,000 $0 $850,000 HOLD TBD CH - Cooling Tower $2,500,000 $393,443 $0 $393,443 HOLD TBD UH- Relocate ATC $250,000 $250,000 $0 $250,000 HOLD TBD
CAPITAL TOTAL $11,585,556
MUHA FY21 Expense Projects > $250,000
190036 Parkshore Exterior Sealing $350,000 $350,000 $190,000 BEE Mint Hill Construction Complete University Active Project List > $250,000 December 2020
MUSC Approved Funds Committed Balance to Projected Final Project # Description Budget to Date Finish A/E Contractor Status Completion
Approved Projects 9834 IOP Chiller # 2 Replacement $2,500,000 $281,775 $2,218,225 MECA McCarter Award Pends December 2021 9835 Energy Performance Contract $30,000,000 $25,092,765 $4,907,235 Ameresco Ameresco Construction June 2021 9840 BSB Envelope Repairs (Roof) $7,000,000 $2,610,700 $4,389,300 REI Bone Dry Construction July 2021 9841 SEI Chiller Replacement $2,500,000 $2,493,746 $6,254 MECA McCarter Construction March 2021 9845 BSB Replace AHU 5 and 3 with new AHU $1,200,000 $269,107 $930,893 RMF Design August 2021 9846 Pharmacy Addition/Innov Instruc Classroom Renov $58,000,000 $5,340,190 $52,659,810 Compass 5 Whiting Turner GMP Award Pends August 2022 9847 HCC Mechanical Systems Replacement $3,500,000 $235,000 $3,265,000 RMF CR Hipp Award pends December 2020 9848 BSB Replace AHU #4 and #4A (serve animal area) $1,700,000 $63,000 $1,637,000 RMF Triad Budget Inc SFAA Approval Pends June 2021 9851 BSB AHU #1 Replacement $4,950,000 $344,525 $4,605,475 RMF Design December 2021 9852 MUSC Combined Heat & Power Facility $1,500,000 $1,500,000 $0 Ameresco Design Design July 2021 50077 DDB Exterior Envelope Repairs $650,000 $554,000 $96,000 BEE Watts Construction December 2020 50082 PG2 Elevator Renovation $750,000 $475,000 $275,000 E&F in house American Construction March2021 50085 Misc Roof Replace/Repairs $400,000 $40,000 $360,000 BEE Design June 2021 50086 UH to Quad F & HCC CW Connection (Item 5) $921,452 $48,750 $872,702 MECA Bidding June 2021 50087 CSB & UH 10 " CW Connection (Item 12) $814,252 $28,500 $785,752 MECA Bidding June 2021 50095 T-G Humidifier Replacement $700,000 $33,000 $667,000 RMF HOLD for protest June 2021 50096 Walton ATS Replacement $600,000 $365,000 $235,000 RMF Metro Construction June 2021 50100 IOP Sleep Lab $990,000 74,595 $915,405 Liollio HOLD per COM TBD 50111 BEB Exterior Envelope Repairs $850,000 $819,000 $31,000 BEE Watts Construction December 2020 50112 T-G Replace Boiler DA Tank $800,000 $780,000 $20,000 RMF McCarter Construction December 2020 50114 Wellness Center Downstairs Locker & Free Weight $750,317 $610,000 $140,317 Coe Satchel Construction September 2020 50117 CHP Bookstore Renovation $625,000 $448,000 $177,000 MPS Chastain Construction March 2021 50118 CSB Primary Transformer Replacement $925,000 $56,200 $868,800 GWA Design June 2021 50120 HCC 4th Floor Roof Replacement $975,000 $0 $975,000 Design Proposal Pends TBD 50121 Walton Research Building Roof Replacement $400,000 $0 $400,000 Design Proposal Pends TBD 50122 CSB Fuel Tanks Replacement $900,000 $0 $900,000 Design Proposal Pends TBD 50123 CODM Clinics Building Cooling Tower Upgrade $980,000 $0 $980,000 Design Proposal Pends TBD 50124 CSB Cooling Tower Piping Upgrade $300,000 $0 $300,000 Design Proposal Pends TBD 50125 IOP Cooling Tower Upgrade $980,000 $0 $980,000 Design Proposal Pends TBD 50126 Miscs Research Hoods Phoenix Control Upgrades $450,000 $0 $450,000 Design Proposal Pends TBD 50127 DDB Air Cooled Chiller Replacement $400,000 $0 $400,000 Design Proposal Pends TBD 50128 BSB Chiller #6 Replacement $900,000 $0 $900,000 Design Proposal Pends TBD MEDICAL UNIVERSITY OF SOUTH CAROLINA CONSTRUCTION CONTRACTS FOR REPORTING DECEMBER 10, 2020
MUSC Indefinite Delivery Releases:
Stenstrom & Associates $ 68,501.00 MUSC Psychiatric Hospital Roof Repairs
MUSC General Construction Projects:
Chastain Construction Inc.. $ 387,000.00 President Street Garage Elevator Modernization
C.R. Hipp Construction Inc. $3,049,300.00 Hollings Cancer Center Mechanical Equipment Replacement
McCarter Mechanical Inc. $2,500.000.00 Psych Institute Chiller #1 Replacement
Metro Electric Company Inc. $ 285,000.00 MUSC Walton Research Building ATS Replacement
Satchel Construction LLC $ 543,419.00 Wellness Center Downstairs Locker and Free Weight Rooms Renovation
MEDICAL UNIVERSITY OF SOUTH CAROLINA PROFESSIONAL SERVICES FOR REPORTING DECEMBER 10, 2020
MUSC Indefinite Delivery Releases
BEE Group $80,355.00 Consulting Services Roof Survey and Roof Management Plan
Other Contracts
RMF Engineering, Inc. $280,150.00 BSB Air Handler Unit #1(West Side) Replacement
Ameresco, Inc. $1,500,000.00 MUSC Combined Heat and Power Facility
IDC Contracts
S&ME, Inc.
Indefinite Delivery Contract to provide Industrial Hygiene Services on an as-needed basis over a two year period throughout the campus. Services not to exceed $500,000 with individual releases not to exceed $200,000.
ESP Associates Inc.
Indefinite Delivery Contract to provide Industrial Hygiene Services on an as-needed basis over a two year period throughout the campus. Services not to exceed $500,000 with individual releases not to exceed $200,000. MEDICAL UNIVERSITY OF SOUTH CAROLINA (MUSC) BOARD OF TRUSTEES CONSENT AGENDA December 11, 2020 101 Colcock Hall/Via Teleconference
Education, Faculty & Student Affairs Committee: Ms. Barbara Johnson-Williams, Chair
Consent Agenda for Approval
Item 22. Institutional Commitment to Graduate Medical Education ...... Dr. Benjamin Clyburn Associate Dean for Graduate Medical Education
Item 23. Endowed Chair Appointments ...... Dr. Lisa Saladin Executive Vice President for Academic Affairs and Provost
College of Medicine Lee R. Leddy, M.D., Professor and Chair in the Department of Orthopaedics and Physical Medicine, for appointment to the John A. Siegling, M.D., Endowed Chair in Orthopaedic Surgery, effective December 11, 2020.
Yiannis Koutalos, Ph.D., Professor in the Department of Ophthalmology for appointment to the Barbara And Stanley Andrie Endowed Chair for Bioengineering and Vision Research, effective December 11, 2020.
Ryan Tedford, M.D., Professor, in the Department of Medicine for appointment to the Dr. Peter C. Gazes Endowed Chair in Congestive Heart Failure, effective December 11, 2020.
Item 24. Distinguished University Professor ...... Dr. Lisa Saladin Executive Vice President for Academic Affairs and Provost
College of Medicine Craig E. Crosson, Ph.D., Professor, Department of Ophthalmology, for appointment as Distinguished University Professor, effective December 11, 2020.
William P. Moran, M.D., Professor, Department of Medicine, for appointment as Distinguished University Professor, effective December 11, 2020.
Robert K. Stuart, M.D., Professor, Department of Medicine, for appointment as Distinguished University Professor, effective December 11, 2020.
College of Health Professions Steven A. Kautz, Ph.D., Professor, Department of Health Sciences and Research, for appointment as Distinguished University Professor, effective December 11, 2020.
Item 25. Affiliate Faculty Appointments ...... Dr. Lisa Saladin Executive Vice President for Academic Affairs and Provost
College of Pharmacy R. Khan, Ph.D., as Affiliate Professor, in the Department of Drug Discovery and Biomedical Sciences, effective July 1, 2020. College of Medicine Joseph Romagnuolo, M.D., as Affiliate Professor, in the Department of Medicine, Division of Gastroenterology and Hepatology, effective September 1, 2020
Item 26. Faculty Appointments ...... Dr. Lisa Saladin Executive Vice President for Academic Affairs and Provost
College of Medicine Anne Marie Albano, Ph.D. as Adjunct Professor, in the Department of Psychiatry and Behavioral Sciences, retroactive to March 15, 2020
Neena L. Champaigne, M.D., as Clinical Associate Professor, in the Department of Pediatrics, Division of Pediatric Genetics, effective December 1, 2020
College of Health Professions Michael Madson, Ph.D., as Adjunct Associate Professor in the Department of Clinical Sciences, Division of Healthcare Studies, effective August 7, 2020.
College of Pharmacy Vanessa A. Fitsanakis, Ph.D., as Affiliate Professor, in the Department of Drug Discovery and Biomedical Sciences, effective July 1, 2020
Jeffrey J. Pu, M.D. Ph.D., [joint appointment] as Associate Professor, in the Department of Drug Discovery and Biomedical Sciences, effective August 1, 2020. Dr. Pu’s primary appointment rests in the College of Medicine, Department of Medicine, Division of Hematology/Oncology, with dual appointment as Associate Professor, in the Department of Microbiology and Immunology.
Item 27. Emeritus / Emerita ...... Dr. Lisa Saladin Executive Vice President for Academic Affairs and Provost
College of Medicine Donald Lee Fylstra, M.D., from Professor to Professor Emeritus, in the Department of Obstetrics and Gynecology, Division of Benign OB, effective July 1, 2020.
Louis Michael Luttrell, M.D., Ph.D., from Professor to Professor Emeritus, in the Department of Medicine, Division of Endocrinology effective January 1, 2021.
Petra K. Warren., M.D. from MUSC AHEC Assistant Professor (Spartanburg/Family Medicine), to MUSC AHEC Assistant Professor Emerita (Spartanburg/Family Medicine), effective to July 1, 2020
College of Pharmacy C. Wayne Weart, Pharm.D., from Professor to Professor Emeritus, in the Department of Clinical Pharmacy and Outcome Sciences, effective July 1, 2020.
Item 28. Change in Faculty Status ...... Dr. Lisa Saladin Executive Vice President for Academic Affairs and Provost
College of Medicine John B. Cahill Jr., M.D. from Professor to Clinical Professor in the Department of Pediatrics, Division of Pediatric Neonatology, effective June 1, 2020
Thomas B. Naselaris, Ph.D., from Associate Professor to Adjunct Associate Professor, in the Department of Neuroscience, effective November 1, 2020
Item 29. Faculty Tenure ...... Dr. Lisa Saladin Executive Vice President for Academic Affairs and Provost
College of Medicine Jeffrey J. Pu, M.D., Ph.D., Associate Professor with Tenure, on the academic clinician track, effective August 1, 2020.
Item 30. College of Health Professions Department Split ...... Dr. Lisa Saladin Executive Vice President for Academic Affairs and Provost
Approval is requested to split the College of Health Professions, Department of Health Professions into two departments, Department of Rehabilitation Sciences and Department of Clinical Sciences effective September 1, 2020.
Item 31. Faculty Appointment Transfers ...... Dr. Lisa Saladin Executive Vice President for Academic Affairs and Provost
College of Health Professions Approval is requested to transfer the following faculty appointments from the Department of Health Professions to the Department of Rehabilitation Sciences, effective September 1, 2020.
Department of Rehabilitation Sciences, Division of Occupational Therapy Shirley L. Anderson, BS, Instructor Hazel L. Breland, PhD, FAOTA, OTR/L, Associate Professor Nancy E. Carson, PhD, FAOTA, OTR/L, Professor Patricia C. Coker-Bolt, PhD, OTR/L, FAOTA, FNAP, Professor Amanda K. Giles, OTD, OTR/L, Associate Professor Emily S. Grattan, PhD, OTR/L, Assistant Professor Tambra Prantner-Marik, OTD, OTR/L, CHT, Assistant Professor Amanda Sammons, DSc, OTR/L, ATC, Assistant Professor Na Jin Seo, PhD, Associate Professor Cristina Reyes Smith, OTD, OTR/L, CHT, Assistant Professor Craig A. Velozo, PhD, OTR/L, FAOTA, Professor Peter J. Bowman, MHS, OTD, Assistant Professor Emeritus Michelle L. Woodbury, PhD, OTR/L, Associate Professor Elizabeth J. Crawford, OTD, OTR/L, Adjunct Instructor Scott D. Hutchison, OTD, MSR, Adjunct Instructor Annika Z. Jansson, MSOT, OTR/L, Adjunct Instructor Monica D. Keen, OTD, OTR/L, Adjunct Instructor Rebecca J. McFalls, MHS, OTR/L, Adjunct Instructor Brenda Batten Reagan, MS, Adjunct Instructor Kelly Callahan Rishe, MSOT, OTR/L, Adjunct Instructor Bridget Scheidler, OTR/L, CAPS, Adjunct Instructor Donna Tisdale, MHS, OTR/L, Adjunct Instructor
Department of Rehabilitation Sciences, Division of Physical Therapy Mark G. Bowden, PT, PhD, Associate Professor Sandra S. Brotherton, PT, PhD, CEEAA, Professor Debora D. Brown, PT, DPT, FNAP, Professor Jesse C. Dean, PhD, Associate Professor Cynthia Brown Dodds, PT, PhD, PCS, Associate Professor Rebecca C. English, DPT, Instructor Zoher F. Kapasi, PhD, PT, MBA, FAPTA, Professor Sara Knox, PT, PhD, DPT, Assistant Professor Sara V. Kraft, PT, DPT, NCS, ATP, Associate Professor Stephanie K. McGowan, PT, DSc, OCS, Assistant Professor Eric D. Monsch, PT, DPT, NCS, Instructor David C. Morrisette, PT, PhD, OCS, ATC, FAAOMPT, Professor Lisa S. Saladin, PT, PhD, FAPTA, Professor Richard L. Segal, PT, PhD, FAPTA, Professor Gretchen A. Seif, PT, DPT, MHS, OCS, FAAOMPT, Associate Professor David O. Sword, PT, DPT, CCS, CEP, CSCS, Associate Professor K. Jackson Thomas, PT, EdD, Professor Holly P. Wise, PT, PhD, FNAP, Professor Christopher M. Gregory, PhD, PT, Associate Professor Susan J. Middaugh, PhD, Professor Steve A. Kautz, PhD, Professor Patricia Day Bennett, PT, DPT, OCS, Adjunct Instructor William G. Boissonneault, DHSc, Adjunct Associate Professor Maureen C. Cron, PT, DPT, NCS, Adjunct Instructor Matthew V. Fansler, PT, DPT, Adjunct Instructor Sinead O. Farrelly, PT, DPT, NCS, Adjunct Instructor Dana Meadows, PT, DPT, Adjunct Instructor Michelle McLeod, PhD, ATC, PES, Adjunct Instructor Dana Meadows, PT, DPT, Adjunct Instructor Erica J. Pfieffer, DPT, Adjunct Instructor Nathan K. Harris, PT, DPT, ATC, CSCS, Adjunct Instructor Jodie M. Smith, PT, DPT, COMT, OCS, Adjunct Instructor Jason St. Clair, DPT, Adjunct Instructor Michael Timko, PT, MS, FAAOMPT, Adjunct Instructor Tara V. Wilson, PT, DPT, NCS, Adjunct Instructor David W. Comeau, PhD, Affiliate Instructor Mark J. Rutledge, MHS, Affiliate Instructor James Price Stoker, MA, Affiliate Instructor
Department of Rehabilitation Sciences, Division of Speech Language Pathology Heather Shaw Bonilha, PhD, CCC-SLP, Professor Diane A. Andrews, MS, Affiliate Assistant Professor Julie A. Blair, MA, Affiliate Instructor Heather C. McGhee, MS, Affiliate Instructor Nevitte S. Morris, MSP, Affiliate Instructor Audra K. Schiller, MSR, Affiliate Instructor Kristen Dye Thayer, MS, Affiliate Instructor Caroline Mitchell Warren, MS, Affiliate Instructor
Item 32. Faculty Appointment Transfers ...... Dr. Lisa Saladin Executive Vice President for Academic Affairs and Provost
College of Health Professions Approval is requested to transfer the following faculty appointments from the Department of Health Professions to the Department of Clinical Sciences, effective September 1, 2020.
Department of Clinical Sciences, Division of Anesthesia for Nurses Michelle M. Ballister, DNP, APRN, CRNA, CHSE, Associate Professor Christine Coe, APRN, MHS, CRNA, Assistant Professor Brian Gegel, DNAP, CRNA, Assistant Professor Candace B. Jaruzel, PhD, MSN, CRNA, Associate Professor Angela R. Mund, DNP, CRNA, Associate Professor Thomas Gauderman, DC, BSN, RN, PHN, Adjunct Instructor Dennis J. McKenna, CRNA, DNAP, Adjunct Assistant Professor Gina Orr, CRNA, Adjunct Instructor Lisa Rogers, DNAP, CRNA, Adjunct Assistant Professor Benjamin E. Thomas, MSNA, Adjunct Instructor Brittany T. Benson, MSNA, CRNA, Affiliate Instructor Shanna A. Black, MSNA, CRNA, Affiliate Instructor Bethany Bradley, CRNA, MSNA, BSN, Affiliate Instructor Ginger L. Brister, MHS, Affiliate Instructor Robin Thompson Buchanan, MHS, Affiliate Instructor Jennifer Gottlieb Caldwell, MSNA, Affiliate Instructor Jennifer L. Cannon, MSNA, Affiliate Instructor Leslie Anne Stewart Cerenzia, MS, Affiliate Instructor Alyssa W. Cleveland, CRNA, Affiliate Instructor Kathleen Comley, MSN, Affiliate Instructor Annette Waldo Cooper, MSNA, Affiliate Instructor Keara L. Cox, MS, Affiliate Instructor Susan Cox Craven, MNA, Affiliate Instructor Rhiannan Mize Davis, CRNA, Affiliate Instructor Tina L. Davis, MSNA, Affiliate Instructor Donna B. Embrey, MS, Affiliate Instructor Debra L. Feller, MSN, Affiliate Instructor Marianne O’Connell Fiutem, MHS, Affiliate Instructor Cecilia A. Franko, MHS, CRNA, Affiliate Instructor Myra Coe Frick, MSNA, Affiliate Instructor Alexandra Garcia, CRNA, MSNA, BSN, Affiliate Instructor Jennifer L. Hale, MSNA, CRNA, Affiliate Instructor Helen E. Harman, BSN, Affiliate Instructor Susan S. Heath, BSN, Affiliate Instructor Heather N. Highland, MSNA, Affiliate Instructor Elizabeth Lawton Grantham Hirsch, MSNA, CRNA, Affiliate Instructor Phillip G. Ivy, MSNA, Affiliate Instructor Elizabeth A. Jennings, MHS, CRNA, Affiliate Instructor Jennifer M. Jones, MSN, Affiliate Instructor Christopher A. Keto, CRNA, Affiliate Instructor Kimberly A. Kirby, MHS, Affiliate Instructor Lester J. Kitten, MHS, Affiliate Instructor Tammy J. Lamont, MHS, Affiliate Instructor Rachel K. Lynn, MSNA, Affiliate Instructor James H. Mahaffee, CRNA, Affiliate Instructor Lynn McInerny, MSNA, Affiliate Instructor Regan R. McKinney, MSNA, Affiliate Instructor Rita J. Meyers, MHS, Affiliate Instructor Alice Forrester Michaux, MSNA, CRNA, Affiliate Instructor Theresa L. Morgan, MSNA, Affiliate Instructor Elizabeth A. Norton, MS, CRNA, Affiliate Instructor Donald R. Pagley, Jr., MHS, Affiliate Instructor Melissa A. Paladino, MSN, CRNA, Affiliate Instructor Michael R. Rose, MD, Affiliate Instructor Marianna Polito Ross, CRNA, Affiliate Instructor Regan Walsh Saxton, MHS, CRNA, Affiliate Instructor Amy Jo Schmoll, MSNA, Affiliate Instructor Milton J. Seymour III, MS, Affiliate Instructor Anthony M. Sloan, CRNA, Affiliate Instructor Amy Leatherman Smith, MS, Affiliate Instructor Martha M. Smith, BSN, CRNA, Affiliate Instructor Margaret Ann Winnicki Stark, MSNA, Affiliate Instructor George R. Sweet, BS, Affiliate Instructor Jane Hanahan Swing, MSN, CRNA, Affiliate Instructor Samuel V. Tripp, MSNA, Affiliate Instructor Laura A. Uebelhoer, MHS, Affiliate Instructor Jodi Lynn Brendes Weber, MHS, Affiliate Instructor Tamara J. Weis, CRNA, MSN, Affiliate Instructor Adrianne E. West, MSN, Affiliate Instructor Sarah Enoch White, MS, Affiliate Instructor Raymond M. White, MSNA, Affiliate Instructor
Department of Clinical Sciences, Division of Cardiovascular Perfusion Laura Dell’Aiera, MHA, CCP, Instructor David C. Fitzgerald, CCP, MPH, DHA, Assistant Professor Joseph J. Sistino, PhD, CCP, Professor Emeritus Desiree K. Bonadonna, MPS, FPP, CCP, LP, Adjunct Instructor Jeffrey R. Acsell, MPS, CCP, Affiliate Assistant Professor Dafne A. Chianella, BS, Instructor Affiliate Heidi M. Frear, BS, Instructor Affiliate Mary Martschink McCall, MSN, CCP, Affiliate Assistant Professor Anthony G. Shackelford, DHA, CCP, Affiliate Assistant Professor Alicia N. Sievert Stone, MS, CCP, Affiliate Assistant Professor Catherine J. Yeager, BS, Affiliate Instructor
Department of Clinical Sciences, Division of Healthcare Studies Elizabeth A. Brown, PhD, MPA, Assistant Professor Lauren Gellar, PhD, MS, MCHES, Associate Professor Ashley L. Hamm, MPH, CHES, Adjunct Instructor Michael J. Madson, PhD, Adjunct Associate Professor Annie Thibault, MS, Adjunct Instructor
Department of Clinical Sciences, Division of Physician Assistant Studies Clint C. Blankenship, PharmD, PA-C, Associate Professor Gilbert A. Boissonneault, PhD, PA-C, Professor Christopher R. Chillura, PA-C, MSPAS, Assistant Professor Matthew K. Ewald, MPAS, PA-C, Assistant Professor Helen S. Martin, DHSc, PA-C, DFAAPA, Associate Professor Patrick M. McNeal, PA-C, Instructor Leslie Prager Woodall, MSPAS, PA-C, Assistant Professor David M. Countryman, MD, Assistant Professor Edward C. O’Bryan III, MD, Associate Professor Crispin F. Reeves, MS, Instructor Suzanne Thomas, PhD, Professor Megan Diminich Bunch, MHS, PA-C, Adjunct Instructor Kristen L. Canady, PA-C, Adjunct Instructor Jessica Casey, PA-C, Adjunct Instructor Rebecca Cumbee, PA-C, Adjunct Instructor Heather Short Duggen, PA-C, Adjunct Instructor Jennifer Fralix, MSPAS, PA-C, Adjunct Instructor Megan Bales Fulton, MPAS, Adjunct Instructor Martha Rawlings Green, MSPAS, Adjunct Instructor Ashley L. Hamm, MPH, CHES, Adjunct Instructor Lindsay T. Heffner, PA-C, Adjunct Instructor Heather E. Helble, PA-C, Adjunct Instructor Gina L. Hogg, PA-C, Adjunct Instructor Aislinn Hopkins, PA-C, Adjunct Instructor Benjamin F. King, PA-C, Adjunct Instructor Brittany R. Lueking, MSPAS, PA-C, Adjunct Instructor Carly, McDonald, PA-C, MMS, Adjunct Instructor Elisabeth M. Poindexter, MPA, MPAS, PA-C, Adjunct Instructor Meredith Gray Provost, PA-C, Adjunct Instructor Elizabeth S. Spitz, PA-C, Adjunct Instructor Zachary W. Sutton, MS, MSPAS, PA-C, Instructor Anna M. Swanson, PA-C, Adjunct Instructor Warren Whitworth, MS, Adjunct Instructor Nyala M. Edwards, PA-C, Adjunct Instructor Jennifer Rinker, PhD, Adjunct Instructor Sherlonda Talat Adkins, PA-C, Affiliate Instructor Kenneth H. Becker, MD, Affiliate Instructor Carol Brittsan, MPAS, Affiliate Instructor Sheri Carter Byrd, MD, Affiliate Instructor Timothy Carr, MD, Affiliate Instructor Mark W. Carroll, MD, Affiliate Instructor Corey K. Crain MD, Affiliate Instructor Karen S. Garn, PA-C, Affiliate Instructor Vonda Gravely, MD, Affiliate Instructor Reshma Khan, MD, Affiliate Instructor Scott Lancer, MD Affiliate Instructor Kim James Masters, MD, Affiliate Assistant Professor Rex S. Morgan, MD, Affiliate Instructor Philip B. Nelson, MPAS, Affiliate Assistant Professor Jesse Price, MS, MMS, PA-C, Affiliate Instructor Jerry W. Robinson, MD, Affiliate Instructor Christopher C. Stephanoff, MA, Affiliate Instructor Svetlanta Chirina Stuck, MSPAS, Affiliate Instructor Alexander Bondoc Vinuya, MD, Affiliate Instructor Eric S. Weinstein, MD, Affiliate Instructor Thomas C. Appleby, MD, Affiliate Instructor Edward C. Morrison, MD, Affiliate Instructor John T. Ramey, MD, Affiliate Assistant Professor
Finance and Administration Committee: Mr. Jim Battle, Chair
Item 33. Foundation for Research Development Financial Report ...... Michael Rusnak Executive Director, Foundation for Research Development
MEDICAL UNIVERSITY OF SOUTH CAROLINA Medical University Hospital Authority College of Medicine
Institutional Commitment to Graduate Medical Education
Medical education is a major component of the mission of the Medical University of South Carolina, the Medical University Hospital Authority and the College of Medicine. The Board of Trustees, the President of MUSC and the administrators, faculty and staff are committed to provide graduate medical education using the financial, educational and personnel resources necessary to ensure the highest quality programs. These graduate medical education programs will further our mission of educating future physicians for the State of South Carolina while providing the highest quality care for our patients to include:
- Patient Safety – including opportunities for residents to report errors, unsafe conditions and near misses, and to participate in interprofessional teams to promote and enhance safe care. - Quality Improvement – including how sponsoring institutions engage residents in the use of data to improve systems of care, reduce health care disparities and improve patient outcomes. - Transitions of Care – including how sponsoring institutions demonstrate effective standardization and oversight of transitions of care. - Supervision – including how sponsoring institutions maintain and oversee policies of supervision concordant with ACGME requirements in an environment at both the institutional and program level that assures the absence of retribution. - Duty Hour Oversight, Fatigue Management and Mitigation – including how sponsoring institutions; (i) demonstrate effective and meaningful oversight of duty hours across all residency programs institution-wide; (ii) design systems and provide settings that facilitate fatigue management and mitigation; and (iii) provide effective education of faculty members and residents in sleep, fatigue recognition and fatigue mitigation. - Professionalism – with regard to how sponsoring institutions educate for professionalism, monitor behavior on the part of residents and faculty and respond to issues concerning; (i) accurate reporting of program information; (ii) integrity in fulfilling educational and professional responsibilities; and (iii) veracity in scholarly pursuits.
We pledge to emphasize coordinated care with community physicians and to take advantage of cooperative opportunities to work with other institutions to fulfill mutual educational objectives.
We commit ourselves to provide graduate medical education programs that enable physicians in training to develop personal, clinical and professional competence under the guidance and supervision of the faculty and staff. The program directors will assure that patients receive safe, appropriate and humane care by resident physicians who will gradually assume responsibility for patient care based upon each trainee’s demonstrated clinical competence. We further commit to conduct these programs in compliance with the institutional and specific requirements of the ACGME, the Joint Commission and in accordance with all applicable federal and state laws and regulations. As a major research institution, MUSC will encourage residents to participate in a wide range of scholarly activities including research and publications.
______President, MUSC Dean, MUSC College of Medicine
______CEO, Medical University Hospital Authority Senior Associate Dean for GME ACGME Designated Institutional Official
November 2020
MUSC Foundation for Research Development
Statements of Financial Position
9/30/2020 9/30/2019
Assets
Cash and cash equivalents $286,678 $516,896 Cash and cash equivalents - held for others $753,758 $779,381 Accounts receivable - Licensees, net of allowance $176,107 $145,887 Accounts receivable - MUSC & affiliates $805,105 $876,719 Prepaid expenses $25,684 $23,510 Investments $406,762 $392,806 Investments - illiquid $84,881 $84,881 Property and equipment, net $28,908 $32,007
Total Assets $2,567,884 $2,852,087
Liabilities and Net Assets
Liabilities Accounts payable $58,816 $82,159 Accounts payable - MUSC $612,914 $683,886 Lease payable $6,756 $729 Due to MUSCP (UMA) - accrued personnel expenses $147,796 $192,145 Unearned revenue and deposits $20,000 $10,524 Funds held for others $753,758 $779,381
Total Liabilities $1,600,040 $1,748,825
Net Assets Unrestricted $893,982 $1,051,026 Board designated for technology development $73,862 $52,236 Total Net Assets $967,844 $1,103,262
Total Liabilities and Net Assets $2,567,884 $2,852,087 MUSC Foundation for Research Development Income Statement Three Months Ended September 30, 2020
Period ended 9/30/2020 FY21 Budget Actual Budget Variance
Revenues Support from MUSC Office of Provost $350,000 $350,000 $0 $1,400,000 Royalties and license fees $104,576 $60,000 $44,576 $995,000 Distributions to MUSC, inventors, departments and labs ($69,323) ($42,000) ($27,323) ($696,500) Royalties and license fees, net of distributions $35,253 $18,000 $17,253 $298,500 Investment income $4,728 $5,600 ($872) $22,400 Miscellaneous income $7,202 $5,000 $2,202 $20,000 Total Revenues $397,183 $378,600 $18,583 $1,740,900
Expenses Personnel $343,335 $355,000 $11,665 $1,339,964 Patent prosecution $70,030 $92,162 $22,132 $368,650 Professional fees $11,000 $13,700 $2,700 $30,000 Administrative expenses IT maintenance - software and hardware $5,292 $5,375 $83 $21,500 Telecommunication $1,229 $1,500 $271 $6,000 Travel - Non-employee $0 $2,125 $2,125 $8,500 Travel - Employee $0 $3,000 $3,000 $12,000 Professional development-conferences & continuing educ $335 $2,500 $2,165 $10,000 Office supplies, support and equipment $2,040 $4,500 $2,460 $18,000 Real property rental $19,500 $15,500 ($4,000) $62,000 Lease payments $1,019 $1,125 $106 $4,500 Insurance $3,899 $3,900 $1 $15,600 Dues, memberships, subscriptions and sponsorships $5,000 $3,125 ($1,875) $12,500 Special activities $258 $2,575 $2,317 $10,300 Depreciation expense $2,635 $2,650 $15 $10,600 Total Administrative expenses $41,206 $47,875 $6,669 $191,500
Total Expenses $465,571 $508,737 $43,167 $1,930,114
NET SURPLUS/(DEFICIT) ($68,388) ($130,137) $61,750 ($189,214)